Management - Canis Learning Systems
Transcription
Management - Canis Learning Systems
Management Course: Health Care Administration MBAHC−9 California College for Health Sciences MBA Health Care Program abc McGraw-Hill/Irwin McGraw−Hill Primis ISBN: 0−390−55206−2 Text: Effective Behavior in Organizations, Seventh Edition Cohen Harvard Business Review Industry and Competitive Strategy Articles Harvard Business School POM Cases Harvard Business Review Service Management Articles Contemporary Management, Fourth Edition Jones−George This book was printed on recycled paper. Management http://www.mhhe.com/primis/online/ Copyright ©2005 by The McGraw−Hill Companies, Inc. All rights reserved. Printed in the United States of America. Except as permitted under the United States Copyright Act of 1976, no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system, without prior written permission of the publisher. This McGraw−Hill Primis text may include materials submitted to McGraw−Hill for publication by the instructor of this course. The instructor is solely responsible for the editorial content of such materials. 111 MGMTGEN ISBN: 0−390−55206−2 Management Contents Jones−George • Contemporary Management, Fourth Edition I. Management 1 2. The Evolution of Management Thought 1 Cohen • Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power 35 Text 35 Harvard Business Review Service Management Articles Deregulation and Regulatory Backlash in Health Care 62 Article 62 Harvard Business Review Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care 83 Article 83 Harvard Business School POM Cases Deaconess−Glover Hospital (A) 99 Case 99 Harvard Business Review Industry and Competitive Strategy Articles Making Competition in Health Care Work 123 Article 123 Will Disruptive Innovations Cure Health Care? (HBR)(OnPoint)(Enhanced)(Edition) 139 Article 139 iii Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 CHAPTER 2 The Evolution of Management Thought Learning Objectives After studying this chapter, you should be able to: • Describe how the need to increase organizational efficiency and effectiveness has guided the evolution of management theory. • Explain the principle of job specialization and division of labor, and tell why the study of person-task relationships is central to the pursuit of increased efficiency. • Identify the principles of administration and organization that underlie effective organizations. • Trace the changes in theories about how managers should behave to motivate and control employees. • Explain the contributions of management science to the efficient use of organizational resources. • Explain why the study of the external environment and its impact on an organization has become a central issue in management thought. 1 2 Jones−George: Contemporary Management, Fourth Edition I. Management © The McGraw−Hill Companies, 2005 2. The Evolution of Management Thought A Manager’s Challenge Finding Better Ways to Make Cars A Manager’s Challenge What is the best way to use people’s skills? Car production has changed dramatically over the years as managers have applied different principles of management to organize and control work activities. Prior to 1900, small groups What Kind of Personal Computers Do Customers modified to fit together. This system, a type of Want? small-batch production, was very expensive; of skilled workers cooperated to hand-build cars with parts that often had to be altered and assembling just one car took considerable time and effort; and skilled workers could produce only a few cars in a day. Although these cars were of high quality, they were too expensive. Managers of early car companies needed better techniques to increase efficiency, reduce costs, and sell more cars. Henry Ford revolutionized the car industry. In 1913, Ford opened the Highland Park car plant in Detroit to produce the Model T Ford, and his team of manufacturing managers pioneered the development of mass- production manufacturing, a system that made the small-batch system almost obsolete overnight. In mass production, moving conveyor belts bring the cars to the workers. Each worker performs a single assigned (a) The photo on top, taken in 1904 inside a Daimler Motor Company factory, is an example of the use of small-batch production, a production system in which small groups of people work together and perform all the tasks needed to assemble a product. (b) In 1913, Henry Ford revolutionized the production process of a car by pioneering mass production manufacturing, a production system in which a conveyor belt brings each car to the workers, and each individual worker performs a single task along the production line. Even today cars are still built using this system, as evidenced in the photo of workers along a modern-day computerized automobile assembly line. Jones−George: Contemporary Management, Fourth Edition 42 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two task along a production line, and the speed of the conveyor belt is the primary means of controlling workers’ activities. Ford experimented to discover the most efficient way for each worker to perform an assigned task. The result was that each worker performed one narrow, specialized task, such as bolting on the door or attaching the door handle, and jobs in the Ford car plant became very repetitive. They required little use of a worker’s skills.1 Ford’s management approach increased efficiency and reduced costs by so much that by 1920 he was able to reduce the price of a car by two-thirds and to sell more than 2 million cars a year.2 Ford became the leading car company in the world, and competitors rushed to adopt the new mass-production techniques. The next change in management thinking about car assembly occurred in Japan when Ohno Taiichi, a Toyota production engineer, pioneered the development of lean manufacturing in the 1960s after touring the U.S. plants of the Big Three car companies. The management philosophy behind lean manufacturing is to continuously find methods to improve the efficiency of the production process in order to reduce costs, increase quality, and reduce car assembly time. Lean production is based on the idea that if workers have input and can participate continually in the decision-making process, their skills and knowledge can be used to increase efficiency. In lean manufacturing, workers work on a moving production line, but they are organized into small teams, each of which is responsible for a particular phase of car assembly, such as installing the car’s transmission or electrical wiring system. Each team member is expected to learn the tasks of all members of that team, and each work group is responsible not only for assembling cars but also for continuously finding ways to increase quality and reduce costs. By 1970, Japanese managers had applied the new lean-production system so efficiently that Overview they were producing higher-quality cars at lower prices than their U.S. counterparts. By 1980 Japanese companies dominated the global car market. To compete with the Japanese, managers of U.S. carmakers visited Japan to learn the new management principles of lean production. As a result, companies such as General Motors (GM) established the Saturn plant to experiment with this new way of involving workers; GM also established a joint venture with Toyota called New United Motor Manufacturing Inc. (NUMMI) to learn how to achieve the benefits of lean production. Meanwhile, Ford and Chrysler began to change their work processes to take advantage of employees’ skills and knowledge. In the 1990s global car companies increased the number of robots used on the production line and began to use advanced IT to build and track the quality of cars being produced. Indeed, for a time it seemed that robots rather than employees would be building cars in the future. However, Toyota discovered something interesting at its fully roboticized car plant. When only robots build cars, efficiency does not continually increase because, unlike people, robots cannot provide input to improve the work process. The crucial thing is to find the right balance between using people, computers, and IT. In the 2000s, global car companies are continuing to compete fiercely to improve and perfect better ways of making cars. Toyota is constantly pioneering new ways to manage its assembly lines to increase efficiency; however, other Japanese carmakers such as Nissan are catching up fast. U.S. carmakers are catching up too: Ford, which made major advances in the 1990s, has now been surpassed by both Chrysler and GM. Both announced in 2004 that their productivity was fast approaching that of Japanese companies and that they expected to match the leaders, Toyota and Nissan, within the next 10 years. As this sketch of the evolution of management thinking in global car manufacturing suggests, changes in management practices occur as managers, theorists, researchers, and consultants seek new ways to increase organizational efficiency and effectiveness. The driving force 3 4 Jones−George: Contemporary Management, Fourth Edition I. Management © The McGraw−Hill Companies, 2005 2. The Evolution of Management Thought 43 The Evolution of Management Thought Figure 2.1 The Evolution of Management Theory Organizational Environment Theory Management Science Theory Behavioral Management Theory Administrative Management Theory Scientific Management Theory 1890 1900 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 behind the evolution of management theory is the search for better ways to utilize organizational resources. Advances in management thought typically occur as managers and researchers find better ways to perform the principal management tasks: planning, organizing, leading, and controlling human and other organizational resources. In this chapter, we examine how management thought has evolved in modern times and the central concerns that have guided ongoing advances in management theory. First, we examine the so-called classical management theories that emerged around the turn of the 20th century. These include scientific management, which focuses on matching people and tasks to maximize efficiency, and administrative management, which focuses on identifying the principles that will lead to the creation of the most efficient system of organization and management. Next, we consider behavioral management theories developed both before and after World War II; these focus on how managers should lead and control their workforces to increase performance. Then we discuss management science theory, which developed during World War II and has become increasingly important as researchers have developed rigorous analytical and quantitative techniques to help managers measure and control organizational performance. Finally, we discuss business in the 1960s and 1970s and focus on the theories developed to help explain how the external environment affects the way organizations and managers operate. By the end of this chapter you will understand the ways in which management thought and theory have evolved over time. You will also understand how economic, political, and cultural forces have affected the development of these theories and the ways in which managers and their organizations behave. In Figure 2.1 we summarize the chronology of the management theories discussed in this chapter. Scientific Management Theory The evolution of modern management began in the closing decades of the 19th century, after the industrial revolution had swept through Europe and America. In the new economic climate, managers of all types of organizations— political, educational, and economic—were increasingly trying to find better ways to satisfy customers’ needs. Many major economic, technical, and cultural changes were taking place at this time. The introduction of steam power and the development of sophisticated machinery and Jones−George: Contemporary Management, Fourth Edition 44 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two equipment changed the way goods were produced, particularly in the weaving and clothing industries. Small workshops run by skilled workers who produced handmanufactured products (a system called crafts production) were being replaced by large factories in which sophisticated machines controlled by hundreds or even thousands of unskilled or semiskilled workers made products. For example, raw cotton and wool, which in the past had been spun into yarn by families or whole villages working together, were now shipped to factories where workers operated machines that spun and wove large quantities of yarn into cloth. Owners and managers of the new factories found themselves unprepared for the challenges accompanying the change from small-scale crafts production to large-scale mechanized manufacturing. Moreover, many of the managers and supervisors in these workshops and factories were engineers who had only a technical orientation. They were unprepared for the social problems that occur when people work together in large groups in a factory or shop system. Managers began to search for new techniques to manage their organizations’ resources, and soon they began to focus on ways to increase the efficiency of the worker-task mix. Job Specialization and the Division of Labor job specialization The process by which a division of labor occurs as different workers specialize in different tasks over time. Initially, management theorists were interested in the subject of why the new machine shops and factory system were more efficient and produced greater quantities of goods and services than older, crafts-style production operations. Nearly 200 years before, Adam Smith had been one of the first writers to investigate the advantages associated with producing goods and services in factories. A famous economist, Smith journeyed around England in the 1700s studying the effects of the industrial revolution.3 In a study of factories that produced various pins or nails, Smith identified two different manufacturing methods. The first was similar to crafts-style production, in which each worker was responsible for all of the 18 tasks involved in producing a pin. The other had each worker performing only 1 or a few of the 18 tasks that go into making a complete pin. In a comparison of the relative performance of these different ways of organizing production, Smith found that the performance of the factories in which workers specialized in only one or a few tasks was much greater than the performance of the factory in which each worker performed all 18 pin-making tasks. In fact, Smith found that 10 workers specializing in a particular task could make 48,000 pins a day, whereas those workers who performed all the tasks could make only a few thousand at most.4 Smith reasoned that this difference in performance was due to the fact that the workers who specialized became much more skilled at their specific tasks and as a group were thus able to produce a product faster than the group of workers who each performed many tasks. Smith concluded that increasing the level of job specialization—the process by which a division of labor occurs as different workers specialize in specific tasks over time—increases efficiency and leads to higher organizational performance.5 Armed with the insights gained from Adam Smith’s observations, other managers and researchers began to investigate how to improve job specialization to increase performance. Management practitioners and theorists focused on how managers should organize and control the work process to maximize the advantages of job specialization and the division of labor. 5 6 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 The Evolution of Management Thought 45 F. W. Taylor and Scientific Management Frederick W. Taylor, founder of Scientific Management, and one of the first people to study the behavior and performance of people at work. scientific management The systematic study of relationships between people and tasks for the purpose of redesigning the work process to increase efficiency. • • • Frederick W. Taylor (1856–1915) is best known for defining the techniques of scientific management, the systematic study of relationships between people and tasks for the purpose of redesigning the work process to increase efficiency. Taylor was a manufacturing manager who eventually became a consultant and taught other managers how to apply his scientific management techniques. Taylor believed that if the amount of time and effort that each worker expends to produce a unit of output (a finished good or service) can be reduced by increasing specialization and the division of labor, the production process will become more efficient. According to Taylor, the way to create the most efficient division of labor could best be determined by scientific management techniques, rather than intuitive or informal rule-of-thumb knowledge. Based on his experiments and observations as a manufacturing manager in a variety of settings, he developed four principles to increase efficiency in the workplace: Principle 1: Study the way workers perform their tasks, gather all the informal job knowledge that workers possess, and experiment with ways of improving how tasks are performed. To discover the most efficient method of performing specific tasks, Taylor studied in great detail and measured the ways different workers went about performing their tasks. One of the main tools he used was a time-and-motion study, which involves the careful timing and recording of the actions taken to perform a particular task. Once Taylor understood the existing method of performing a task, he then experimented to increase specialization. He tried different methods of dividing and coordinating the various tasks necessary to produce a finished product. Usually this meant simplifying jobs and having each worker perform fewer, more routine tasks, as at the pin factory or on Ford’s car assembly line. Taylor also sought to find ways to improve each worker’s ability to perform a particular task—for example, by reducing the number of motions workers made to complete the task, by changing the layout of the work area or the type of tools workers used, or by experimenting with tools of different sizes. Principle 2: Codify the new methods of performing tasks into written rules and standard operating procedures. Once the best method of performing a particular task was determined, Taylor specified that it should be recorded so that this procedure could be taught to all workers performing the same task. These new methods further standardized and simplified jobs—essentially making jobs even more routine. In this way efficiency could be increased throughout an organization. Principle 3: Carefully select workers who possess skills and abilities that match the needs of the task, and train them to perform the task according to the established rules and procedures. To increase specialization, Taylor believed workers had to understand the tasks that were required and be thoroughly trained to perform the tasks at Jones−George: Contemporary Management, Fourth Edition 46 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two • the required level. Workers who could not be trained to this level were to be transferred to a job where they were able to reach the minimum required level of proficiency.6 Principle 4: Establish a fair or acceptable level of performance for a task, and then develop a pay system that provides a reward for performance above the acceptable level. To encourage workers to perform at a high level of efficiency, and to provide them with an incentive to reveal the most efficient techniques for performing a task, Taylor advocated that workers benefit from any gains in performance. They should be paid a bonus and receive some percentage of the performance gains achieved through the more efficient work process.7 By 1910 Taylor’s system of scientific management had become nationally known and in many instances was faithfully and fully practiced.8 However, managers in many organizations chose to implement the new principles of scientific management selectively. This decision ultimately resulted in problems. For example, some managers using scientific management obtained increases in performance, but rather than sharing performance gains with workers through bonuses as Taylor had advocated, they simply increased the amount of work that each worker was expected to do. Many workers experiencing the reorganized work system found that as their performance increased, managers required that they do more work for the same pay. Workers also learned that increases in performance often meant fewer jobs and a greater threat of layoffs because fewer workers were needed. In addition, the specialized, simplified jobs were often monotonous and repetitive, and many workers became dissatisfied with their jobs. Scientific management brought many workers more hardship than gain and a distrust of managers who did not seem to care about workers’ well-being.9 These dissatisfied workers resisted attempts to use the new scientific management techniques and at times even withheld their job knowledge from managers to protect their jobs and pay. It is not difficult for workers to conceal the true potential efficiency of a work system to protect their interests. Experienced machine operators, for example, can slow their machines in undetectable ways by adjusting the tension in the belts or by misaligning the gears. Workers sometimes even develop informal work rules that discourage high performance and encourage shirking as work groups attempt to identify an acceptable or fair performance level (a tactic discussed in the next section). Unable to inspire workers to accept the new scientific management techniques for performing tasks, some organizations increased the mechanization of the work process. For example, one reason why Henry Ford introduced moving conveyor belts in his factory was the realization that when a conveyor belt controls the pace of work (instead of workers setting their own pace), workers can be pushed to perform at higher levels—levels that they may have thought were beyond their reach. Charlie Chaplin captured this aspect of mass production in one of the opening scenes of his famous movie Modern Times (1936). In the film, Chaplin caricatured a new factory employee fighting to work at the machine-imposed pace but losing the battle to the machine. Henry Ford also used the principles of scientific management to identify the tasks that each worker should perform on the production line and thus to determine the most effective way to create a division of labor to suit the needs of a mechanized production system. 7 8 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought The Evolution of Management Thought © The McGraw−Hill Companies, 2005 47 Charlie Chaplin tries to extricate a fellow employee from the machinery of mass production in this scene from Modern Times. The complex machinery is meant to represent the power that machinery has over the worker in the new work system. From a performance perspective, the combination of the two management practices—(1) achieving the right mix of worker-task specialization and (2) linking people and tasks by the speed of the production line—makes sense. It produces the huge savings in cost and huge increases in output that occur in large, organized work settings. For example, in 1908 managers at the Franklin Motor Company using scientific management principles redesigned the work process, and the output of cars increased from 100 cars a month to 45 cars a day; workers’ wages, however, increased by only 90 percent.10 From other perspectives, however, scientific management practices raise many concerns. The definition of workers’ rights, not by the workers themselves, but by the owners or managers as a result of the introduction of the new management practices, raised an ethical issue, which we examine in the following “Ethics in Action.” Fordism in Practice Ethics in Action From 1908 to 1914, through trial and error, Henry Ford’s talented team of production managers pioneered the development of the moving conveyor belt and thus changed manufacturing practices forever. Although the technical aspects of the move to mass production were a dramatic financial success for Ford and for the millions of Americans who could now afford cars, for the workers who actually produced the cars many human and social problems resulted. With simplification of the work process, workers grew to hate the monotony of the moving conveyor belt. By 1914 Ford’s car plants were experiencing huge employee turnover—often reaching levels as high as 300 or 400 percent per year as workers left because they could not handle the work-induced stress.11 Henry Ford recognized these problems and made an announcement: Jones−George: Contemporary Management, Fourth Edition 48 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two From that point on, to motivate his workforce, he would reduce the length of the workday from nine hours to eight hours, and the company would double the basic wage from $2.50 to $5.00 per day. This was a dramatic increase, similar to an announcement today of an overnight doubling of the minimum wage. Ford became an internationally famous figure, and the word Fordism was coined for his new approach.12 Ford’s apparent generosity, however, was matched by an intense effort to control the resources—both human and material—with which his empire was built. He employed hundreds of inspectors to check up on employees, both inside and outside his factories. In the factory supervision was close and confining. Employees were not allowed to leave their places at the production line, and they were not permitted to talk to one another. Their job was to concentrate fully on the task at hand. Few employees could adapt to this system, and they developed ways of talking out of the sides of their mouths, like ventriloquists, and invented a form of speech that became known as the “Ford Lisp.”13 Ford’s obsession with control brought him into greater and greater conflict with managers, who often were fired when they disagreed with him. As a result, many talented people left Ford to join a growing number of rival car companies. Outside the workplace, Ford went so far as to establish what he called the “Sociological Department” to check up on how his employees lived and the ways they spent their time. Inspectors from this department visited the homes of employees and investigated their habits and problems. Employees who exhibited behaviors contrary to Ford’s standards (for instance, if they drank too much or were always in debt) were likely to be fired. Clearly, Ford’s efforts to control his employees led him and his managers to behave in ways that today would be considered unacceptable and unethical and in the long run would impair an organization’s ability to prosper. Despite the problems of worker turnover, absenteeism, and discontent at Ford Motor Company, managers of the other car companies watched Ford reap huge gains in efficiency from the application of the new management principles. They believed that their companies would have to imitate Ford if they were to survive. They followed Taylor and used many of his followers as consultants to teach them how to adopt the techniques of scientific management. In addition, Taylor elaborated his principles in several books, including Shop Management (1903) and The Principles of Scientific Management (1911), which explain in detail how to apply the principles of scientific management to reorganize the work system.14 Taylor’s work has had an enduring effect on the management of production systems. Managers in every organization, whether it produces goods or services, now carefully analyze the basic tasks that must be performed and try to devise the work systems that allow their organizations to operate most efficiently. The Gilbreths Two prominent followers of Taylor were Frank Gilbreth (1868–1924) and Lillian Gilbreth (1878–1972), who refined Taylor’s analysis of work movements and made many contributions to time-and-motion study.15 Their aims were to (1) break up and analyze every individual action necessary to perform a partic- 9 10 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought The Evolution of Management Thought © The McGraw−Hill Companies, 2005 49 ular task into each of its component actions, (2) find better ways to perform each component action, and (3) reorganize each of the component actions so that the action as a whole could be performed more efficiently—at less cost in time and effort. The Gilbreths often filmed a worker performing a particular task and then separated the task actions, frame by frame, into their component movements. Their goal was to maximize the efficiency with which each individual task was performed so that gains across tasks would add up to enormous savings of time and effort. Their attempts to develop improved management principles were captured—at times quite This scene from Cheaper by the Dozen illustrates how “efficient families,” humorously—in the movie Cheaper by such as the Gilbreths, use formal family courts to solve problems of assigning the Dozen, a new version of which chores to different family members and to solve disputes when they arise. appeared in 2004, which depicts how the Gilbreths (with their 12 children) tried to live their own lives according to these efficiency principles and apply them to daily actions such as shaving, cooking, and even raising a family.16 Eventually, the Gilbreths became increasingly interested in the study of fatigue. They studied how the physical characteristics of the workplace contribute to job stress that often leads to fatigue and thus poor performance. They isolated factors that result in worker fatigue, such as lighting, heating, the color of walls, and the design of tools and machines. Their pioneering studies paved the way for new advances in management theory. In workshops and factories, the work of the Gilbreths, Taylor, and many others had a major effect on the practice of management. In comparison with the old crafts system, jobs in the new system were more repetitive, boring, and monotonous as a result of the application of scientific management principles, and workers became increasingly dissatisfied. Frequently, the management of work settings became a game between workers and managers: Managers tried to initiate work practices to increase performance, and workers tried to hide the true potential efficiency of the work setting to protect their own well-being.17 Administrative Management Theory administrative management The study of how to create an organizational structure that leads to high efficiency and effectiveness. Side by side with scientific managers studying the person-task mix to increase efficiency, other researchers were focusing on administrative management, the study of how to create an organizational structure that leads to high efficiency and effectiveness. Organizational structure is the system of task and authority relationships that control how employees use resources to achieve the organization’s goals. Two of the most influential views regarding the creation of efficient systems of organizational administration were developed in Europe: Max Weber, a Jones−George: Contemporary Management, Fourth Edition 50 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two German professor of sociology, developed one theory; Henri Fayol, the French manager who developed the model of management introduced in Chapter 1, developed the other. The Theory of Bureaucracy bureaucracy A formal system of organization and administration designed to ensure efficiency and effectiveness. Max Weber (1864–1920), wrote at the turn of the 20th century, when Germany was undergoing its industrial revolution.18 To help Germany manage its growing industrial enterprises at a time when it was striving to become a world power, Weber developed the principles of bureaucracy—a formal system of organization and administration designed to ensure efficiency and effectiveness. A bureaucratic system of administration is based on the five principles summarized in Figure 2.2. • authority The power to hold people accountable for their actions and to make decisions concerning the use of organizational resources. • • • • Principle 1: In a bureaucracy, a manager’s formal authority derives from the position he or she holds in the organization. Authority is the power to hold people accountable for their actions and to make decisions concerning the use of organizational resources. Authority gives managers the right to direct and control their subordinates’ behavior to achieve organizational goals. In a bureaucratic system of administration, obedience is owed to a manager, not because of any personal qualities— such as personality, wealth, or social status—but because the manager occupies a position that is associated with a certain level of authority and responsibility.19 Principle 2: In a bureaucracy, people should occupy positions because of their performance, not because of their social standing or personal contacts. This principle was not always followed in Weber’s time and is often ignored today. Some organizations and industries are still affected by social networks in which personal contacts and relations, not job-related skills, influence hiring and promotional decisions. Principle 3: The extent of each position’s formal authority and task responsibilities, and its relationship to other positions in an organization, should be clearly specified. When the tasks and authority associated with various positions in the organization are clearly specified, managers and workers know what is expected of them and what to expect from each other. Moreover, an organization can hold all its employees strictly accountable for their actions when they know their exact responsibilities. Principle 4: Authority can be exercised effectively in an organization when positions are arranged hierarchically, so employees know whom to report to and who reports to them.20 Managers must create an organizational hierarchy of authority that makes it clear who reports to whom and to whom managers and workers should go if conflicts or problems arise. This principle is especially important in the armed forces, FBI, CIA, and other organizations that deal with sensitive issues involving possible major repercussions. It is vital that managers at high levels of the hierarchy be able to hold subordinates accountable for their actions. Principle 5: Managers must create a well-defined system of rules, standard operating procedures, and norms so that they can effectively control behavior within an organization. 11 12 Jones−George: Contemporary Management, Fourth Edition I. Management © The McGraw−Hill Companies, 2005 2. The Evolution of Management Thought 51 The Evolution of Management Thought Figure 2.2 Weber’s Principles of Bureaucracy System of written rules and standard operating procedures that specify how employees should behave. Clearly specified system of task and role relationships. A bureaucracy should have a: Clearly specified hierarchy of authority. Selection and evaluation system that rewards employees fairly and equitably. rules Formal written instructions that specify actions to be taken under different circumstances to achieve specific goals. standard operating procedures (SOPs) Specific sets of written instructions about how to perform a certain aspect of a task. norms Unwritten, informal codes of conduct that prescribe how people should act in particular situations. Rules are formal written instructions that specify actions to be taken under different circumstances to achieve specific goals (for example, if A happens, do B). Standard operating procedures (SOPs) are specific sets of written instructions about how to perform a certain aspect of a task. A rule might state that at the end of the workday employees are to leave their machines in good order, and a set of SOPs would specify exactly how they should do so, itemizing which machine parts must be oiled or replaced. Norms are unwritten, informal codes of conduct that prescribe how people should act in particular situations. For example, an organizational norm in a restaurant might be that waiters should help each other if time permits. Rules, SOPs, and norms provide behavioral guidelines that increase the performance of a bureaucratic system because they specify the best ways to accomplish organizational tasks. Companies such as McDonald’s and WalMart have developed extensive rules and procedures to specify the behaviors required of their employees, such as “Always greet the customer with a smile.” Weber believed that organizations that implement all five principles establish a bureaucratic system that improves organizational performance. The specification of positions and the use of rules and SOPs to regulate how tasks are performed make it easier for managers to organize and control the work of subordinates. Similarly, fair and equitable selection and promotion systems improve managers’ feelings of security, reduce stress, and encourage organizational members to act ethically and further promote the interests of the organization.21 If bureaucracies are not managed well, however, many problems can result. Sometimes, managers allow rules and SOPs, “bureaucratic red tape,” to become so cumbersome that decision making is slow and inefficient and organizations Jones−George: Contemporary Management, Fourth Edition 52 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two are unable to change. When managers rely too much on rules to solve problems and not enough on their own skills and judgment, their behavior becomes inflexible. A key challenge for managers is to use bureaucratic principles to benefit, rather than harm, an organization. Fayol’s Principles of Management Henri Fayol (1841–1925), was the CEO of Comambault Mining. Working at the same time as, but independently from, Weber, Fayol identified 14 principles (summarized in Table 2.1) that he believed essential to increase the efficiency of the management process.22 We discuss these principles in detail here because, although they were developed at the turn of the 20th century, they remain the bedrock on which much of recent management theory and research is based. In fact, as the “Management Insight” following this discussion suggests, modern writers such as well-known management guru Tom Peters continue to extol these principles. DIVISION OF LABOR A champion of job specialization and the division of labor for reasons already mentioned, Fayol was nevertheless among the first to point out the downside of too much specialization: boredom—a state of mind likely to cause a fall in product quality, worker initiative, and flexibility. As a result, Fayol advocated that workers be given more job duties to perform or be encouraged to assume more responsibility for work outcomes, a principle increasingly applied today in organizations that empower their workers. AUTHORITY AND RESPONSIBILITY Like Weber, Fayol emphasized the importance of authority and responsibility. Fayol, however, went beyond Weber’s formal authority, which derives from a manager’s position in the hierarchy, to recognize the informal authority that derives from personal expertise, technical knowledge, moral worth, and the ability to lead and to generate commitment from subordinates. (The study of authority is the subject of recent research into leadership, discussed in Chapter 12.) unity of command A reporting relationship in which an employee receives orders from, and reports to, only one superior. UNITY OF COMMAND The principle of unity of command specifies that an employee should receive orders from, and report to, only one superior. Fayol believed that dual command, the reporting relationship that exists when two supervisors give orders to the same subordinate, should be avoided except in exceptional circumstances. Dual command confuses subordinates, undermines order and discipline, and creates havoc within the formal hierarchy of authority. Assessing any manager’s authority and responsibility in a system of dual command is difficult, and the manager who is bypassed feels slighted and angry and may be uncooperative in the future. line of authority The chain of command extending from the top to the bottom of an organization. LINE OF AUTHORITY The line of authority is the chain of command extending from the top to the bottom of an organization. Fayol was one of the first management theorists to point out the importance of limiting the length of the chain of command by controlling the number of levels in the managerial hierarchy. The greater the number of levels in the hierarchy, the longer communication between managers at the top and bottom takes and the slower the pace of planning and organizing. Restricting the number of hierarchical levels to lessen these communication problems enables an organization to act quickly and flexibly; this is one reason for the recent trend toward restructuring (discussed in Chapter 1). 13 14 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought The Evolution of Management Thought © The McGraw−Hill Companies, 2005 53 Table 2.1 Fayol’s 14 Principles of Management Division of Labor Job specialization and the division of labor should increase efficiency, especially if managers take steps to lessen workers’ boredom. Authority and Responsibility Managers have the right to give orders and the power to exhort subordinates for obedience. Unity of Command An employee should receive orders from only one superior. Line of Authority The length of the chain of command that extends from the top to the bottom of an organization should be limited. Centralization Authority should not be concentrated at the top of the chain of command. Unity of Direction The organization should have a single plan of action to guide managers and workers. Equity All organizational members are entitled to be treated with justice and respect. Order The arrangement of organizational positions should maximize organizational efficiency and provide employees with satisfying career opportunities. Initiative Managers should allow employees to be innovative and creative. Discipline Managers need to create a workforce that strives to achieve organizational goals. Remuneration of Personnel The system that managers use to reward employees should be equitable for both employees and the organization. Stability of Tenure of Personnel Long-term employees develop skills that can improve organizational efficiency. Subordination of Individual Interests to the Common Interest Employees should understand how their performance affects the performance of the whole organization. Esprit de Corps Managers should encourage the development of shared feelings of comradeship, enthusiasm, or devotion to a common cause. Fayol also pointed out that when organizations are split into different departments or functions, each with its own hierarchy, it is important to allow middle and first-line managers in each department to interact with managers at similar levels in other departments. This interaction helps to speed decision making, because managers know each other and know whom to go to when problems arise. For cross-departmental integration to work, Fayol noted the importance of keeping one’s superiors informed about what is taking place so that lower-level decisions do not harm activities taking place in other parts of the organization. One alternative to cross-departmental integration is to create cross-departmental teams controlled by a team leader (see Chapter 1). centralization The concentration of authority at the top of the managerial hierarchy. CENTRALIZATION Fayol also was one of the first management writers to focus on centralization, the concentration of authority at the top of the managerial hierarchy. Fayol believed that authority should not be concentrated at the top of the chain of command. One of the most significant issues that top managers face is how much authority to centralize at the top of the organization and what authority to decentralize to managers and workers at lower hierarchical levels. This is an important issue because it affects the behavior of people at all levels in the organization. Jones−George: Contemporary Management, Fourth Edition 54 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two If authority is very centralized, only managers at the top make important decisions, and subordinates simply follow orders. This arrangement gives top managers great control over organizational activities and helps ensure that the organization is pursuing its strategy, but it makes it difficult for the people who are closest to problems and issues to respond to them in a timely manner. It also can lower the motivation of middle and first-line managers and make them less flexible and adaptable because they become reluctant to make decisions on their own, even when doing so is necessary. They get used to passing the buck. As we saw in Chapter 1, the pendulum is now swinging toward decentralization, as organizations seek to empower middle managers and create self-managed teams that monitor and control their own activities both to increase organizational flexibility and to reduce operating costs and increase efficiency. unity of direction The singleness of purpose that makes possible the creation of one plan of action to guide managers and workers as they use organizational resources. equity The justice, impartiality, and fairness to which all organizational members are entitled. order The methodical arrangement of positions to provide the organization with the greatest benefit and to provide employees with career opportunities. initiative The ability to act on one’s own, without direction from a superior. UNITY OF DIRECTION Just as there is a need for unity of command, there is also a need for unity of direction, the singleness of purpose that makes possible the creation of one plan of action to guide managers and workers as they use organizational resources. An organization without a single guiding plan becomes inefficient and ineffective; its activities become unfocused, and individuals and groups work at cross-purposes. Successful planning starts with top managers working as a team to craft the organization’s strategy, which they communicate to middle managers, who decide how to use organizational resources to implement the strategy. EQUITY As Fayol wrote, “For personnel to be encouraged to carry out their duties with all the devotion and loyalty of which they are capable, they must be treated with respect for their own sense of integrity, and equity results from the combination of respect and justice.”23 Equity—the justice, impartiality, and fairness to which all organizational members are entitled—is receiving much attention today; the desire to treat employees fairly is a primary concern for many managers. (Equity theory is discussed in Chapter 12). ORDER Like Taylor and the Gilbreths, Fayol was interested in analyzing jobs, positions, and individuals to ensure that the organization was using resources as efficiently as possible. To Fayol, order meant the methodical arrangement of positions to provide the organization with the greatest benefit and to provide employees with career opportunities that satisfy their needs. Thus, Fayol recommended the use of organizational charts to show the position and duties of each employee and to indicate which positions an employee might move to or be promoted into in the future. He also advocated that managers engage in extensive career planning to help ensure orderly career paths. Career planning is of primary interest today as organizations increase the resources they are willing to devote to training and developing their workforces. INITIATIVE Although order and equity are important means to fostering commitment and loyalty among employees, Fayol believed that managers must also encourage employees to exercise initiative, the ability to act on their own, without direction from a superior. Used properly, initiative can be a major source of strength for an organization because it leads to creativity and innovation. Managers need skill and tact to achieve the difficult balance between the organization’s need for order and employees’ desire for initiative. 15 16 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought The Evolution of Management Thought © The McGraw−Hill Companies, 2005 55 Fayol believed that the ability to strike this balance was a key indicator of a superior manager. discipline Obedience, energy, application, and other outward marks of respect for a superior’s authority. DISCIPLINE In focusing on the importance of discipline—obedience, energy, application, and other outward marks of respect for a superior’s authority—Fayol was addressing the concern of many early managers: How to create a workforce that was reliable and hardworking and would strive to achieve organizational goals. According to Fayol, discipline results in respectful relations between organizational members and reflects the quality of an organization’s leadership and a manager’s ability to act fairly and equitably. REMUNERATION OF PERSONNEL Fayol proposed reward systems including bonuses and profit-sharing plans, which are increasingly utilized today as organizations seek improved ways to motivate employees. Convinced from his own experience that an organization’s payment system has important implications for organizational success, Fayol believed that effective reward systems should be equitable for both employees and the organization, encourage productivity by rewarding well-directed effort, not be subject to abuse, and be uniformly applied to employees. STABILITY OF TENURE OF PERSONNEL Fayol also recognized the importance of long-term employment, and the idea has been echoed by contemporary management gurus such as Tom Peters, Jeff Pfeffer, and William Ouchi. When employees stay with an organization for extended periods of time, they develop skills that improve the organization’s ability to utilize its resources. SUBORDINATION OF INDIVIDUAL INTERESTS TO THE COMMON INTEREST The interests of the organization as a whole must take precedence over the interests of any one individual or group if the organization is to survive. Equitable agreements must be established between the organization and its members to ensure that employees are treated fairly and rewarded for their performance and to maintain the disciplined organizational relationships so vital to an efficient system of administration. esprit de corps Shared feelings of comradeship, enthusiasm, or devotion to a common cause among members of a group. ESPRIT DE CORPS As this discussion of Fayol’s ideas suggests, the appropriate design of an organization’s hierarchy of authority and the right mix of order and discipline foster cooperation and commitment. Likewise, a key element in a successful organization is the development of esprit de corps, a French expression that refers to shared feelings of comradeship, enthusiasm, or devotion to a common cause among members of a group. Esprit de corps can result when managers encourage personal, verbal contact between managers and workers and encourage communication to solve problems and implement solutions. (Today, the term organizational culture is used to refer to these shared feelings; this concept is discussed at length in Chapter 3.) Some of the principles that Fayol outlined have faded from contemporary management practices, but most have endured. The characteristics of organizations that Tom Peters and Robert Waterman identified as being “excellently managed” in their best-selling book In Search of Excellence (1982) are discussed in the following “Management Insight.”24 Jones−George: Contemporary Management, Fourth Edition 56 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two Peters and Waterman’s Excellent Companies Management Insight In the early 1980s, Tom Peters and Robert Waterman identified 62 organizations that they considered to be the best-performing organizations in the United States. They asked the question: Why do these companies perform better than their rivals? and discovered that successful organizations have managers who manage according to three sets of related principles. Those principles have a great deal in common with Fayol’s principles. First, Peters and Waterman argued, top managers of successful companies create principles and guidelines that emphasize managerial autonomy and entrepreneurship and encourage risk taking and initiative. For example, they allow middle managers to develop new products, even though there is no assurance that these products will be winners. In high-performing organizations, top managers are closely involved in the day-to-day operations of the company, provide unity of command and unity of direction, and do not simply make decisions in an isolated ivory tower. Top managers decentralize authority to lower-level managers and nonmanagerial employees and give them the freedom to get involved and the motivation to get things done. The second approach that managers of excellent organizations use to increase performance is to create one central plan that puts organizational goals at center stage. In high-performing organizations, managers focus attention on what the organization does best, and the emphasis is on continuously improving the goods and services the organization provides to its customers. Managers of top-performing companies resist the temptation to get sidetracked into pursuing ventures outside their area of expertise just because they seem to promise a quick return. These managers also focus on customers and establish close relationships with them to learn their needs, for responsiveness to customers increases competitive advantage. The third set of management principles pertains to organizing and controlling the organization. Excellent companies establish a division of work and a division of authority and responsibility that will motivate employees to subordinate their individual interests to the common interest. Inherent in this approach is the belief that high performance derives from individual skills and abilities and that equity, order, initiative, and other indications of respect for the individual create the esprit de corps that fosters productive behavior. An emphasis on entrepreneurship and respect for every employee leads the best managers to create a structure that gives employees room to exercise initiative and motivates them to succeed. Because a simple, streamlined managerial hierarchy is best suited to achieve this outcome, top managers keep the line of authority as short as possible. They also decentralize authority to permit employee participation, but they keep enough control to maintain unity of direction. As this insight into contemporary management suggests, the basic concerns that motivated Fayol continue to motivate management theorists.25 The principles that Fayol and Weber set forth still provide a clear and appropriate set of guidelines that managers can use to create a work setting that makes efficient and effective use of organizational resources. These principles remain the bedrock of modern management theory; recent researchers have refined or developed them 17 18 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 The Evolution of Management Thought 57 to suit modern conditions. For example, Weber’s and Fayol’s concerns for equity and for establishing appropriate links between performance and reward are central themes in contemporary theories of motivation and leadership. Behavioral Management Theory behavioral management The study of how managers should behave to motivate employees and encourage them to perform at high levels and be committed to the achievement of organizational goals. Because the writings of Weber and Fayol were not translated into English and published in the United States until the late 1940s, American management theorists in the first half of the 20th century were unaware of the contributions of these European pioneers. American management theorists began where Taylor and his followers left off. Although their writings were all very different, these theorists all espoused a theme that focused on behavioral management, the study of how managers should personally behave to motivate employees and encourage them to perform at high levels and be committed to achieving organizational goals. The Work of Mary Parker Follett If F. W. Taylor is considered the father of management thought, Mary Parker Follett (1868–1933) serves as its mother.26 Much of her writing about management and about the way managers should behave toward workers was a response to her concern that Taylor was ignoring the human side of the organization. She pointed out that management often overlooks the multitude of ways in which employees can contribute to the organization when managers allow them to participate and exercise initiative in their everyday work lives.27 Taylor, for example, never proposed that managers should involve workers in analyzing their jobs to identify better ways to perform tasks or should even ask workers how they felt about their jobs. Instead, he used time-and-motion experts to analyze workers’ jobs for them. Follett, in contrast, argued that because workers know the most about their jobs, they should be involved in job analysis and managers should allow them to participate in the work development process. Follett proposed that “authority should go with knowledge . . . whether it is up the line or down.” In other words, if workers have the relevant knowledge, then workers, rather than managers, should be in control of the work process itself, and managers should behave as coaches and facilitators—not as monitors and supervisors. In making this statement, Follett anticipated the current interest in self-managed teams and empowerment. She also recognized the importance of having managers in different departments communicate directly with each other to speed decision making. She advocated what she called “cross-functioning”: members of different departments working together in cross-departmental teams to accomplish projects—an approach that is increasingly utilized today.28 Fayol also mentioned expertise and knowledge as important sources of managers’ authority, but Follett went further. She proposed that knowledge and expertise, and not managers’ formal authority deriving from their position in the hierarchy, should Mary Parker Follett, an early management decide who will lead at any particular moment. She believed, as do thinker who advocated that “Authority many management theorists today, that power is fluid and should should go with knowledge . . . whether it is flow to the person who can best help the organization achieve its up the line or down.” goals. Follett took a horizontal view of power and authority, in Jones−George: Contemporary Management, Fourth Edition 58 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two contrast to Fayol, who saw the formal line of authority and vertical chain of command as being most essential to effective management. Follett’s behavioral approach to management was very radical for its time. The Hawthorne Studies and Human Relations Probably because of its radical nature, Follett’s work was unappreciated by managers and researchers until quite recently. Most continued to follow in the footsteps of Taylor and the Gilbreths. To increase efficiency, they studied ways to improve various characteristics of the work setting, such as job specialization or the kinds of tools workers used. One series of studies was conducted from 1924 to 1932 at the Hawthorne Works of the Western Electric Company.29 This research, now known as the Hawthorne studies, began as an attempt to investigate how characteristics of the work setting—specifically the level of lighting or illumination— affect worker fatigue and performance. The researchers conducted an experiment in which they systematically measured worker productivity at various levels of illumination. The experiment produced some unexpected results. The researchers found that regardless of whether they raised or lowered the level of illumination, productivity increased. In fact, productivity began to fall only when the level of illumination dropped to the level of moonlight, a level at which, presumably, workers could no longer see well enough to do their work efficiently. The researchers found these results puzzling and invited a noted Harvard psychologist, Elton Mayo, to help them. Mayo proposed another series of experiments to solve the mystery. These experiments, known as the relay assembly test experiments, were designed to investigate the effects of other aspects of the work context on job performance, such as the effect of the number and length of rest periods and hours of work on fatigue and monotony.30 The goal was to raise productivity. During a two-year study of a small group of female workers, the researchers again observed that productivity increased over time, but the increases could not be solely attributed to the effects of changes in the work setting. Gradually, the researchers discovered that, to some degree, the results they were obtaining were influenced by the fact that the researchers themselves had become part of the experiment. In other words, the presence of the researchers was affecting the results because the workers Workers in a telephone manufacturing plant, in 1931. Around this time, researchers at the Hawthorne Works of the Western Electric Company enjoyed receiving attention and being the began to study the effects of work setting characteristics—such as subject of study and were willing to colighting and rest periods—on productivity. To their surprise, they operate with the researchers to produce discovered that workers’ productivity was affected more by the attention the results they believed the researchers they received from researchers than by the characteristics of the work desired. setting—a phenomenon that became known as the Hawthorne Effect. 19 20 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought The Evolution of Management Thought Hawthorne effect The finding that a manager’s behavior or leadership approach can affect workers’ level of performance. human relations movement A management approach that advocates the idea that supervisors should receive behavioral training to manage subordinates in ways that elicit their cooperation and increase their productivity. informal organization The system of behavioral rules and norms that emerge in a group. organizational behavior The study of the factors that have an impact on how individuals and groups respond to and act in organizations. © The McGraw−Hill Companies, 2005 59 Subsequently, it was found that many other factors also influence worker behavior, and it was not clear what was actually influencing the Hawthorne workers’ behavior. However, this particular effect—which became known as the Hawthorne effect—seemed to suggest that workers’ attitudes toward their managers affect the level of workers’ performance. In particular, the significant finding was that each manager’s personal behavior or leadership approach can affect performance. This finding led many researchers to turn their attention to managerial behavior and leadership. If supervisors could be trained to behave in ways that would elicit cooperative behavior from their subordinates, then productivity could be increased. From this view emerged the human relations movement, which advocates that supervisors be behaviorally trained to manage subordinates in ways that elicit their cooperation and increase their productivity. The importance of behavioral or human relations training became even clearer to its supporters after another series of experiments—the bank wiring room experiments. In a study of workers making telephone switching equipment, researchers Elton Mayo and F. J. Roethlisberger discovered that the workers, as a group, had deliberately adopted a norm of output restriction to protect their jobs. Workers who violated this informal production norm were subjected to sanctions by other group members. Those who violated group performance norms and performed above the norm were called “ratebusters”; those who performed below the norm were called “chiselers.” The experimenters concluded that both types of workers threatened the group as a whole. Ratebusters threatened group members because they revealed to managers how fast the work could be done. Chiselers were looked down on because they were not doing their share of the work. Work-group members disciplined both ratebusters and chiselers to create a pace of work that the workers (not the managers) thought was fair. Thus, a work group’s influence over output can be as great as the supervisors’ influence. Since the work group can influence the behavior of its members, some management theorists argue that supervisors should be trained to behave in ways that gain the goodwill and cooperation of workers so that supervisors, not workers, control the level of work-group performance. One of the main implications of the Hawthorne studies was that the behavior of managers and workers in the work setting is as important in explaining the level of performance as the technical aspects of the task. Managers must understand the workings of the informal organization, the system of behavioral rules and norms that emerge in a group, when they try to manage or change behavior in organizations. Many studies have found that, as time passes, groups often develop elaborate procedures and norms that bond members together, allowing unified action either to cooperate with management to raise performance or to restrict output and thwart the attainment of organizational goals.31 The Hawthorne studies demonstrated the importance of understanding how the feelings, thoughts, and behavior of work-group members and managers affect performance. It was becoming increasingly clear to researchers that understanding behavior in organizations is a complex process that is critical to increasing performance.32 Indeed, the increasing interest in the area of management known as organizational behavior, the study of the factors that have an impact on how individuals and groups respond to and act in organizations, dates from these early studies. Jones−George: Contemporary Management, Fourth Edition 60 I. Management © The McGraw−Hill Companies, 2005 2. The Evolution of Management Thought Chapter Two Theory X and Theory Y Several studies after World War II revealed how assumptions about workers’ attitudes and behavior affect managers’ behavior. Perhaps the most influential approach was developed by Douglas McGregor. He proposed two sets of assumptions about how work attitudes and behaviors not only dominate the way managers think but also affect how they behave in organizations. McGregor named these two contrasting sets of assumptions Theory X and Theory Y (see Figure 2.3).33 Theory X A set of negative assumptions about workers that lead to the conclusion that a manager’s task is to supervise workers closely and control their behavior. Theory Y A set of positive assumptions about workers that lead to the conclusion that a manager’s task is to create a work setting that encourages commitment to organizational goals and provides opportunities for workers to be imaginative and to exercise initiative and self-direction. Figure 2.3 Theory X versus Theory Y Source: D. McGregor, The Human Side of Enterprise, 1960, McGraw-Hill, reproduced with permission of the McGrawHill Companies, Inc. THEORY X According to the assumptions of Theory X, the average worker is lazy, dislikes work, and will try to do as little as possible. Moreover, workers have little ambition and wish to avoid responsibility. Thus, the manager’s task is to counteract workers’ natural tendencies to avoid work. To keep workers’ performance at a high level, the manager must supervise workers closely and control their behavior by means of “the carrot and stick”—rewards and punishments. Managers who accept the assumptions of Theory X design and shape the work setting to maximize their control over workers’ behaviors and minimize workers’ control over the pace of work. These managers believe that workers must be made to do what is necessary for the success of the organization, and they focus on developing rules, SOPs, and a well-defined system of rewards and punishments to control behavior. They see little point in giving workers autonomy to solve their own problems because they think that the workforce neither expects nor desires cooperation. Theory X managers see their role as closely monitoring workers to ensure that they contribute to the production process and do not threaten product quality. Henry Ford, who closely supervised and managed his workforce, fits McGregor’s description of a manager who holds Theory X assumptions. THEORY Y In contrast, Theory Y assumes that workers are not inherently lazy, do not naturally dislike work, and, if given the opportunity, will do what is good for the organization. According to Theory Y, the characteristics of the work setting determine whether workers consider work to be a source of satisfaction or punishment, and managers do not need to closely control workers’ behavior to make them perform at a high level because workers exercise selfcontrol when they are committed to organizational goals. The implication of Theory Y, according to McGregor, is that “the limits of collaboration in the THEORY X THEORY Y The average employee is lazy, dislikes work, and will try to do as little as possible. Employees are not inherently lazy. Given the chance, employees will do what is good for the organization. To ensure that employees work hard, managers should closely supervise employees. To allow employees to work in the organization's interest, managers must create a work setting that provides opportunities for workers to exercise initiative and self-direction. Managers should create strict work rules and implement a well-defined system of rewards and punishments to control employees. Managers should decentralize authority to employees and make sure employees have the resources necessary to achieve organizational goals. 21 22 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 The Evolution of Management Thought 61 organizational setting are not limits of human nature but of management’s ingenuity in discovering how to realize the potential represented by its human resources.”34 It is the manager’s task to create a work setting that encourages commitment to organizational goals and provides opportunities for workers to be imaginative and to exercise initiative and self-direction. When managers design the organizational setting to reflect the assumptions about attitudes and behavior suggested by Theory Y, the characteristics of the organization are quite different from those of an organizational setting based on Theory X. Managers who believe that workers are motivated to help the organization reach its goals can decentralize authority and give more control over the job to workers, both as individuals and in groups. In this setting, individuals and groups are still accountable for their activities, but the manager’s role is not to control employees but to provide support and advice, to make sure employees have the resources they need to perform their jobs, and to evaluate them on their ability to help the organization meet its goals. Henri Fayol’s approach to administration more closely reflects the assumptions of Theory Y, rather than Theory X. One company that has always operated with the type of management philosophy inherent in Theory Y is Hewlett-Packard, the subject of the next “Manager as a Person.” The Hewlett-Packard Way Manager as a Person Managers at the electronics company Hewlett-Packard (HP) consistently put into practice principles derived from Theory Y. (Go to the company’s Web site at www.hp.com for additional information.) Founders William Hewlett and David Packard—Bill and Dave, as they are still known throughout the organization—established a philosophy of management known as the “HP Way” that is people-oriented, stresses the importance of treating every person with consideration and respect, and offers recognition for achievements.35 HP’s philosophy rests on a few guiding principles. One is a policy of longterm employment. HP goes to great lengths not to lay off workers. At times when fewer people were needed, rather than lay off workers management cut pay and shortened the workday until demand for HP products picked up. This policy strengthened employees’ loyalty to the organization. The HP Way is based on several golden rules about how to treat members of the organization so that they feel free to be innovative and creative. HP managers believe that every employee of the company is a member of the HP Faced with questions about the company’s team. They emphasize the need to survival, HP CEO Carly Fiorina was forced increase the level of communication break with the tradition of “long-term among employees, believing that horiemployment” and lay off over 40 percent of the zontal communication between peers, workforce. Jones−George: Contemporary Management, Fourth Edition 62 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two not just vertical communication up and down the hierarchy, is essential for creating a positive climate for innovation. To promote communication and cooperation between employees at different levels of the hierarchy, HP encourages informality. Managers and workers are on a first-name basis with each other and with the founders, Bill and Dave. In addition, Bill and Dave pioneered the technique known as “managing by wandering around.” People are expected to wander around learning what others are doing so that they can tap into opportunities to develop new products or find new avenues for cooperation. Bill and Dave also pioneered the principle that employees should spend 15 percent of their time working on projects of their own choosing, and they encouraged employees to take equipment and supplies home to experiment with them on their own time. HP’s product design engineers leave their current work out in the open on their desks so that anybody can see what they are doing, can learn from it, or can suggest ways to improve it. Managers are selected and promoted because of their ability to engender excitement and enthusiasm for innovation in their subordinates. HP’s offices have low walls and shared laboratories to facilitate communication and cooperation between managers and workers. In all these ways, HP managers seek to promote each employee’s desire to be innovative and also to create a team and family atmosphere based on cooperation.36 The results of HP’s practices helped it become one of the leading electronics companies in the world. In 2001, however, HP, like most other high-tech companies, was experiencing major problems because of the collapse of the telecommunications industry, and the company announced that it was searching for ways to reduce costs. At first, its current CEO, Carly Fiorino, in keeping with the management philosophy and values of the company’s founders, announced that HP would not lay off employees but asked them to accept lower salaries and unpaid leave to help the company through this rough spot.37 It soon became clear, however, that HP’s very survival was at stake as it battled with efficient global competitors such as Dell and Canon. To fight back, HP merged with Compaq, but by 2004 it had been forced to lay off over 40 percent of its employees and outsource thousands of jobs abroad in order to remain competitive. Fiorino still believes, however, that HP’s values will survive its crisis and help it become the global leader in the next decade.38 Management Science Theory management science theory An approach to management that uses rigorous quantitative techniques to help managers make maximum use of organizational resources. Management science theory is a contemporary approach to management that focuses on the use of rigorous quantitative techniques to help managers make maximum use of organizational resources to produce goods and services. In essence, management science theory is a contemporary extension of scientific management, which, as developed by Taylor, also took a quantitative approach to measuring the worker-task mix to raise efficiency. There are many branches of management science, and once again, IT, which is having a significant impact on all kinds of management practices, is affecting the tools managers use to make decisions.39 Each branch of management science deals with a specific set of concerns: • Quantitative management utilizes mathematical techniques—such as linear and nonlinear programming, modeling, simulation, queuing theory, and chaos theory—to help managers decide, for example, how much inventory to hold at different times of the year, where to locate a new factory, and how best to 23 24 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought The Evolution of Management Thought • • • © The McGraw−Hill Companies, 2005 63 invest an organization’s financial capital. IT offers managers new and improved ways of handling information so that they can make more accurate assessments of the situation and better decisions. Operations management provides managers with a set of techniques that they can use to analyze any aspect of an organization’s production system to increase efficiency. IT, through the Internet and through growing B2B networks, is transforming the way managers handle the acquisition of inputs and the disposal of finished products. Total quality management (TQM) focuses on analyzing an organization’s input, conversion, and output activities to increase product quality.40 Once again, through sophisticated software packages and computer-controlled production, IT is changing the way managers and employees think about the work process and ways of improving it. Management information systems (MISs) help managers design systems that provide information about events occurring inside the organization as well as in its external environment—information that is vital for effective decision making. Once again, IT gives managers access to more and better information and allows more managers at all levels to participate in the decisionmaking process. All these subfields of management science, enhanced by sophisticated IT, provide tools and techniques that managers can use to help improve the quality of their decision making and increase efficiency and effectiveness. We discuss many of the important developments in management science theory thoroughly in Part 6 of this book. In particular, Chapter 17, “Managing Information Systems and Technologies,” describes the management of information systems and technologies, and Chapter 18, “Operations Management: Managing Quality, Efficiency, and Responsiveness to Customers,” focuses on IT, operations management, and TQM. Organizational Environment Theory organizational environment The set of forces and conditions that operate beyond an organization’s boundaries but affect a manager’s ability to acquire and utilize resources. An important milestone in the history of management thought occurred when researchers went beyond the study of how managers can influence behavior within organizations to consider how managers control the organization’s relationship with its external environment, or organizational environment—the set of forces and conditions that operate beyond an organization’s boundaries but affect a manager’s ability to acquire and utilize resources. Resources in the organizational environment include the raw materials and skilled people that an organization requires to produce goods and services, as well as the support of groups, including customers who buy these goods and services and provide the organization with financial resources. One way of determining the relative success of an organization is to consider how effective its managers are at obtaining scarce and valuable resources.41 The importance of studying the environment became clear after the development of open-systems theory and contingency theory during the 1960s. The Open-Systems View One of the most influential views of how an organization is affected by its external environment was developed by Daniel Katz, Robert Kahn, and James Thompson in the 1960s.42 These theorists viewed the organization as an Jones−George: Contemporary Management, Fourth Edition 64 Figure 2.4 The Organization as an Open System I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two ENVIRONMENT Input stage Conversion stage Output stage • Raw materials • Money and capital • Human resources • Machinery • Computers • Human skills • Goods • Services Organization obtains inputs from its environment Organization transforms inputs and adds value to them Organization releases outputs to its environment Sales of outputs allow organization to obtain new supplies of inputs open system A system that takes in resources from its external environment and converts them into goods and services that are then sent back to that environment for purchase by customers. closed system A system that is selfcontained and thus not affected by changes occurring in its external environment. entropy The tendency of a closed system to lose its ability to control itself and thus to dissolve and disintegrate. open system—a system that takes in resources from its external environment and converts or transforms them into goods and services that are sent back to that environment, where they are bought by customers (see Figure 2.4). At the input stage an organization acquires resources such as raw materials, money, and skilled workers to produce goods and services. Once the organization has gathered the necessary resources, conversion begins. At the conversion stage the organization’s workforce, using appropriate tools, techniques, and machinery, transforms the inputs into outputs of finished goods and services such as cars, hamburgers, or flights to Hawaii. At the output stage the organization releases finished goods and services to its external environment, where customers purchase and use them to satisfy their needs. The money the organization obtains from the sales of its outputs allows the organization to acquire more resources so that the cycle can begin again. The system just described is said to be open because the organization draws from and interacts with the external environment in order to survive; in other words, the organization is open to its environment. A closed system, in contrast, is a self-contained system that is not affected by changes in its external environment. Organizations that operate as closed systems, that ignore the external environment, and that fail to acquire inputs are likely to experience entropy, the tendency of a closed system to lose its ability to control itself and thus to dissolve and disintegrate. Management theorists can model the activities of most organizations by using the open-systems view. Manufacturing companies like Ford and General Electric, for example, buy inputs such as component parts, skilled and semiskilled labor, and robots and computer-controlled manufacturing equipment; then at the conversion stage they use their manufacturing skills to assemble inputs into outputs of cars and appliances. As we discuss in later chapters, competition between organizations for resources is one of several major challenges to managing the organizational environment. 25 26 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 65 The Evolution of Management Thought Figure 2.5 Contingency Theory of Organizational Design Organizations in stable environments choose a mechanistic structure (centralized authority, vertical communication flows, control through strict rules and procedures) Characteristics of the environment Determine the design of an organization's structure and control systems There is no one best way to organize; organizational structure depends on the environment in which an organization operates. synergy Performance gains that result when individuals and departments coordinate their actions. Organizations in changing environments choose an organic structure (decentralized authority, horizontal communication flows, cross-departmental cooperation) Researchers using the open-systems view are also interested in how the various parts of a system work together to promote efficiency and effectiveness. Systems theorists like to argue that the whole is greater than the sum of its parts; they mean that an organization performs at a higher level when its departments work together rather than separately. Synergy, the performance gains that result from the combined actions of individuals and departments, is possible only in an organized system. The recent interest in using teams combined or composed of people from different departments reflects systems theorists’ interest in designing organizational systems to create synergy and thus increase efficiency and effectiveness. Contingency Theory contingency theory The idea that the organizational structures and control systems managers choose depend on—are contingent on— characteristics of the external environment in which the organization operates. Another milestone in management theory was the development of contingency theory in the 1960s by Tom Burns and G. M. Stalker in Britain and Paul Lawrence and Jay Lorsch in the United States.43 The crucial message of contingency theory is that there is no one best way to organize: The organizational structures and the control systems that managers choose depend on—are contingent on—characteristics of the external environment in which the organization operates. According to contingency theory, the characteristics of the environment affect an organization’s ability to obtain resources; and to maximize the likelihood of gaining access to resources, managers must allow an organization’s departments to organize and control their activities in ways most likely to allow them to obtain resources, given the constraints of the particular environment they face. In other words, how managers design the organizational hierarchy, choose a control system, and lead and motivate their employees is contingent on the characteristics of the organizational environment (see Figure 2.5). An important characteristic of the external environment that affects an organization’s ability to obtain resources is the degree to which the environment is changing. Changes in the organizational environment include changes in technology, which can lead to the creation of new products (such as compact discs) and result in the obsolescence of existing products (eight-track tapes); the entry of new competitors (such as foreign organizations that compete for available resources); and unstable economic conditions. In general, the more quickly the organizational environment is changing, the greater are the problems associated Jones−George: Contemporary Management, Fourth Edition 66 I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Chapter Two with gaining access to resources and the greater is managers’ need to find ways to coordinate the activities of people in different departments to respond to the environment quickly and effectively. mechanistic structure An organizational structure in which authority is centralized, tasks and rules are clearly specified, and employees are closely supervised. organic structure An organizational structure in which authority is decentralized to middle and first-line managers and tasks and roles are left ambiguous to encourage employees to cooperate and respond quickly to the unexpected. MECHANISTIC AND ORGANIC STRUCTURES Drawing on Weber’s and Fayol’s principles of organization and management, Burns and Stalker proposed two basic ways in which managers can organize and control an organization’s activities to respond to characteristics of its external environment: They can use a mechanistic structure or an organic structure.44 As you will see, a mechanistic structure typically rests on Theory X assumptions, and an organic structure typically rests on Theory Y assumptions. When the environment surrounding an organization is stable, managers tend to choose a mechanistic structure to organize and control activities and make employee behavior predictable. In a mechanistic structure, authority is centralized at the top of the managerial hierarchy, and the vertical hierarchy of authority is the main means used to control subordinates’ behavior. Tasks and roles are clearly specified, subordinates are closely supervised, and the emphasis is on strict discipline and order. Everyone knows his or her place, and there is a place for everyone. A mechanistic structure provides the most efficient way to operate in a stable environment because it allows managers to obtain inputs at the lowest cost, giving an organization the most control over its conversion processes and enabling the most efficient production of goods and services with the smallest expenditure of resources. McDonald’s restaurants operate with a mechanistic structure. Supervisors make all important decisions; employees are closely supervised and follow well-defined rules and standard operating procedures. In contrast, when the environment is changing rapidly, it is difficult to obtain access to resources, and managers need to organize their activities in a way that allows them to cooperate, to act quickly to acquire resources (such as new types of inputs to produce new kinds of products), and to respond effectively to the unexpected. In an organic structure, authority is decentralized to middle and first-line managers to encourage them to take responsibility and act quickly to pursue scarce resources. Departments are encouraged to take a cross-departmental or functional perspective, and, as in Mary Parker Follett’s model, authority rests with the individuals and departments best positioned to control the current problems the organization is facing. In an organic structure, control is much looser than it is in a mechanistic structure, and reliance on shared norms to guide organizational activities is greater. Managers in an organic structure can react more quickly to a changing environment than can managers in a mechanistic structure. However, an organic structure is generally more expensive to operate because it requires that more managerial time, money, and effort be spent on coordination. So it is used only when needed—when the organizational environment is unstable and rapidly changing. Summary and Review In this chapter we examined the evolution of management theory and research over the last century. Much of the material in the rest of this book stems from developments and refinements of this work. SCIENTIFIC MANAGEMENT THEORY The search for efficiency started with the study of how managers could improve person-task relationships to increase efficiency. The concept of job specialization and division of labor 27 28 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought The Evolution of Management Thought © The McGraw−Hill Companies, 2005 67 remains the basis for the design of work settings in modern organizations. New developments such as lean production and total quality management are often viewed as advances on the early scientific management principles developed by Taylor and the Gilbreths. ADMINISTRATIVE MANAGEMENT THEORY Max Weber and Henri Fayol outlined principles of bureaucracy and administration that are as relevant to managers today as they were when developed at the turn of the 20th century. Much of modern management research refines these principles to suit contemporary conditions. For example, the increasing interest in the use of crossdepartmental teams and the empowerment of workers are issues that managers also faced a century ago. BEHAVIORAL MANAGEMENT THEORY Researchers have described many different approaches to managerial behavior, including Theories X and Y. Often, the managerial behavior that researchers suggest reflects the context of their own historical era and culture. Mary Parker Follett advocated managerial behaviors that did not reflect accepted modes of managerial behavior at the time, and her work was largely ignored until conditions changed. MANAGEMENT SCIENCE THEORY The various branches of management science theory provide rigorous quantitative techniques that give managers more control over each organization’s use of resources to produce goods and services. ORGANIZATIONAL ENVIRONMENT THEORY The importance of studying the organization’s external environment became clear after the development of open-systems theory and contingency theory during the 1960s. A main focus of contemporary management research is to find methods to help managers improve the ways they utilize organizational resources and compete successfully in the global environment. Strategic management and total quality management are two important approaches intended to help managers make better use of organizational resources. Jones−George: Contemporary Management, Fourth Edition I. Management © The McGraw−Hill Companies, 2005 2. The Evolution of Management Thought Management in Action Topics for Discussion and Action Discussion 1. Choose a fast-food restaurant, a department store, or some other organization with which you are familiar, and describe the division of labor and job specialization it uses to produce goods and services. How might this division of labor be improved? 2. Apply Taylor’s principles of scientific management to improve the performance of the organization you chose in item 1. 3. In what ways are Weber’s and Fayol’s ideas about bureaucracy and administration similar? In what ways do they differ? 4. Which of Weber’s and Fayol’s principles seem most relevant to the creation of an ethical organization? 5. Why was the work of Mary Parker Follett ahead of its time? To what degree do you think it is appropriate today? 7. Why are mechanistic and organic structures suited to different organizational environments? Action 8. Question a manager about his or her views of the relative importance of Fayol’s 14 principles of management. 9. 6. What is contingency theory? What kinds of organizations familiar to you have been successful or unsuccessful in dealing with contingencies from the external environment? Visit at least two organizations in your community, and identify those that seem to operate with a Theory X or a Theory Y approach to management. Building Management Skills Managing Your Own Business Now that you understand the concerns addressed by management thinkers over the last century, use this exercise to apply your knowledge to developing your management skills. magine that you are the founding entrepreneur of a software company that specializes in developing games for home computers. Customer demand for your games has increased so much that over the last year your company has grown from a busy 1-person operation to one with 16 employees. In addition to yourself, you employ six software developers to produce the software, three graphic artists, two computer technicians, two marketing and sales personnel, and two secretaries. In the next year you I 68 expect to hire 30 new employees, and you are wondering how best to manage your growing company. 1. Use the principles of Weber and Fayol to decide on the system of organization and management that you think will be most effective for your growing organization. How many levels will the managerial hierarchy of your organization have? How much authority will you decentralize to your subordinates? How will you establish the division of labor between subordinates? Will your subordinates work alone and report to you or work in teams? 2. Which management approach (for example, Theory X or Y) do you propose to use to run your organization? In 50 words or less write a statement describing the management approach you believe will motivate and coordinate your subordinates, and tell why you think this style will be best. 29 30 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Managing Ethically Mr. Edens Profits from Watching His Workers’ Every Move Read the case below, “Mr. Edens Profits from Watching His Workers’ Every Move,” and think about the following issues. C ontrol is one of Ron Edens’s favorite words. “This is a controlled environment,” he says of the blank brick building that houses his company, Electronic Banking System Inc. Inside, long lines of women sit at spartan desks, slitting envelopes, sorting contents and filling out “control cards” that record how many letters they have opened and how long it has taken them. Workers here, in “the cage,” must process three envelopes a minute. Nearby, other women tap keyboards, keeping pace with a quota that demands 8,500 strokes an hour. The room is silent. Talking is forbidden. The windows are covered. Coffee mugs, religious pictures and other adornments are barred from workers’ desks. In his office upstairs, Mr. Edens sits before a TV monitor that flashes images from eight cameras posted through the plant. “There’s a little bit of Sneaky Pete to it,” he says, using a remote control to zoom in on a document atop a worker’s desk. “I can basically read that and figure out how someone’s day is going.” This day, like most others, is going smoothly, and Mr. Edens’s business has boomed as a result. “We maintain a lot of control,” he says. “Order and control are everything in this business.” Mr. Edens’s business belongs to a small but expanding financial service known as “lockbox processing.” Many companies and charities that once did their paperwork in-house now “out-source” clerical tasks to firms like EBS, which processes donations to groups such as Mothers Against Drunk Driving, the Doris Day Animal League, Greenpeace and the National Organization for Women. More broadly, EBS reflects the explosive growth of jobs in which workers perform low-wage and limited tasks in white-collar settings. This has transformed towns like Hagerstown—a blue-collar community hit hard by industrial layoffs in the 1970s—into sites for thousands of jobs in factory-sized offices. Many of these jobs, though, are part time and most pay far less than the manufacturing occupations they replaced. Some workers at EBS start at the minimum wage of $4.25 an hour and most earn about $6 an hour. The growth of such jobs—which often cluster outside major cities—also completes a curious historic circle. During the Industrial Revolution, farmers’ daughters went to work in textile towns like Lowell, Mass. In post-industrial America, many women of modest means and skills are entering clerical mills where they process paper instead of cloth (coincidentally, EBS occupies a former garment factory). “The office of the future can look a lot like the factory of the past,” says Barbara Garson, author of The Electronic Sweatshop and other books on the modern workplace. “Modern tools are being used to bring 19th-century working conditions into the white-collar world.” The time-motion philosophies of Frederick Taylor, for instance, have found a 1990s correlate in the phone, computer and camera, which can be used to monitor workers more closely than a foreman with a stopwatch ever could. Also, the nature of the work often justifies a vigilant eye. In EBS workers handle thousands of dollars in checks and cash, and Mr. Edens says cameras help deter would-be thieves. Tight security also reassures visiting clients. “If you’re disorderly, they’ll think we’re out of control and that things could get lost,” says Mr. Edens, who worked as a financial controller for the National Rifle Association before founding EBS in 1983. But tight observation also helps EBS monitor productivity and weed out workers who don’t keep up. “There’s multiple uses,” Mr. Edens says of surveillance. His desk is covered with computer printouts recording the precise toll of keystrokes tapped by each data-entry worker. He also keeps a day-to-day tally of errors. The work floor itself resembles an enormous classroom in the throes of exam period. Desks point toward the front, where a manager keeps watch from a raised platform that workers call “the pedestal” or “the birdhouse.” Other supervisors are positioned toward the back of the room. “If you want to watch someone,” Mr. Edens explains, “it’s easier from behind because they don’t know you’re watching.” There also is a black globe hanging from the ceiling, in which cameras are positioned. Mr. Edens sees nothing Orwellian about this omniscience. “It’s not a Big Brother attitude,” he says. “It’s more of a calming attitude.” But studies of workplace monitoring suggest otherwise. Experts say that surveillance can create a hostile environment in which workers feel pressured, paranoid and prone to stress-related illness. Surveillance also can be used punitively, to intimidate workers or to justify their firing. 69 Jones−George: Contemporary Management, Fourth Edition I. Management Following a failed union drive at EBS, the National Labor Relations Board filed a series of complaints against the company, including charges that EBS threatened, interrogated, and spied on workers. As part of an out-of-court settlement, EBS reinstated a fired worker and posted a notice that it would refrain from illegal practices during a second union vote, which also failed. “It’s all noise,” Mr. Edens says of the unfair labor charges. As to the pressure that surveillance creates, Mr. Edens sees that simply as “the nature of the beast.” He adds: “It’s got to add stress when everyone knows their production is being monitored. I don’t apologize for that.” Mr. Edens also is unapologetic about the Draconian work rules he maintains, including one that forbids all talk unrelated to the completion of each task. “I’m not paying people to chat. I’m paying them to open envelopes,” he says. Of the blocked windows. Mr. Edens adds: “I don’t want them looking out—it’s distracting. They’ll make mistakes.” This total focus boosts productivity but it makes many workers feel lonely and trapped. Some try to circumvent the silence rule, like kids in a school library. “If you don’t turn your head and sort of mumble out of the side of your mouth, supervisors won’t hear you most of the time,” Cindy Kesselring explains during her lunch break. Even so, she feels isolated and often longs for her former job as a waitress. “Work is your social life, particularly if you’ve got kids,” says the 27-year-old mother. “Here it’s hard to get to know people because you can’t talk.” During lunch, workers crowd in the parking lot outside, chatting nonstop. “Some of us don’t eat much because the more you chew the less you can talk,” Ms. Kesselring says. There aren’t other breaks and workers aren’t allowed to sip coffee or eat at their desks during 70 © The McGraw−Hill Companies, 2005 2. The Evolution of Management Thought the long stretches before and after lunch. Hard candy is the only permitted desk snack. New technology, and the breaking down of labor into discrete, repetitive tasks, also have effectively stripped jobs such as those at EBS of whatever variety and skills clerical work once possessed. Workers in the cage (an antiquated banking term for a money-handling area) only open envelopes and sort contents; those in the audit department compute figures; and data-entry clerks punch in the information that the others have collected. If they make a mistake, the computer buzzes and a message such as “check digit error” flashes on the screen. “We don’t ask these people to think—the machines think for them,” Mr. Edens says. “They don’t have to make any decisions.” This makes the work simpler but also deepens its monotony. In the cage, Carol Smith says she looks forward to envelopes that contain anything out of the ordinary, such as letters reporting that the donor is deceased. Or she plays mental games. “I think to myself, A goes in this pile, B goes here and C goes there—sort of like Bingo.” She says she sometimes feels “like a machine,” particularly when she fills out the “control card” on which she lists “time in” and “time out” for each tray of envelopes. In a slot marked “cage operator” Ms. Smith writes her code number, 3173. “That’s me,” she says. Barbara Ann Wiles, a keyboard operator, also plays mind games to break up the boredom. Tapping in the names and addresses of new donors, she tries to imagine the faces behind the names, particularly the odd ones. “Like this one, Mrs. Fittizzi,” she chuckles. “I can picture her as a very stout lady with a strong accent, hollering on a street corner.” She picks out another: “Doris Angelroth—she’s very sophisticated, a monocle maybe, drinking tea on an overstuffed mohair couch.” It is a world remote from the one Ms. Wiles inhabits. Like most EBS employees, she must juggle her low-paying job with child care. On this Friday, for instance, Ms. Wiles will finish her eight-hour shift at about 4 P.M., go home for a few hours, then return for a second shift from midnight to 8 A.M. Otherwise, she would have to come in on Saturday to finish the week’s work. This way I can be home on the weekend to look after my kids,” she says. Others find the work harder to leave behind at the end of the day. In the cage, Ms. Smith says her husband used to complain because she often woke him in the middle of the night. “I’d be shuffling my hands in my sleep,” she says, mimicking the motion of opening envelopes. Her cage colleague, Ms. Kesselring, says her fiancé has a different gripe. “He dodges me for a couple of hours after work because I don’t shut up—I need to talk, talk, talk,” she says. And there is one household task she can no longer abide. “I won’t pay bills because I can’t stand to open another envelope,” she says. “I’ll leave letters sitting in the mailbox for days.” Questions 1. Which of the management theories described in the chapter does Ron Edens make most use of? 2. What do you think are the effects of this approach on (a) workers and (b) supervisors? 3. Do you regard Ron Eden’s approach to management as ethical and acceptable or unethical and unacceptable in the 2000s? Why? Source: Tony Horwitz, “Mr. Edens Profits from Watching His Workers’ Every Move,” The Wall Street Journal, December 1, 1994. 31 32 Jones−George: Contemporary Management, Fourth Edition I. Management © The McGraw−Hill Companies, 2005 2. The Evolution of Management Thought Small Group Breakout Exercise Modeling an Open System Form groups of three to five people, and appoint one group member as the spokesperson who will communicate your findings to the class when called on by the instructor. Then discuss the following scenario. T hink of an organization with which you are all familiar, such as a local restaurant, store, or bank. After choosing an organization, model it from an open-systems perspective. Identify its input, conversion, and output processes; and identify forces in the external environment that help or hurt the organization’s ability to obtain resources and dispose of its goods or services. Exploring the World Wide Web R esearch Ford’s Web site (www.ford.com), and locate and read the material on Ford’s history and evolution over time. What have been the significant stages in the company’s development? What problems and issues confronted managers at these stages? What are the challenges facing Ford’s managers now? Be the Manager How to Manage a Hotel Y ou have been called in to advise the owners of an exclusive new luxury hotel. For the venture to succeed, hotel employees must focus on providing customers with the highest-quality customer service possible. The challenge is to devise a way of organizing and controlling employees that will promote high-quality service, that will encourage employees to be committed to the hotel, and that will reduce the level of employee turnover and absenteeism—which are typically high in the hotel business. Questions 1. How do the various theories of management discussed in this chapter offer clues for organizing and controlling hotel employees? 2. Which parts would be the most important for an effective system to organize and control employees? Additional Activities on the Build Your Management Skills DVD • Test Your Knowledge: Management’s Historical Figures 71 Jones−George: Contemporary Management, Fourth Edition I. Management 2. The Evolution of Management Thought © The McGraw−Hill Companies, 2005 Case in the News What You Don’t Know About Dell D ell is the master at selling direct, bypassing middlemen to deliver PCs cheaper than any of its rivals. And few would quarrel that it’s the model of efficiency, with a farflung supply chain knitted together so tightly that it’s like one electrical wire, humming 24/7. Yet all this has been true for more than a decade. And although the entire computer industry has tried to replicate Dell’s tactics, none can hold a candle to the company’s results. As it turns out, it’s how Michael Dell manages the company that has elevated it far above its selldirect business model. What’s Dell’s secret? At its heart is his belief that the status quo is never good enough, even if it means painful changes for the man with his name on the door. When success is achieved, it’s greeted with five seconds of praise followed by five hours of postmortem on what could have been done better. Says Michael Dell: “Celebrate for a nanosecond. Then move on.” After the outfit opened its first Asian factory, in Malaysia, the CEO sent the manager heading the job one of his old running shoes to congratulate him. The message: This is only the first step in a marathon. Just as crucial is Michael Dell’s belief that once a problem is uncovered, it should be dealt with quickly and directly, without excuses. “There’s no ‘The dog ate my homework’ here,” says Dell. No, indeedy. After Randall D. Groves, then head of the server business, delivered 16 percent higher sales last year, he was demoted. Never mind that none of its rivals came close to that. It 72 could have been better, say two former Dell executives. Groves referred calls to a Dell spokesman, who says Groves’s job change was part of a broader reorganization. Above all, Michael Dell expects everyone to watch each dime— and turn it into at least a quarter. Unlike most tech bosses, Dell believes every product should be profitable from Day One. To ensure that, he expects his managers to be walking databases, able to cough up information on everything from top-line growth to the average number of times a part has to be replaced in the first 30 days after a computer is sold. But there’s one number he cares about most: operating margin. To Dell, it’s not enough to rack up profits or grow fast. Execs must do both to maximize long-term profitability. That means products need to be priced low enough to induce shoppers to buy, but not so low that they cut unnecessarily into profits. When Dell’s top managers in Europe lost out on profits in 1999 because they hadn’t cut costs far enough, they were replaced. “There are some organizations where people think they’re a hero if they invent a new thing,” says Rollins. “Being a hero at Dell means saving money.” It’s this combination—reaching for the heights of perfection while burrowing down into every last data point—that no rival has been able to imitate. “It’s like watching Michael Jordan stuff the basketball,” says Merrill Lynch & Co. technology strategist Steven Milunovich. “I see it. I understand it. But I can’t do it.” How did this Mike come by his management philosophy? It started 19 years ago, when he was ditching classes to sell homemade PCs out of his University of Texas dorm room. Dell was the scrappy underdog, fighting for his company’s life against the likes of IBM and Compaq Computer Corp. with a directsales model that people thought was plain nuts. Now, Michael Dell is worth $17 billion, while his 40,000employee company is about to top $40 billion in sales. Yet he continues to manage Dell with the urgency and determination of a college kid with his back to the wall. “I still think of us as a challenger,” he says. “I still think of us attacking.” All this has kept Dell on track as rivals have gone off the rails. Since 2000, the company has been adding market share at a faster pace than at any time in its history— nearly three percentage points in 2002. A renewed effort to control costs sliced overhead expenses to just 9.6 percent of revenue in the most recent quarter and boosted productivity to nearly $1 million in revenue per employee. That’s three times the revenue per employee at IBM and almost twice HewlettPackard Co.’s rate. Still, for the restless Michael Dell, that’s not nearly enough. He wants to make sure the company he has spent half his life building can endure after he’s gone. So he and Rollins have sketched out an ambitious financial target: $60 billion in revenues by 2006. That’s twice what the company did in 2001 and enough to put it in league with the largest, most powerful companies in the world. Getting there will require the same kind of success that the company achieved in PCs—but in altogether new markets. Already, Michael Dell is moving the company into printers, networking, handheld computers, and 33 34 Jones−George: Contemporary Management, Fourth Edition I. Management tech services. His latest foray: Dell is entering the cutthroat $95 billion consumer-electronics market with a portable digital-music player, an online music store, and a flat-panel television set slated to go on sale in October 2004. Dell also faces an innovation dilemma. Its penny-pinching ways leave little room for investments in product development and future technologies, especially compared with rivals. Even in the midst of the recession, IBM spent $4.75 billion or 5.9 percent of its revenues, on research and development in 2002, while HP ponied up $3.3 billion, or 4.8 percent of revenues. And Dell? Just a paltry $455 million, or 1.3 percent. Rivals say that handicaps Dell’s ability to move much beyond PCs, particularly in such promising markets as digital imaging and util- 2. The Evolution of Management Thought ity computing. “Dell is a great company, but they are a one-trick pony,” says HP CEO Carleton S. Fiorina. What’s more, Dell has shown little patience for the costs of entering new markets, killing off products— like its high-end server—when they didn’t produce quick profits, rather than staying committed to a longterm investment. “They’re the best in the world at what they do,” says IBM server chief William M. Zeitler. “The question is, will they be best at the Next Big Thing?” Dell’s track record suggests the CEO will meet his $60 billion revenue goal by 2006. Already, Dell has grabbed large chunks of the markets for inexpensive servers and datastorage gear. After just two quarters, its first handheld computer has captured 37 percent of the U.S. market for such devices. And Rollins says © The McGraw−Hill Companies, 2005 initial sales of Dell printers are double its internal targets. With the potential growth in PCs and new markets, few analysts doubt that Dell can generate the 15 percent annual growth needed to reach the mark. Questions 1. What are the main principles behind Michael Dell’s approach to managing? 2. List these principles then compare them to those developed by Henry Fayol. In what ways are they similar or different? Source: Andrew Park and Peter Burrows, “What You Don’t Know About Dell.” Reprinted from the November 3, 2003, issue of BusinessWeek Online by special permission. © 2003 McGraw-Hill Companies, Inc. 73 Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power Text © The McGraw−Hill Companies, 2002 Chapter Leadership Exerting Influence and Power MANAGERIAL BULLETIN 11 “The core The Power of Personal Commitment and Vulnerability problem for So how do you motivate people? Not with techniques, but by risking yourself with a personal, lifelong commitment to greatness—by demonstrating courage. You don’t teach it so much as challenge it into existence. leaders is SOURCE: Peter Koestenbaum, Philosopher and Consultant to Top Executives, quoted in Polly Labarre, “Do You Have the Will to Lead,” Fast Company, March 2000, p. 222. getting others to do what is necessary to accomplish the organization’s goals.” 35 36 252 Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power Text © The McGraw−Hill Companies, 2002 CHAPTER 11 The topic of leadership has fascinated people through the ages. After much discussion and research, the pursuit of a universal definition of effective leadership is still intriguing but elusive. The world awaits definitive answers to such questions as: What makes a good leader? Who can be a leader? Can anyone be a leader? Can leadership skills be taught? What makes followers follow? What are the limits to leadership? Social science researchers for years pursued the notion that there must be some common qualities shared by all leaders. Many long lists of sterling qualities (aggressiveness, wisdom, charisma, courage, and so forth) have been generated but have not been found to apply to all leaders in all situations. To be effective a leader’s qualities must relate somehow to the situation he or she is in and to the nature of the followers. This view is consistent with the situational approach taken throughout this book, yet is barely widely accepted. The belief does not easily fade away that General Patton, Mahatma Gandhi, Vince Lombardi, Golda Meir, and Martin Luther King—or the heads of AOL, GM, Microsoft, and John Hancock—must have had exactly the same qualities. Throughout this and the next chapter, we will be using the terms manager and leader interchangeably, even though customarily there is a distinction. A manager is usually considered to be someone who makes sure that work is carried out properly, while a leader is considered to be the person who decides on what the work ought to be (i.e., the direction to be taken). The two roles are increasingly hard to separate, since most managers today do have some responsibility for setting direction, and few get to just carry out routine work. As you might expect, insofar as there are common components to the manager’s or leader’s job, a few traits appear to be consistent requirements. In Chapter 1 we induced from Mintzberg’s analysis of a manager’s job some of the skills required by a manager. Recall that a manager needs interpersonal skills to acquire information needed for decision making. Leaders need to have the ability to influence other people’s behavior, a readiness to absorb interpersonal stress, the capacity to structure social interactions to task needs, some self-confidence, and the drive to exercise initiative in social situations, all of which are directly related to the nature of managerial work. The role of the CEO is to produce poetry and plumbing. James March Effective leaders also have a strong drive for responsibility and task completion, energy and persistence for accomplishing goals yet a willingness to tolerate frustration and delay (since working with and through others does not always result in immediate action!), some willingness to take risks and be original in solving problems, and, perhaps most important, a willingness to accept the consequences of making decisions and taking action.1 In general, you can see that these traits are closely related to the kinds of situations in which virtually all leaders find themselves, having to build relationships in order to accomplish tasks and having to take responsibility for their system’s performance. The particular requirements for effective leadership in each situation, however, may well outweigh all of these traits or make only certain ones critical in importance. As we will show in Chapter 12, different kinds of tasks, different kinds of subordinates, and differing leader characteristics all affect what leader behavior will be effective. Thus, possession of the qualities listed does not guarantee that one will become a leader, nor does the absence of any one of them rule out the possibility of Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 253 MANAGERIAL BULLETIN In the Lead: Some Managers Are More than Bosses—They’re Leaders, Too Managers “know how to write business plans, while leaders get companies—and people—to change,” says Carol Bartz, chief executive of Autodesk Inc. When she was recruited six years ago to head the Silicon Valley software company, profits were flat, and sales growth was slowing dramatically. New software releases were way behind schedule. The prior CEO had left amid open rebellion by the company’s young and undisciplined programmers, who viewed top management as an overbearing evil. Ms. Bartz didn’t hesitate to impose her views. She rounded up employees she determined were “opinion leaders” and persuaded them that no matter how inventive they were at 3 A.M. dreaming up new software, they wouldn’t get anywhere if they didn’t deliver products on time. The new version of the company’s flagship product made it to market just four days late. Within six months, she dumped marginal businesses, made an acquisition and reassigned programmers, ignoring those who advise new CEOs to respect the past. “That’s a mistake,” insists Ms. Bartz. “If you just do what’s already been done, how do you show your value? You have to make tough decisions.” She also impressed employees with her personal courage. On her second day at Autodesk, Ms. Bartz, a former Sun Microsystems executive, was diagnosed with breast cancer. Figuring that as a new CEO it wasn’t the time to disappear, she refused to let her illness distract her from her job. She had a stopgap lumpectomy, then worked a month before getting the radical mastectomy she needed. Straightforward and unpretentious, with a hearty laugh, Ms. Bartz links her leadership strength to knowing that “you constantly have to reinvent yourself.” Since 1992, she has more than doubled Autodesk’s revenue to more than $600 million. “Human nature says cling to what you have, whether that’s an old coat, a boyfriend, or a way of doing business,” she says. A leader has to enjoy saying, “leave that behind.” SOURCE: Carol Hymowitz, “In the Lead,” The Wall Street Journal, December 8, 1998, p. B1. (Copyright © 1998, Dow Jones & Company, Inc.) MANAGERIAL BULLETIN Leadership Practices and Attitudes (Competencies) Common to 62 Companies The five core leadership attribute buckets: “Tell” (Giving direction). “IQ” (Mental horsepower). “Sell” (Influencing others). “EQ” (Emotional Intelligence). “Initiate” (Making things happen). “Know” (Business and technical acumen). “Relate” (Building relationships). “Grow” (personal development). “Ego” (Strong sense of self). SOURCE: George O. Klemp, “Leadership Practices and Attitudes (Competencies) Common to 62 Companies,” in Putting It Together (Cambria Consulting, Inc., 1998). Next, the four core leadership practice buckets: becoming an effective leader. We, therefore, must emphasize that the potential for leadership may be assumed to be widely distributed among the general population, and a wide variety of leader behaviors may be effective in particular situations.2 What, then, must be taken into account by leaders who wish to be effective in their particular organization? What behavior works best under what conditions? 37 38 Cohen: Effective Behavior in Organizations, Seventh Edition 254 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text CHAPTER 11 MANAGERIAL BULLETIN Can Leadership Be Taught? Leadership is no longer seen as the exclusive preserve of the inhabitants of executive row. The nurturing of “corporate Gandhis” has given way to a focus on developing leadership abilities among employees at all levels of our organizations. An executive, a manager, a supervisor, an hourly worker—all can learn to develop a vision for the future. All can learn to accept new responsibilities, to take risks, to build consensus and trust among subordinates and peers. Certainly not everyone has the potential of a Lee Iacocca. But everyone possesses innate leadership abilities to some degree and those abilities can be improved. SOURCE: Chris Lee, Training, July 1989. That is what we explore in this and the next chapter. We begin in this chapter with an analysis of leadership in general as the exercise of power and influence, then continue in Chapter 12 with the roles of formally appointed managers and their leadership choices. Leadership as Influence The core problem for leaders in organizations involves getting others to do what is necessary to accomplish the organization’s goals. This is a complex process, because the goals as well as the means for accomplishing them are often unclear, subject to discussion or negotiation, and can change over time. A leader’s boss (or bosses), peers, and subordinates all have ideas about what should be done and how to do it, and they are likely to try to get their ideas heard. Furthermore, leaders are only human and unlikely to know everything, so they need to be able to alter their views when others make good points. Nevertheless, once goals are determined, leaders or managers must find a way to create the conditions that will cause (or allow) subordinates to work hard and to direct that work toward organizational ends. This may call for many different kinds of influence behavior aimed in many directions: negotiating a larger budget; getting other departments to deliver accurate and timely information; providing vision, direction, or training to subordinates; simplifying or complicating work; obtaining a deserved salary increase for someone, and so forth. All these activities—up, sideways, and down—ultimately are aimed at getting others, especially subordinates, to do what is necessary to accomplish successfully the work of the system being led. Leadership is the ability to get men to do what they don’t want to do and like it. Harry Truman As countless leaders have discovered countless times, this is more easily said than done. Subordinates don’t always know how to work well, don’t always work as hard as is necessary, and don’t automatically care about the unit’s or organization’s success. The fact is, leaders are interdependent with many others, especially their followers. They have an effect on, and in turn are affected by, those with whom they must work. The key element is the influence the leader has on others and the influence Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 255 MANAGERIAL BULLETIN Training Bosses to Use Influence, Not Raw Aggression, Improves Their Effectiveness Coaching—as executive development has come to be called—is not new. But corporate shrinkage and the dawning era of flexible, decentralized management are making obsolete the idea that executives can expect to muscle their way to a career pinnacle and then coast until retirement. Increasingly, they are expected to be, in the words of the anthropologist Harvey Sarles, “autodidacts,” or self-teachers and lifelong learners, whose performance will evolve and improve. SOURCE: Barbara Presley Noble, “At Work: In Praise of Executive Coaching,” New York Times, April 24, 1994, p. F23. they have in return. For this reason we can think of leadership as a process in which the involved parties influence one another in particular ways. Influence is any act or potential act that affects the behavior of another person(s). Let’s look at the implications of using the concept. First, influence cannot happen in isolation from others; it takes at least two to “tangle,” just as with interpersonal relationships. The person who wants to influence must find someone to influence. Second, if you think about it carefully, you will see that only in the most extreme situations could one person in an influence transaction have all the influence—that is, affect the other’s behavior without being affected in turn by the other’s reaction. The machinist who leaps to attention when the boss gives an order, the secretary who bursts into tears when feeling that a request to work late is unreasonable, the student who challenges an assignment due the day after vacation—all exert influence on the person trying to influence them. Cooperating humbly, for example, affects the person who is asking for cooperation and “pulls” more of the same from him or her. As Gandhi showed so well in India, humble, passive noncooperation can have a profound influence on those giving orders. Even the person who follows directions he or she knows are wrong out of fear of being fired or punished has influence on the behavior of the tyrant, allowing further exploitation and mistakes, because the directions were not resisted. We must be careful then to remember that influence succeeds in moving others in desired directions only when the net influence, the amount of A’s influence on B compared with B’s influence on A, is greater. In the classroom or on the job, students and workers can be less or more influential than teachers and supervisors. Leadership is net influence in a direction desired by the person possessing it. To understand this process better, we need to look at various types of influence. One important aspect of influence is whether or not it is formal or informal, part of a job’s definition or acquired in some other way. Formal influence is influence prescribed for the holder of an “office” or a position in a particular social system. It is influence assigned to a position. The coach of a team has formal influence in initiating practice sessions, selecting starting players and substitutes, and so forth. Informal influence is influence not prescribed for the office holder but nevertheless affecting other members of the social system. On the same team, for example, there may be several players whose advice other players and even the coach seek on such matters as techniques and strategy against opponents. Although by position the players have no special influence allotted or assigned to them, their knowledge or personal attractiveness, or both, give them influence anyway. Influence based on special knowledge is expert influence, while influence based on personal charm is called charisma. 39 40 256 Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power Text © The McGraw−Hill Companies, 2002 CHAPTER 11 In addition to the distinction between formal and informal influence (i.e., assigned or unassigned), we need to add the concepts of legitimacy and illegitimacy. Legitimate influence is exerted by a person who is seen as having the right to do so by those influenced. In other words, legitimate influence is accepted as proper by the person being influenced. Conversely, illegitimate influence is exerted by a person not seen as having the right to do so by those being influenced. Illegitimate influence is not accepted as proper by the person being influenced. The basis for considering an influencer as legitimate may be (1) a positive assessment of his or her personal qualities, such as competence, experience, and age and (2) the acceptance of the process (such as election, appointment, or automatic succession) by which the person acquired a role calling for the exercise of influence. Legitimacy will usually be limited to areas within the scope of the system and its goals. For example, most people will believe that the boss may legitimately give orders about how to sell a machine but not about where to go on vacation. But within the scope of the organization, orders, requests, and directions will be seen as proper when they come from someone who has acquired an office by an approved process or has personal qualities considered appropriate. To despise legitimate authority, no matter in whom it is invested, is unlawful; it is rebellion against God’s will. Leo XII Immortale Dei November 1, 1885 On the other hand, even in the army—where soldiers are taught to “salute the uniform, not the man,” suggesting that mere appointment to rank guarantees legitimacy—a soldier may refuse to follow direct orders under a variety of circumstances. To illustrate, if the commanding officer has disruptive personality characteristics or has acquired his office in objectionable ways, such as perceived favoritism, there may be rebellion. Furthermore, when influence is not seen as acquired legitimately, soldiers and other subordinates have many ways of subverting any orders from a person whose influence they do not accept, such as dragging their heels by following literally all rules in the books. Going passive is a common way of resisting what is seen as illegitimate influence. Because having formal influence does not ensure legitimacy nor does having informal influence ensure illegitimacy, it is useful to combine the two categories into the four possible combinations, as shown in Figure 11–1. By looking at the combinations, we can see the ways in which influence is exercised. Formal-legitimate influence is what is usually meant when people say “the boss has the authority” to enforce particular behaviors. It is the influence both prescribed for the holder of an office in a social system and seen as his or her right to exert by the other members of it. Many leadership activities in organizations involve formal-legitimate influence by someone who has been assigned a role with supervisory responsibilities and who can use organizational means to reward or punish subordinates. The right to hire, fire, promote, and adjust pay reinforces this kind of influence. Because most people who accept jobs in an organization are reasonably willing to accept directions from their “boss” on job-related matters, legitimacy is often taken for granted and assumed to go with any formal role. During such times as the student strikes in the late 1960s and early 1970s or the rebellions of workers in France, it becomes evident that the legitimacy of those with formal organizational positions is precarious and rests upon the attitudes of the “followers.” Students challenged the rights of professors to determine subject matter, give exams and grades, hire and fire colleagues; and they exerted influence on other activities that had traditionally been Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power Text LEADERSHIP: EXERTING INFLUENCE AND POWER FIGURE 11–1 © The McGraw−Hill Companies, 2002 257 Examples of Types of Influence Legitimate (accepted as proper) Illegitimate (not accepted as proper) Formal (assigned) Boss gives work-related orders to subordinate: “Stop making widgets and begin making frammisses.” Informal (not assigned) Respected colleague helps you solve a problem by showing you the proper order to make calculations. Teacher assigns an analytical paper, based on concepts in the text. Basketball benchwarmer notices flaw in opponent’s defense, convinces coach to alter offense. Co-worker threatens to beat you up if you continue to produce so much. Boss makes strong hints about subordinate’s family life: “Send your son to a private school.” Student put in charge of class discussion by instructor. Fellow students ridicule you for asking questions in class, despite instructor’s request for questions. seen as part of faculty prerogatives. More recently, students have challenged college trustees about investments in companies using child labor, and challenged administrators about pay levels of building and grounds workers. Pressure from workers in several European countries has led to change in what were traditionally considered management’s prerogatives. In several countries, workers must even be consulted for such decisions as plant location and new investments in equipment. Thus, the boundaries of legitimacy for decisions is changing. Furthermore, legitimacy, even for someone in a formal position, must be earned and may occasionally need renewal. At different times a formal leader may find legitimacy slipping away because of questions about competence or about the way in which the person is leading. Similarly, some subordinates may see the boss as legitimate while others don’t. It is often the case that an appointed leader is perceived as legitimate by those with similar backgrounds and as illegitimate by those with backgrounds different from the leader’s. A scientist might not, for example, accept the influence of an engineer as a project leader as readily as would another engineer. Since legitimacy is an attitude about a person by other persons, it can change just as do other attitudes. Nevertheless, much of the work of organizations is done because there is a considerable amount of legitimacy granted to those in formal positions; but that is by no means the only kind of leadership exerted. A great deal of influence is based upon knowledge, expertise (whether perceived or real), or personal charm rather than position.3 This informal-legitimate influence by a member of a social system stands apart from the prescribed influence of his or her office but is accepted as within one’s rights by the others in the system. It is not predictable from organization charts but is essential to organizational functioning. Some people know things or behave in charismatic ways that others value, regardless of position, and are given influence accordingly. The most expert auditor in an accounting office may be consulted by other auditors and listened to even though he or she has no formal assignment to help others. The rewards and punishments available to this kind of influencer are more personal—that is, he or she can give or withhold important information or support in return for gratitude and respect. Leadership in classroom groups is often of the “expert” kind, with the most knowledgeable member(s) of the group gradually becoming respected and listened to even when there is no formal leader. In fact, among many student groups there is a widespread student norm that no peer should give orders or directions to another student, so even those students put in leadership roles by a class exercise often hold back from giving directions. Conversely, a fellow student making a “grab for power” will usually be resisted by other students. Sometimes such a person has quickly volunteered for a leadership role before others dare to and is allowed to take it despite feelings that “it isn’t right”; in 41 42 Cohen: Effective Behavior in Organizations, Seventh Edition 258 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text CHAPTER 11 MANAGERIAL BULLETIN A Title Is No Guarantee of Power And these considerations . . . hamstrung [Mayor] LaGuardia in his dealings with [Robert] Moses: Moses’ popularity; Moses’ immense influence with a governor and a legislature from whom the mayor constantly needed favors; Moses’ ability to ram through the great public works that the mayor desperately wanted . . . scandal-free and in time for the next election. With good reason, he doubted whether anyone else could. The powers that the mayor possessed over Moses’ authorities in theory he did not possess in practice. Political realities gave him no choice but to allow Moses to remain at their head. And the mayor knew it. Moses knew it, too. After reading the bond agreements and contracts, LaGuardia dropped all further discussion of the authorities’ powers. Moses never raised the matter again. But thereafter he treated LaGuardia not as his superior but as an equal. In the areas in which he was interested—transportation and recreation—Robert Moses, who had never been elected by the people of the city to any office, was thence forward to have at least as much voice in determining the city’s future as any official the people had elected—including the mayor. SOURCE: Robert A. Caro, The Power Broker: Robert Moses and The Fall of New York (New York: Alfred A. Knopf, © 1974). that case, the student has formal-illegitimate influence, which may not last long, unless he or she is seen as helping the group reach its goals. Similarly, in organizations where members are accustomed to having considerable say in matters affecting them, the boss’s decision to create a new position located between him or her and the others (“because the work load is too heavy for me”) can result in resentment toward whoever is put in that new job and lead only to grudging cooperation. If that person, however, has the formal authorization to administer some organizational rewards and punishments, he or she may end up with considerable influence anyway. Finally, the person who acquires influence over others by personal access to some valued rewards or feared punishments is using informal-illegitimate influence. Physical threats by a fellow worker can coerce compliance that would otherwise be refused, as can special relationships with higher-ups. In one New Hampshire school system, for example, by maintaining a close relationship with several powerful school board members, the music director forced principals to release students for weeklong band trips and to arrange schedules to suit his convenience. He thus obtained more influence over principals than was called for by his position or was seen as his right by them. Although he obtained compliance, he also created considerable resentment and was constantly criticized behind his back by the principals. I must admit my management style was too simple sometimes. Chinese track coach Ma Junren, after confirming that he occasionally beat up members of his worldclass squad, Newsweek, April 3, 1995 Taking Initiative as an Act of Leadership Have you ever found yourself in a room that was so hot and stuffy that you and other students were having trouble concentrating on the lecture or discussion? What do you do? Wait and hope the instructor will recognize the problem and call a break; or raise your hand, point out the difficulty, and suggest opening some windows and taking a Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power Text LEADERSHIP: EXERTING INFLUENCE AND POWER © The McGraw−Hill Companies, 2002 259 break? Raising your hand could be an act of leadership. To wait for the designated leader (instructor) to act could mean missing an opportunity to make it a better class. Taking initiative might have the payoff of enhancing your influence (or status) but also involves the risk of being “shot down” by the formal leader of the class. In the next chapter we examine the obligations and choices of those who have been formally appointed to managerial positions, that is, who are in a formal role. In this chapter we have been discussing the exercise of influence by anyone and have defined leadership as influence. We might also define leadership as those actions that move a group toward its goals (such as opening a window when the room is stuffy). The distinction between formal and informal leadership is a useful reminder that as group members and as subordinates anyone can exert influence (leadership)—and often should. In small work groups, it is important for all members to take initiative. Similarly, it can be important that a subordinate exert initiative in a staff meeting or a committee meeting and not just wait for all leadership to come from the designated manager or chairperson. How People Are Influenced There are three processes (not mutually exclusive) by which people are influenced— compliance, identification, and internalization.4 The very same behavior (namely, doing what you are told to do by another person) can stem from any one or a combination of these processes. Compliance amounts to doing something because of the costs of not doing it. You go along with the “order” on the outside, but inside you may feel resentment or resignation. Any leader’s influence can rest on compliance, particularly where there is fear of punishment or a desire to gain some reward; this may be the only way in which an informal-illegitimate leader can exert influence. Where compliance is operating, leaders will be successful only as long as they have control over whatever it is followers need or want. Identification occurs when you are influenced by someone because of the attractiveness of that person, because the person either is likable and has charisma or represents something to which you aspire (e.g., an important position). Formal, designated leaders or managers often exert influence because subordinates identify with them. They may also be legitimized by their subordinates through the same process. Identification with a charismatic leader can dramatically affect behavior for people who want to believe in lofty goals that will somehow be ennobling. When such people see a leader as having a grand vision of what is possible and offering specific means for achieving their dreams, they identify with the leader and dedicate themselves to the cause. This can lead to extraordinary efforts by followers on behalf of the leader and, thus, unusually high organizational performance. That is why effective high-level executives spend so much time creating a vision or “story” about where they see their organization (or unit) going and then telling and retelling it to colleagues, subordinates, and outsiders.5 Ironically, it has been claimed that charismatic leaders only succeed because they make followers feel weak and dependent. But some charismatic leaders can make followers feel more powerful, more confident, and more capable, not less.6 Followers come to see themselves as achieving their own goals through the leader, not as having the leader’s goals forced on them. When this happens, influence through identification with the leader can spread to another mode, internalization. Internalization, the third kind of influence, happens when leaders have the necessary expertise and values to be credible to their followers; they come to believe that what the leader suggests is in fact the best course of action for them. The leader’s opinions are seen as valid and trustworthy. The effect is that followers internalize the leader’s opinions, thus giving full legitimization to the leader—formally designated or not. 43 44 Cohen: Effective Behavior in Organizations, Seventh Edition 260 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text CHAPTER 11 MANAGERIAL BULLETIN Managing Your Career: Silicon Valley Hybrid—A Boss Who Makes Others’ Ideas Pay Off At McKinsey, the emphasis was on getting the right answer, [Gregory Slayton, CEO of ClickAction, Inc.] says. But “Silicon Valley is all about the strength of your network. If no one answers your call, you can’t get that answer implemented.” . . . To succeed as a Silicon Valley CEO, he says, requires more than “intellectual firepower.” He considers himself an “implementer,” whose successes have come mostly from other people’s ideas. What is needed, he says, is the ceaseless drive to make things happen, the willingness to make a decision when you have only 10% of the information you would like to have, and the ability to forge trusting relationships. That ability is critical in motivating the workers of the new economy, he says. “You have to get them interested in the greater cause you’re pursuing,” he explains. “If not, they’re out there playing video games and trading on E*Trade.” SOURCE: Hal Lancaster, “Silicon Valley Hybrid: A Boss Who Makes Others’ Ideas Pay,” The Wall Street Journal, October 26, 1999. . . . the ultimate paradox of social leadership and social power. To be an effective leader, one must turn all of his so-called followers into leaders. David C. McClelland Power: The Inner Experience Over the long run, the most successful managers are those whose influence is based on credibility—that is, where the followers are convinced by the logic of the leader’s ideas and requests and internalize the influence. You can see how a combination of these factors can have different effects. Compliance may be necessary under certain conditions (e.g., an emergency or when the task is minor and implementation is easily enforced) but is difficult for a manager to sustain. Some people will do what you want strictly out of compliance and some because they identify with you or your position. To maximize your effectiveness as a leader, however, it is best to build credibility and reach people through internalization, so that they will do what is necessary because they want to. Generating Employee Commitment The important outcome of both identification and internalization is commitment, which is an attitude driven from within the person. You know when you are committed to something—a person, an activity, a belief—when your behavior is motivated by forces inside yourself and not from outside pressures, as with compliance. In the past, organizations have depended heavily on compliance and control to accomplish their goals; today more and more organizations are attempting to build employee commitment, which obviously has more long-lasting benefits. Leadership efforts have been directed to three major areas: the work itself, the relations among people, and the organization as a whole. Approaches to building commitment to the work itself include both formal methods, such as work redesign, and informal ones, such as permitting employees a high degree of freedom to manage their own work procedures. Approaches to generating interpersonal commitment also have included formal and informal methods Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 261 MANAGERIAL BULLETIN Winning Strategies of Corporate Stars Headhunters Neff and Citrin found America’s top business leaders share these six principles: 1. 2. 3. Live with integrity, lead by example. “Integrity builds the trust in senior management that is . . . critical for high-performing organizations.” Develop a winning strategy or “big idea.” “A successful leader must go to the company’s roots and build on the things the organization truly does best.” Build a great management team. Great leaders hired managers “whose skills and experiences complemented their own, but whose passion, attitudes, and values were one and the same.” 4. 5. 6. Inspire employees to greatness. “Communicate continuously, listen carefully, genuinely tolerate failure as a learning experience.” Create a flexible, responsive organization. “The best leaders have redesigned their organizations to make sure decisions can be made fast.” Use reinforcing management systems. “Compensation . . . must be consistent with and reinforce the values and strategy of the organization.” SOURCE: “In Search of Leadership: A Talk with Headhunters Turned Authors Citrin and Neff,” Business Week, November 15, 1999, p. 172. (Copyright 1999 McGraw-Hill, Inc.) such as planned team-building or informal encouragement of collaborative norms. Similarly, organizational commitment is developed in both formal and informal ways. The “transformational” leader, who inspires people to excel and articulates a meaningful vision for the organization, uses both ways to build employee commitment.7 In Chapter 12 we introduce you to the concept of “developmental leadership,” which is similar to that of transformational leadership, but which goes beyond it by spelling out practical applications in the workplace. It might interest you to know that the traits of the transformational or developmental leader are claimed to be more typically characteristic of women than of men. The implications of this for future organizational needs and for personal learning and opportunity are extremely important.8 However, recent survey evidence raises questions about whether there are real differences between men and women managers: . . . a 15-year survey of 41,000 executives—25% of them female—at 5,000 companies shows that women are slightly more high-handed than the guys are when making decisions . . . Discovery Learning . . . came to that conclusion by investigating whether managers solve business problems autocratically—preferring to make unilateral decisions—or “inclusively . . .” [W]here an autocratic style was deemed appropriate, women chose “my-way-or-the-highway” 35% of the time, guys only 31.5% . . . “Did [women managers] make it to these levels because they operate more like men, or is there basically no difference?” . . . if your boss is a Ms., don’t automatically expect her decision-making to be warm and fuzzy.9 Finally, it is important to recognize that, while the three areas of commitment discussed above tend to be related, they also exist independently of each other. Many workers are committed to their work and not to their colleagues or to the organization as a whole. And many employees are committed to their “team” and even to the organization and feel a very low level of identification with the work they are doing. Because there are a variety of combinations of the three dimensions, it is important for a manager to develop a diagnostic profile of the three as they fit his or her part of the organization. Such a diagnosis allows for a focused approach to 45 46 Cohen: Effective Behavior in Organizations, Seventh Edition 262 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text CHAPTER 11 MANAGERIAL TOOLS Gaining Commitment from Your Employees: Some Key Points For the individual, it depends on: 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. Involvement. Choice. Meeting positive expectations. Feeling supported and valued. Need fulfillment. Feedback that facilitates improvement. Intrinsic satisfactions. Challenge and opportunities to grow. Being treated fairly. Affirmation of self-concept. In interpersonal relationships, it depends on: 1. Mutual support, acceptance and reinforcement of self. 2. Openness where needed and appropriate. 3. Trust and confidence (mutual). 4. Compatible styles: a. Similar or b. Complementary. 5. Acceptance or appreciation of differences, or both. 6. Opportunities to problem solve jointly. 7. Willingness to manage conflicts. For a group, it depends on: Norms that support organizational goals. Cohesiveness around those norms. Rewards at a group level. Group being valued by organization. Acceptance of individual differences in abilities, preferences, and values. 6. Ability to match member resources to any given task. 1. 2. 3. 4. 5. For the total system, it depends on: 1. The parts being aware of the whole. 2. Groups being willing to accept each other’s legitimacy and importance. 3. Willingness of people to interact across group boundaries. 4. Recognition of the importance of reciprocity. 5. Appreciating the importance of diversity with respect to: a. Ideas and b. People. SOURCE: Stephen L. Fink, High Commitment Workplaces, Quorum Books, 1992. actions that will address problems of commitment where they exist. In the Managerial Tools box above, we have listed some of the key issues that pertain to employee commitment as they affect the individual, interpersonal relationships, group behavior, and the organization as a whole. Power The capacity to exert influence is power. (Often “power” and “influence” are used interchangeably.) People who have the ability to exert one or more of the four types of influence have power, which can be used toward the organization’s ends or toward subgroup or individual goals, including those in direct opposition to organizational goals. As suggested earlier, no one is completely without influence, but some people have more net influence than others and hence more power. Power is often perceived to be a bit “dirty,” at least in the United States, something vulgar, but it is more than a set of sneaky tactics for grinding others into the dirt; power in organizations is the ability to make things happen.10 Organizational work cannot be done without that ability, and managers need to understand it in order to bring together the people and resources to accomplish what must be done and to avoid the negative consequences of power differentials. Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 263 MANAGERIAL BULLETIN Tyrants Beware Nobody minds being subjected to the power of somebody who’s genuinely interested in getting the job done and making more money and extracting maximum performance. But nobody wants to be told that they have to have their pencils sharpened and the erasers all facing in the same direction before they leave the office at night. SOURCE: Michael Korda, “Psychodynamics of Power,” Mainliner, March 1977. MANAGERIAL BULLETIN Rep. Bolling Takes His Leave of Power It took me 32 years to realize that it’s sometimes more important to have the trappings of power than power itself. If you’ve got a good-looking room with a nice chandelier, your colleagues may think you’ve got power. Actually, all you’ve got is a chandelier and room. Washington is full of illusions like that. SOURCE: Dennis Farney, The Wall Street Journal, January 1, 1982. Sources of Power in Organizations How, then, is power obtained by individuals in organizations? In general, The more legitimate one is perceived to be, the greater the likelihood of acceptance of one’s attempts to influence, and the less resentment at going along.11 Power goes to those who are seen as having a right to it. Conversely, the less legitimate forms of influence breed resistance and resentment, although they will probably enhance the power of someone who already possesses other kinds of legitimate influence. Additionally, informal influence is often necessary for those with formal influence if they want more than drudging cooperation; when a formally designated leader does not have some knowledge seen as helpful by subordinates, it will be difficult to secure more than token compliance. As organizations become more complex and technically demanding, more people in leadership positions do not have the technical expertise necessary to gain influence beyond that of their own job description, making it hard for them to get full cooperation from those who know more than they do about some other aspects of the job. They must then find ways of gaining informal influence through their own personal attractiveness and their ability to make friendly relationships—or they must settle for a low-power position relative to their subordinates. Perhaps the primary source of power is the ability to enhance the organization positively in relation to its “environment” or key problems.12 Those who can help the organization achieve its goals by overcoming the most difficult, pressing, and dangerous problems are likely to acquire power. A marketing expert in a company that can sell everything it can make but cannot solve its production problems is less likely to gain power than the production engineer who can eliminate the bottlenecks. So it helps either to acquire skills that are (and will be) critical to the organization or to seek employment where the skills one has are most likely to be needed. 47 48 Cohen: Effective Behavior in Organizations, Seventh Edition 264 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text CHAPTER 11 MANAGERIAL BULLETIN Management: When Young Managers Deliver the Pink Slips Many 20-somethings are managers, and holding onto employees, not letting them go, is their main concern. But when pink slips must be delivered, these young bosses often have to deliver them. . . . Managers have always had to dismiss underlings when their performance lagged or the company’s profits sagged. Even Amazon.com and iVillage.com recently had to trim their staffs for economic reasons. . . . But not so long ago, the bearer of bad tidings was usually an old pro, or . . . old enough to know how to cope with the emotions surrounding it. Today, increasingly, the dirty work is done by people a few years out of college for whom management has mostly meant recruiting employees with stock options and playing the host at happy hours. . . . Aside from the legal implications, young executives are often not equipped to handle the emotional side of firings. SOURCE: Charles Butler, “Management: When Young Managers Deliver the Pink Slips,” New York Times, February 16, 2000, p. 10. ©2000 The New York Times Company. Furthermore, it helps to do things that are not routine, that are unusual or extraordinary in the organization. A person who performs critical tasks in a way that is already established and routinized will receive less power than a person who develops new methods or procedures, starts a new unit or task, creates a new project or product.13 That is why those who are organizationally ambitious do not like to be the second or third person in a job; they would prefer to be the first to do a job, so they can most easily leave their mark. And in any job they move into, they often seek early changes in something, even office layout or decor, to show that they intend to do things differently. That suggests a third important aspect of power acquisition: It is not enough to be doing extraordinary, critical activities; one’s efforts must be visible and recognized. Power goes not just to those who do well, but to those who are also seen to do well.14 (In fact, some cynics claim that appearance is all, though it is hard to sustain power when one does not actually produce.) Those who want power must find ways to achieve recognition. Among other things, it is a political process. This can happen in many ways. A well-written and well-timed report can help promote visibility, as can a well-presented oral report at a meeting. The opportunity to make a presentation to higher-ups creates a natural chance for “showing one’s stuff ” and for demonstrating the importance and relevance of the work done. Similarly, serving on committees, often seen as a nuisance, is a chance to show others besides one’s boss what one can do. “Doing one’s homework” before meetings often helps both to make a good impression and to lead to more responsibility and thus power within the committee. Those who want power look for responsibility, for chances to demonstrate ability to get things done. Through committee work or social contacts, power seekers make connections with one or more people higher in the organization. A higher-up who thinks a person shows promise might become a kind of “sponsor” who will look after the aspirant’s career, help create opportunities, and build reputation. Also, when people are perceived as “having a friend or friends in high places,” then others may defer to them or seek them out even without direct intervention on the powerful person’s part. Because power is a social process of influencing others to act, it comes in part from being able to do things for others that obligate them to be helpful in return by fulfilling the norm of reciprocity.15 Thus, the person seeking power needs to find ways to be helpful to others in the organization. Volunteering to handle unpleasant Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 265 MANAGERIAL BULLETIN Are You More of a Street Fighter or a Jekyll and Hyde? Most bosses think they do a pretty good job of keeping their subordinates happy. Don Bibeault has no such illusions. “I’m not a jolly fellow who’s fun to be with,” . . . “I’m extremely dedicated and determined, and I don’t have time to sugarcoat problems. If that’s considered abrasive behavior, so be it.” [He claims] that being a street fighter is the only way he could be effective. His harsh style helped him revive or liquidate 11 companies . . . as a turnaround specialist. But it did lead to occasional confrontations. SOURCE: Tony Lee, “Are You More of A Street Fighter or a Jekyll and Hyde?” The Wall Street Journal, June 11, 1996, p. B1. MANAGERIAL BULLETIN Is Craig Weatherup Too Nice for PepsiCola’s Own Good? The chief executive of PepsiCo Inc.’s global beverage arm is widely regarded by employees as a benevolent boss. . . . One school of thought has it that Pepsi can never beat an increasingly aggressive Coca-Cola Co. without a certain ruthlessness in the executive suite. “What’s needed at Pepsi is some basic brutality because when you’re dealing with killers that’s the only thing that will help you prevail. . . . “It staggers me that for whatever reason being nice is seen as being inconsistent with being tough,” says [Weatherup]. [His] argument is this: If you’re a visionary but you’re mean, employees won’t follow you. SOURCE: Nikhil Deogun, “Pepsi’s Mr. Nice Guy Vows Not to Finish Last in Battle with Coke,” The Wall Street Journal, March 19, 1997, p. B1. tasks, finding ways to make others’ jobs easier, and doing favors whenever possible are all ways of creating obligations, which can be collected on when needed. That is exactly how politicians, who have to be interested in power, build it. Another way of looking at this is in terms of control of key rewards and punishments in the organization. Power reflects the ability to give rewards or punishments in order to get others to do what one believes needs to be done.16 The more a person has access to controlling rewards and punishments, the greater his or her power.17 Thus, a person who can give the formal rewards or use the formal punishments of an organization—hiring, firing, promoting, adjusting salary, allocating choice assignments or space, giving recommendations, and so forth—and give informal rewards or punishments, such as help, information, and liking, will have the most power. Just what the rewards and punishments are depends on the organization and the perceptions of those in it; but whatever it is that people value or fear, those who control it will have power to influence behavior. Attention to what the rewards are to those in the organization, who manages them, and which departments or units currently get them in greatest proportion, can aid in determining how to get control of them. At the very least, power seekers figure out what rewards they already control so that they can more wisely use them to create obligations or induce cooperation when needed. One common accessible reward (even at lower levels of the organization) is finishing, on time, work that someone else needs and is waiting for. That builds gratitude—or, as it is called in some organizations, chits—which can be “cashed in” when needed. 49 50 Cohen: Effective Behavior in Organizations, Seventh Edition 266 11. Leadership: Exerting Influence and Power Text © The McGraw−Hill Companies, 2002 CHAPTER 11 MANAGERIAL BULLETIN “That Report Is on My Coffee Table” Many of your readers . . . have aspirations of becoming wealthy and powerful. If they succeed, however, I hope their egos will not require offices with private saunas and push-button controls. If one is important and powerful, the right people know it. If not, handpainted china will not change it. With the economy in a depression, dividends being omitted, and millions unemployed, it is embarrassing to read about the conspicuous consumption and crystalline egos of America’s top executives. What we need are offices that look like offices, not living rooms. SOURCE: From a letter to the editor of The Wall Street Journal by Sam Bosch, January 28, 1982. One interesting aspect of the kind of power that is associated with rewards is the power obtained by helping to relieve people’s anxieties (reduce their tensions). “Got a problem? Go see Joe. He’ll help you work it out.” In fact, when this kind of power is carried to an extreme, unusually high expectations can be imposed on the holder and may even put a strain on that person’s ability to retain that power. Pfeffer18 points out the power one obtains by being seen as someone who can reduce uncertainty in an otherwise chaotic situation. Given the nature of organizations today, this source of power is undoubtedly on the increase. Most people have a limited tolerance for uncertainty (or ambiguity); the person who can help to reduce that uncertainty is likely to attract a following. It is not unlike the following of any person who is viewed as “having the answers.” None of the methods described provide for easy access to power; in fact, sheer willingness to work hard is almost always a requisite for acquiring power. As should be clear by now, hard work alone may not be sufficient—it is necessary to work at critical, unusual tasks with or for people who recognize what you are doing—but without hard work it is extremely difficult to acquire power. Furthermore, A desire for power with little genuine concern for the well-being of the organization and for other members can be very destructive to the organization—and even to the power seeker. Consequences of Possessing Power Regardless of the source of power, its possession tends to lead toward certain consequences, not all positive. These can be stated in the following propositions:19 1. The more power attributed to a person, the more he or she is the recipient of: a. Communication. b. Solicitous behavior. c. Deference by others seeking power. This proposition suggests that those with power will be deferred to and that, when those with less power are in the presence of powerful persons, they will address comments to them more than to one another. Large discrepancies in power between individuals, however, can interfere with successful work. If subordinates do not have sufficient power, they often will not be able to get their work done, because they can’t get the resources or responses they need. This in turn reduces the leader’s power. Furthermore, large power gaps often lead to avoidance of the high-power person by the low-power person and to distorted communications—telling the powerful person what one thinks that person wants to hear. Any powerful person will have to Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 267 MANAGERIAL BULLETIN Bite Your Tongue When Evaluating Your Boss? In a study at an insurance company, managers were more positive about upward feedback when their employees signed their name to upward appraisals. But the opposite was true for the employees. They rated their manager’s leadership style more positively when they were held accountable for their opinions. They liked the process better and were more truthful only when their views were kept anonymous. SOURCE: Leo F. Brajkovich, “How Truthful Should You Be When Evaluating Your Boss,” (a research translation of a study by David Antonioni), Academy of Management Executive 9, no. 4 (1995). MANAGERIAL BULLETIN CEO Disease: Egotism Can Breed Corporate Disaster—and the Malady Is Spreading Pampered, protected, and perked, the American CEO can know every indulgence. The executive who finally reaches the top of a major corporation enters an exclusive fraternity. The CEO’s judgment and presence are eagerly sought by other captains of industry and policymakers. CEOs zip around the world in private jets and cash the heftiest personal paychecks in industry. They take home 85 times what the average blue-collar worker makes, unlike their counterparts in Japan, where the ratio is closer to 10 to 1. It is a job that can easily go to one’s head—and often does. SOURCE: Business Week, April 1, 1991 be keenly aware of this problem and work hard to find ways to make less powerful people feel comfortable enough to tell the truth. Without accurate communications (and probably multiple sources), a powerful person will lose touch with actual feelings and is likely to make mistakes. 2. The more a person is treated as though he or she has power, the greater will be his or her self-esteem. Feeling deferred to, powerful people have a tendency to begin to view themselves as important, which enhances how they feel about themselves. Not surprisingly, then, people who are powerful tend to seek one another out. Power breeds more power. Thus, 3. 4. The more power attributed to a person, the more that person will tend to identify with others who also have power. Those with high-attributed power are attracted to and communicate more with others with high-attributed power than with those who have low-attributed power. Many political leaders have been known to shift their attention and allegiance from their constituencies to their fellow politicians. The same thing can happen in an organization, especially as people climb increasingly higher in the hierarchy. Are you familiar with instances in which an emergent social leader in a group was appointed formal leader by the system, thus enhancing his or her degree of influence? 51 52 Cohen: Effective Behavior in Organizations, Seventh Edition 268 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text CHAPTER 11 MANAGERIAL BULLETIN Charmed Forces: Army’s “Baby Generals” Take a Crash Course in Sensitivity Training “Each and every one of you has something that makes you a jerk. Some of you have more than one. I know. I’ve talked to you . . . work on losing that ugly part of your personality.” [Lt. Colonel Olsen] suggests that doubters ask their spouses what he’s talking about: “They know, and they’re dying to tell you.” . . . Gen. Burnette warns that “The first deadly sin of the general officer is arrogance. “Bask in the glow—and get over it.” “You’ll find,” says another lecturer, “there aren’t a whole lot of people who will tell you the truth anymore.” SOURCE: Thomas E. Ricks, “Charmed Forces,” The Wall Street Journal, January 19, 1998, p. A1. Very often the individual is then seen to “change”; he or she is seen as less friendly to “us mere workers” and as playing up to the big bosses. This frequently happens as people find themselves in new leadership roles, having influence over people in areas never before experienced. In fact, one of the dangers of superiors having great power differentials over subordinates is that they begin to perceive any successes as due to their own skills and to discount the capacities of the subordinates. Great power differentials lead to overestimates by the powerful of their own contributions and to blindness to the contributions of others.20 By examining these propositions, you can see why it is often said that power corrupts. The entire constellation of behavior and relationships that follow from the possession of influence generates a cycle in which people with high power tend to become more and more differentiated form those with low power, even though each is dependent upon the other. The person with power has it only because it is given by others; it ends the moment those who are doing the giving choose not to do so. A leader is a leader only so long as there are followers. It certainly raises the question of who really possesses the power, the one who leads or those being led. There go my people. I must find out where they are going so I can lead them. Anonymous Another consequence of power for someone new to a position is the likelihood of being closely observed by subordinates about where the leader’s loyalties and priorities will be, how open they can be, how friendly and close the leader will allow them to be, and the like. Such early “testing” is often symbolic: The test is not direct, and the leader’s reactions are carefully scrutinized for favorable and unfavorable signs of what is to come. A leader who is unaware that such testing is inevitable can make inadvertent mistakes that are hard to live down, sending messages that discourage future openness or cause resentment about assumed attitudes of superiority. Consequences of Not Possessing Power Although too much power can indeed be corrupting, so can too little. Because power is needed to make things happen in organizations—being without it means Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 269 MANAGERIAL BULLETIN The Bureaucrat Gets the Last Word Ed Garvey was scheduled to make a business trip and needed a cash advance. He went to the controller’s office to get the necessary signature on a form in order to receive the cash. Mr. Pomeroy, an administrative assistant, was the person whose signature Ed needed. But first Ed had to get past Mrs. Arnold, the secretary and receptionist in the controller’s office. The Conversation went like this: Ed: I know, but I don’t have 24 hours before I have to leave. I need the cash advance today. Ed: I’d like to see Mr. Pomeroy for just one minute. I need his signature for a cash advance. Pomeroy: I know, but I do have a job to perform. Mrs. Arnold: Mr. Pomeroy is very busy, so you’ll just have to wait. Please sit over there. Ed: Mrs. Arnold, I really have to get back to my office. Could you ask Mr. Pomeroy if he could take a minute to sign this? Mrs. Arnold: Well, I hate to interrupt him, but I’ll see if he can take a moment. (Goes into Pomeroy’s office and returns after about two minutes.) He’ll see you, but you may have to leave the form here. Ed goes into Pomeroy’s office and explains that this trip was a last-minute thing and he was under time pressure. The conversation went like this: Pomeroy: Well, I don’t know if I can take it upon myself to sign this. If I break the rules for you, I could end up with endless requests like this from others. Ed: Look, this is an exceptional situation. The rules don’t cover every situation. Ed: Would you get into trouble if you signed it? Pomeroy: No, but I believe in following proper procedure, Mr. Garvey. Ed: I do too, but sometimes other things are more important than rules. Is there someone over you I can go to? Pomeroy: I don’t think that will be necessary. I’ll make the exception this time, Mr. Garvey, but please try to give me the proper notice in the future. Ed: That’s very nice of you, Mr. Pomeroy. Thank you. When Ed walked out, he had the signature, but he felt like he bought it with his soul. Pomeroy: You know that at least 24 hours is required for approval of a cash advance. insufficient resources, information, and support—managers who lack it have difficulty being effective. The manager who does not know what is going on, can’t get the needed budget, and is not backed by higher-ups will inevitably be resisted by subordinates. Why should they cooperate with someone who can’t deliver? As a result, managers who are in positions that yield too little power (or who fill their positions ineptly and lose what power they had) tend to: 1. 2. 3. Overcontrol subordinates, try to make them cooperate. Become petty tyrants, taking out their frustration on anyone they can dominate. Become turf-minded and rules-oriented, carving out a fiefdom where they can reign supreme. 21 In this way, powerlessness also corrupts, since managers who become so dominating are seldom effective. Their attempts to find someone on whom to exercise power only increase the resentment of their victims, causing even stronger attempts at domination, more resistance, and so on. Without the proper tools, few managers can be successful. 53 54 Cohen: Effective Behavior in Organizations, Seventh Edition 270 11. Leadership: Exerting Influence and Power Text © The McGraw−Hill Companies, 2002 CHAPTER 11 MANAGERIAL TOOLS Currencies Frequently Valued in Organizations Inspiration-Related Currencies Vision Being involved in a task that has larger significance for unit, organization, customers, or society. Excellence Having a chance to do important things really well. Moral/ethical correctness Doing what is “right” by a higher standard than efficiency. Task-Related Currencies New resources Obtaining money, budget increases, personnel, space, and so forth. Challenge/learning Doing tasks that increase skills and abilities. Assistance Getting help with existing projects or unwanted tasks. Task support Receiving overt or subtle backing or actual assistance with implementation. Rapid response Quicker response time. Information Access to organizational as well as technical knowledge. Position-Related Currencies Recognition Acknowledgment of effort, accomplishment, or abilities. Visibility The chance to be known by higher-ups or significant others in the organization. Reputation Being seen as competent, committed. Insiderness/importance A sense of centrality, of “belonging.” Contacts Opportunities for linking with others. Relationship-Related Currencies Understanding Having concerns and issues listened to. Acceptance/inclusion Closeness and friendship. Personal support Personal and emotional backing. Personal-Related Currencies Gratitude Appreciation or expression of indebtedness. Ownership/involvement Ownership of and influence over important tasks. Self-concept Affirmation of one’s values, self-esteem, and identity. Comfort Avoidance of hassles. SOURCE: A. R. Cohen and D. L. Bradford, Influence without Authority (New York: John Wiley & Sons, 1990). Some Currencies of Influence Often people see themselves as having little power, because they do not occupy some formal position of power. But Cohen and Bradford22 point out that “people also underestimate their power, because they aren’t creative in seeing connections between what they have and what someone else wants.” These connections are like “currencies,” which serve as a basis of exchange: “I give you my time, and you give me appreciation.” “I generate ideas, and you feel empowered to act in ways that I, in turn, value.” Managers have a vast array of currencies to influence their subordinates, their peers, and their bosses. Students don’t even begin to recognize the cur- Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 271 MANAGERIAL TOOLS Guide to Managing Your Boss—Or Anyone Else You Don’t Control Understand your boss and the forces surrounding him or her: Boss’s goals and objectives. How boss is rewarded. Pressures on boss: From his or her boss. From the organization. From the environment. Boss’s power (capacity to mobilize resources). Boss’s strengths, weaknesses, blind spots, and hot buttons. Boss’s managerial style—preferred degree of: Control. Information received and shared. Formality. Openness. Work to make your boss’s life easier: Aid in accomplishing boss’s goals. Increase boss’s visibility and reputation. Pick up tasks boss doesn’t like or isn’t good at. Tie your requests/preferences to boss’s /organization’s goals; show how giving you what you want will help achieve the goals. Ask boss for evaluation of how you can perform better: If boss is uncomfortable, offer self-appraisal to ease discussion. Keep boss informed: With frequency preferred by boss. With level of detail preferred by boss. In form preferred by boss: Oral? Brief reports? Extensive reports? Executive summary? Work to demonstrate dependability; keep your word. Reward boss whenever he or she manages in way you prefer: Many bosses feel underappreciated. Public praise increases boss’s reputation, aiding obtaining of resources. SOURCE: Based on J. J. Gabarro and J. P. Kotter, “Managing Your Boss,” Harvard Business Review, January–February 1980; and Allan R. Cohen, “How to Manage Your Boss,” Ms. Magazine, February 1981. rencies they have to influence their instructors, ranging from nods of the head during a lecture to high levels of performance on papers or exams. The Managerial Tools Chart above, shows a variety of currencies that are valued in organizations. Although many are not likely to fit your present circumstances, you might explore the chart and possibly discover some influence currencies you do in fact possess and never realized you have. Also, try using the Personal Application Exercise at the end of the chapter. Liking versus Respect It is not uncommon for those who have power to be less well liked; as noted in the group chapters, the group members who contribute most to getting tasks accomplished are usually most respected but seldom most liked. Informal task leaders often have to trade liking for respect; while occasionally someone can get both, most often: The more a leader strives for popularity, the less effective he or she becomes as task leader. Also, the more the leader strives to maintain task leadership, the more he or she will lose popularity.23 Can you think of any conditions where these propositions would not be true? How important each factor is in comparison with the other depends on the nature of the situation and the person involved in the leadership role. When a strong task leader brings a group through a very difficult situation, popularity may soar, at least for awhile. All leaders have to struggle with the question of how close they can be with their followers. Can a leader also be a friend? If so, does this still allow him or her to push them into working harder? Or, if the leader remains distant, will the followers still feel the loyalty and commitment necessary to put forth sufficient effort? 55 56 Cohen: Effective Behavior in Organizations, Seventh Edition 272 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text CHAPTER 11 MANAGERIAL BULLETIN Falling Stars—Twilight of the Gods: CEO as American Icon Slips into Down Cycle “This whole drive toward empowerment,” says Pillsbury’s [CEO] Mr. Walsh, has meant that CEOs have to cast off their big-shot image in order to communicate with their troops. “You need to engage people on a one-on-one basis and really work hard to make them feel part of the enterprise,” he says. “Great ideas usually come from deep in the organization. They don’t come from CEOs.” SOURCE: Ellen Joan Pollock, The Wall Street Journal, January 5, 1999, p. A1. MANAGERIAL BULLETIN Conflicting Demands on Politicians It is a horrendously difficult mandate this—to remain in the people’s eyes (1) a down-to-earth representative who understands them because he is one of them and (2) a leader to whom they can look up because he is somehow well above the rest of the pack in knowledge, mysteriously endowed with superior strengths and talents, a person who can be trusted to guard, to decide, to lead . . . in short, I suppose, a parent. SOURCE: Meg Greenfield, “The ‘Just Folks’ Pantomine,” Newsweek, October 10, 1994, p. 78. For some situations and people, the task maintenance function must take priority over social maintenance; in other situations and for other individuals, the opposite might be true. The important thing to keep in mind is that there is more than one option and that there may be some trade-offs in each. But why does this dilemma occur? Why is it so difficult to mix these functions? For one thing, not many people are really good at both; as a result, the task leader is likely to be someone who has the best skills or abilities related to the task (as it should be), and the social leader is often the most outgoing person in the group. If that’s the case, then other group members tend to become dependent upon the task leader and may even see him or her as superior to the rest of the group. While this may generate respect for that individual, it also tends to breed resentment. Furthermore, because people are social beings and usually have other interests in addition to interest in working well—or will retreat into socializing when tasks become unpleasant or might lead to conflict—task leaders occasionally have to refocus attention back to getting the task done. As a result, when the task leader pressures others into working, they may feel grateful for the direction but also may feel resentful, annoyed, and resistant to the task.24 This sequence of events is not inevitable and may be overcome when it leads to group success, but it occurs frequently enough to warrant particular attention. We have also found it to be characteristic of a great many work groups in our classes. Does it apply to your own experience? There is yet another problem. With a few exceptions, most people have the greatest difficulty being totally honest or giving directions to those to whom they feel closest. When someone else is emotionally close, people feel the risk is great that the relationship will be harmed by saying negative things or giving directions. Thus they find themselves unable to ask much of close friends. A few people, however, find that when they build close, supportive relationships, they can be both demanding Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 273 MANAGERIAL BULLETIN The Pentagon “Club” Closed Ranks to Shut Out Resor Some defense officials sympathetic to Mr. Resor do feel, however, that he contributed to his own troubles by an unwillingness or inability to deal with the petty intrigues that are, after all, a cornerstone of any selfrespecting bureaucracy. “There was no major conspiracy to undermine Stan; it just happened, and he helped,” said one. “You needed someone who could go to these little empires that have been built up and say, ‘What are your priorities, what are the major issues, what are you doing?’ Stan just waited for people to come to him, and very few did.” A top defense official said in exasperation: “This is a very tough place. There’s a lot of power; a lot of money at stake. In comes Stanley Resor—a very decent gentleman, somewhat old-school, not a self-serving type in any way. “He was entirely wrong for the job.” SOURCE: Bernard Weinraub, New York Times, March 18, 1979, copyright © 1979 by The New York Times Company. Reprinted by permission. and caring—and be cared for and receive demands in return. This kind of openness allows closeness with subordinates without harming productivity, but it requires high skill and mutual commitment and probably only works where both boss and subordinate have roughly equal expertise. The Use and Abuse of Power In general, it should be apparent by now that leadership can be an exciting opportunity to use power or influence for getting work done; but it can be abused. You have undoubtedly known or heard about people in power primarily to serve their own ends, and usually at the expense of others. David McClelland distinguishes between personal power and socialized power, the former referring to self-serving uses (or abuses) and the latter to uses that consider the effects (usually benefits) on others.25 Sometimes it’s difficult to make a clear distinction between the two, especially when a leader claims to be acting for the benefit of others yet engages in behavior that reflects anything but the best of motives. Any act by a person in power that pressures another person to behave in ways that violate that person’s sense of personal worth is a form of manipulation. At best, it’s insensitive; at worst, it’s a form of violence. Today’s organizations are paying increasing attention to these kinds of issues, including the specific problem of sexual harassment in the workplace. Laws and policies are being developed, in part because of pressures from the courts, that are designed to protect individuals from sexual harassment in their jobs. What was once looked on as harmless teasing has come to be recognized as a humiliating abuse of power, unacceptable and unprofessional, as well as illegal. How long it will take to educate organizational leaders and managers, university professors, and the general public to understand such abuses and take action to prevent them remains to be seen. However, it is important for you—as a future manager and as someone who will possess power—to appreciate the ethical burdens of your job and the kinds of actions you might be required to take in living up to those ethics. The Opportunity to Empower Others In the coming years, the effectiveness of leaders/managers will be measured as much by the performance of their subordinates as by their own performance. It will be the job of the leader—of a team, a department, or a company—to empower others to 57 58 Cohen: Effective Behavior in Organizations, Seventh Edition 274 11. Leadership: Exerting Influence and Power Text © The McGraw−Hill Companies, 2002 CHAPTER 11 MANAGERIAL BULLETIN Unmourned Departure “[Departing chairman of Coopers & Lybrand, Eugene Freedman] rubs a lot of people wrong,” . . . “He’s a very aggressive person and very capable. But my guess is, there’s no love for him.” “He’s a legend in his own mind.” According to partners and former partners, Mr. Freedman gave himself big raises when profits flagged. They say he lived in the grand manner befitting a movie mogul, not the head of a public accounting firm, that he sidelined rivals and surrounded himself with hordes of minions. And they say Mr. Freedman used the power of his office to suit his personal agenda and to punish those who stood up to him. SOURCE: Alison Leigh Cowan, “Unmourned Departure at Coopers,” New York Times, January 17, 1994. MANAGERIAL BULLETIN Chainsaw! He Anointed Himself America’s Best CEO, but Al Dunlap Drove Sunbeam into the Ground Sunbeam investors knew that Dunlap’s arrival meant that tough medicine would soon be administered. And at precisely 9 A.M. on Monday, July 22, 1996, when Dunlap marched into the penthouse boardroom at Sunbeam headquarters in Fort Lauderdale, the anxious group of executives gathered around the table knew it, too. Dunlap wasted no time on introductions. Like George C. Scott in the movie Patton, he began by delivering a spellbinding, if sometimes disjointed monologue on himself and the company. “You guys are responsible for the demise of Sunbeam!” Dunlap roared, tossing his glasses onto the table. “I’m here to tell you that things have changed. The old Sunbeam is over today. It’s over!” . . . The men gathered around the conference table were stunned by Dunlap’s attack. “It was like a dog barking at you for hours,” recalled Richard L. Boynton, president of the household-products division. “He just yelled, ranted, and raved. He was condescending, belligerent, and disrespectful.” . . . Almost all his executives believed these goals were impractical. Dunlap, however, refused to acknowledge the near-impossibility of meeting them. Instead, he began putting excruciating pressure on those who reported to him, who in turn passed that intimidation down the line. People were told that either they met their goals or another person would be found to do it for them. Their livelihood hung on making numbers that were not makeable. In Dunlap’s presence, knees trembled and stomachs churned. Underlings feared the torrential harangue that Dunlap could unleash at any moment. At his worst, he became viciously profane, even violent. Executives said he would throw papers or furniture, bang his hands on his desk, and shout so ferociously that a manager’s hair would be blown back by the stream of air that rushed from Dunlap’s mouth. “Hair spray day” became a code phrase among execs, signifying a potential tantrum. . . . “I have thousands of resumes from people who would work here for free,” Dunlap would scream, inches from his victim. “You are being paid to work here, and you can become rich because I’ve given you all these options. And you’re letting me down. I’m working hard for you on the Street, and you’re letting me down.” SOURCE: John A. Byrne, “Chainsaw!” Business Week, October 18, 1999, p. 128. (Copyright 1999 McGraw-Hill, Inc.) perform at their best. Simple rewards and punishments won’t do the job, at least over the long run; it will take efforts at employee involvement, shared purposes or vision, and, in general, a spirit of collaboration heretofore known in few organizations. Even as you consider the situational options available to the leader, keep in Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 275 mind that in most cases any choice that fails to empower others is likely to be a poor one. Coercive approaches, while occasionally necessary and sometimes effective for the short run, rarely sustain positive effects for the long run. In the day of the knowledgeable workforce, when no single individual has a monopoly on talent and answers, good subordinateship cannot consist only of constant agreement with the boss. Bosses cannot afford to send in the clones; they must create, value, and work with strong individuals who have the knowledge the boss does not; and both must learn to blend views rather than always fight to win or compromise away strength. David Bradford and Allan Cohen Power Up KEY CONCEPTS FROM CHAPTER 11 1. 2. 3. 4. 5. 6. Leadership is mostly situational, rather than determined by personality traits. Leadership is an influence process with subordinates, peers, and colleagues. Even subordinates are not totally without influence; thus, leadership is net influence. Influence is an act or potential act that affects the behavior of another person(s). Types of influence: a. Formal: prescribed by office or position. b. Informal: based on expertise or charisma. c. Legitimate: influencer seen by influenced as having the right to do so. d. Illegitimate: influencer seen by influenced as not having the right to do so. e. Types a and b can each combine with c or d when examining influence. People can be influenced through: a. Compliance: fear of influencer. b. Identification: attraction to influencer. c. Internalization: belief in influencer’s beliefs. Importance of employee commitment to: a. The work itself. b. The relationships with others. c. The organization as a whole. Power is the capacity to exert influence, to make things happen. 7. 8. 9. 10. 11. 12. 13. Power is based on: a. Greater legitimacy. b. Ability to enhance organization in relation to key problems. c. Doing new activities rather than routine. d. Visibility, recognition. e. Creating obligations through helpful acts. f. Controlling rewards and punishments. g. Reducing uncertainty. The greater one’s power, the more one receives: a. Communication. b. Solicitous behavior. c. Deference. d. Self-esteem. e. Close observation in new situations. Powerlessness often leads to: a. Overcontrol. b. Petty tyranny. c. Rule orientation and turf-mindedness. Currencies of influence. It is difficult for those with power to gain both respect and liking: a. Task orientation often breeds resentment. b. Closeness to followers may constrain task orientation. The use and abuse of power. Empowerment of others. PERSONAL APPLICATION EXERCISE Assessing Your Influence Currencies As we pointed out in the chapter, you probably have more influence on others than you realize. You may not fully appreciate the behavior—“currencies”—you can offer that are valued by friends, family members, instructors, and others. The following exercise is designed to help you assess your currencies and thereby develop a picture 59 60 Cohen: Effective Behavior in Organizations, Seventh Edition 276 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text CHAPTER 11 of the ways in which you influence others and how you might even increase that influence. We want you to start by identifying two people in each of three categories: (1) friends, (2) family members, and (3) instructors. (Refer to the example below as a guide.) Then list the currencies you can offer that are valued by both individuals in each category and assign a value on a scale of 1 to 10 indicating the importance of that currency to each person, with the higher numbers reflecting greater importance. You should find similarities (closer numbers) and differences (numbers further apart) between the individuals in a category, and you certainly should find some major differences in the currencies of the different categories. In the example, the numbers reflect a closer friendship with B than with A, because the currencies of “caring” and “support” are more highly valued by B. In the family category, the currency that counts more with the father than the mother is “success,” while the opposite is true for the “dependency” currency. In the instructor example, “listening quietly” will work better in accounting class than in organizational behavior (OB), while the opposite will be true for “offering opinions.” If the example were you, can you see how your behavior could be different in the different situations and in relation to the different individuals? This kind of diagnostic process could be a valuable way for you to strengthen your interpersonal power. It could be especially useful in a work environment, where the career stakes are high. EXAMPLE Friends A B Family Mother Father Instructors Caring Support Feedback Help Knowledge of sports Humor 5 5 6 8 2 10 8 10 6 6 9 7 Love Pride Dependency Success Doing chores 10 6 8 5 9 8 7 3 10 9 Listening quietly Asking questions Good work Offering opinions Acctg. OB 9 4 7 10 6 10 3 9 SUGGESTED READINGS Agor, W. H. “The Logic of Intuition: How Top Executives Make Important Decisions.” Organizational Dynamics, Winter 1986, pp. 5–18. Conger, J. A., and R. N. Kanungo. “The Empowerment Process: Integrating Theory and Practice.” Academy of Management Review, July 1988, p. 474. Bass, B. M. Leadership and Performance Beyond Expectations. New York: Free Press, 1985. Deaux, K. “Authority, Gender, Power, and Tokenism.” Journal of Applied Behavioral Science, January– February–March 1978, pp. 22–26. Bateman, T. S., and S. Strasser. “A Longitudinal Analysis of the Antecedents of Organizational Commitment.” Academy of Management Journal 27 (1984), pp. 95–112. Bennis, W., and B. Nanus. Leaders: The Strategies for Taking Charge. New York: Harper & Row, 1985. Caro, R. The Power Broker. New York: Alfred A. Knopf, 1974. Cobb, A. T. “An Episodic Model of Power: Toward an Integration of Theory and Research.” Academy of Management Review, July 1984, pp. 482–93. Conger, J. A. and R. N. Kanungo. “Toward a Behavioral Theory of Charismatic Leadership in Organizational Settings.” Academy of Management Review 12, no. 4 (1987), pp. 637–47. Dobbins, G. H., and S. J. Platz. “Sex Differences in Leadership: How Real Are They?” Academy of Management Review, January 1986, pp. 118–27. Dumaine, Brian. “What the Leaders of Tomorrow See.” Fortune, July 3, 1989. Farmer, Steven M.; John M. Maslyn; Donald B. Fedor; and Jodi S. Goodman. “Putting Upward Influence Strategies in Context.” Journal of Organizational Behavior, January 1997, pp. 17–42. Fink, S. L. High Commitment Workplaces. Westport, CT: Quorum Books, 1992. Cohen: Effective Behavior in Organizations, Seventh Edition 11. Leadership: Exerting Influence and Power © The McGraw−Hill Companies, 2002 Text LEADERSHIP: EXERTING INFLUENCE AND POWER 277 Gabarro, J. J., and J. P. Kotter. “Managing Your Boss.” Harvard Business Review, January–February 1980, pp. 97–100. Pfeffer, J., and G. Salancik. “Who Gets Power and How They Hold on to It.” Organizational Dynamics, Winter 1977. Gault, Stanley; Linda J. Wachner; Mike H. Walsh; David W. Johnson. “Leaders of Corporate Change.” Fortune, December 14, 1992. Quinn, Robert E., and Gretchen M. Spreitzer. “The Road to Empowerment: Seven Questions Every Leader Should Consider.” Organizational Dynamics, Autumn 1997, pp. 37–50. Heller, T. “Changing Authority Patterns: A Cultural Perspective.” Academy of Management Review, July 1985, pp. 488–95. Howell, J. P., and P. W. Dorfman. “Leadership and Substitutes for Leadership among Professional and Nonprofessional Workers.” Journal of Applied Behavioral Science 22, no. 1 (1986), pp. 29–46. Huey, John. “America’s Most Successful Merchant.” Fortune, September 23, 1991. Reichers, A. E. “A Review and Reconceptualization of Organizational Commitment.” Academy of Management Review 10 (1985), pp. 465–76. Sarman, Colin. “Looking for Tomorrow’s Leaders,” Management Today, August 1997, p. 5. Sayles, L. Leadership: What Effective Managers Do and How They Do It. New York: McGraw-Hill, 1979. . “Finding New Heroes for a New Era.” Fortune, January 25, 1993. Schlesinger, L. A., and B. Oshry. “Quality of Work Life and the Manager: Muddle in the Middle.” Organizational Dynamics, Summer 1984, pp. 4–19. . “Where Managers Will Go.” Fortune, January 27, 1992. Sellers, Patricia. “What Exactly Is Charisma?” Fortune, January 15, 1996, pp. 68–75. Kiechel, Walter III. “The Leader as Servant.” Fortune, May 4, 1992. Stewart, Thomas. A. “Get with the New Power Game.” Fortune, January 13, 1997, pp. 58–62. King, D., and B. Bass. Leadership, Power, and Influence. Lafayette, IN: Herman C. Krannert Graduate School of Industrial Administration, Purdue University, 1970. Taylor, Alex, III. “Iacocca’s Last Stand at Chrysler.” Fortune, April 20, 1992. Kotkin, J. “Mr. Iacocca, Meet Mr. Honda.” Inc., November 1989, pp. 436–53. Kotter, J. P. The General Managers. New York: Free Press, 1982. . Power and Influence. New York: Free Press, 1985. Liden, R. C., and T. R. Mitchell. “Ingratiatory Behaviors in Organizations Settings.” Academy of Management Review 13, no. 4 (1988), pp. 572–87. Malone, Thomas W. “Is Empowerment Just a Fad? Control, Decision Making, and IT.” Sloan Management Review, Winter 1997, pp. 23–35. Mangham, Iain. Power and Performance in Organizations. New York: Basil Blackwell, 1988. McGregor, D. Leadership and Motivation. Cambridge, MA: MIT Press, 1966. . “Success Depends on Leadership.” Fortune, November 18, 1991. Trevino, L. K. “Ethical Decision Making in Organizations: A Person-Situation Interactionist Model.” Academy of Management Review, July 1986, pp. 601–17. Tichy, N., and M. A. Devanna. The Transformational Leader. New York: John Wiley & Sons, 1986. Walton, R. E. “From Control to Commitment in the Workplace.” Harvard Business Review March–April 1985, pp. 77–84. Whyte, G. “Escalating Commitment to a Course of Action: A Reinterpretation.” Academy of Management Review 11 (1986), pp. 311–21. Zand, Dale E. The Leadership Triad: Knowledge, Trust, and Power. New York: Oxford University Press, 1997. 61 62 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care James C. Robinson he traditional health care system, organized as a professional guild and financed by indemnity insurance, has been irrevocably changed. Once-complacent taxpayers and formerly paternalistic employers have fought back against inflating costs and escalating premiums, choking back the once massive flow of subsidies for inefficient physician practices, fragmented delivery systems, and cost-unconscious consumer demand. Communityrated insurance pools have fractured as self-interested and often self-insured purchasers pursue better value for their health care dollar. Consumers are increasingly assertive as to their preferences and willingness to pay for particular health benefits and medical interventions. T Three powerful and conflicting forces dominate the trajectory of the health care system. The first and most fundamental is the continuing pressure to adopt new technologies while moderating the economic burden on taxpayers, employers, and consumers. New technologies derive from a broader accumulation of scientific and engineering knowledge, from advances in physics, pharmacology, and pathology that highlight opportunities for intervention in the mechanisms of disease, trauma, recovery, and repair. These advances do not remain under the exclusive purview of scientific or political elites but are communicated widely to the citizenry, generating strong demands for their immediate diffusion. However, this enthusiastic embrace of new clinical interventions is not accompanied by a commensurate commitment on the part of the public to pay for them. The increasing wealth of society permits ever-growing investments in health care and it is to be assumed that expenditures will pace the overall This article is based on my recently published book, The Corporate Practice of Medicine: Competition and Innovation in Health Care. Research support for the book was obtained from the Robert Wood Johnson Foundation and the Milbank Memorial Fund. CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 13 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care growth in the economy. However, even the wealthiest of nations cannot continue on a trajectory that would devote 15, then 20, and then 25% of total resources to health care. The limits on social willingness to pay manifest themselves in the taxpayer revolt, in labor market tradeoffs between wages and fringe benefits, and in the tens of millions of citizens who lack even the most basic of insurance coverage. The second feature of the emerging health care system, which derives from the first, is continued innovation in forms of organization, ownership, contract, finance, and governance. Given the pressure to restrain inflation, large rewards will accrue to those who pioneer cost-decreasing products and processes. Outpatient surgery, home health care, sub-acute facilities, nurse practitioners, inpatient hospitalist teams, practice profiling, drug formularies, case managers for patients with chronic illness, and internet-enabled applications of every description represent clinical innovations that attenuate rather than accentuate the cost of health care (compared to what the traditional hospitalcentered, specialty-dominated, and indemnity-financed system would have generated). Each product and process faces continued pressure towards evolution or extinction, but each exemplifies the process of organizational experimentation that has been unleashed by the transition to unmanaged competition in health care. The emerging corporate system of health care is better able to moderate cost inflation than the traditional system of professional dominance and the only partially implemented systems of utility regulation and managed competition. The corporate health care system has adopted forms of organization, ownership, and contracting from the most dynamic sectors of the larger economy and applied them to the technology, culture, and institutions of medicine. Its foundations lie in the multi-specialty medical groups and health insurance plans that redesign economic incentives and clinical practice at the grassroots level. Medical groups, IPAs, and physician-hospital organizations offer a balance of competition and cooperation that accommodates the social needs for efficiency, adaptation, and innovation. Health plans have adjusted to the heterogeneity of consumer demand by marketing multiple networks, methods of managing utilization, and benefit packages priced with multiple premiums, deductibles, and coinsurance provisions. Product diversification is accompanied by geographic expansion, as plans and providers reduce their dependence on any one region and leverage skills gained in one local market into competitive advantages in others. These multi-state, multi-product firms are consolidating through mergers and acquisitions, leaving most metropolitan markets dominated by a small number of large organizations. Vertical disintegration also is the norm, permitting health plans, medical groups and hospital systems to focus on those services they perform best while coordinating with other services through contractual relationships. Innovation in organizational structures is accompanied by innovation in contractual structures, as plans and providers experiment with new methods of payment, medical management, and quality measurement. 14 CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 63 64 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care However, the long-term viability of an organizational system depends not merely on its economic prowess, but on its compatibility with the social culture and political institutions. In overturning so many traditional practices and expectations in such a short period, corporate health care has brought down upon itself the wrath of the American populist heritage that distrusts big business almost as much as it dislikes big government. The third fundamental feature of the emerging system, therefore, is continued social discontent and political backlash. Legislatures, courts, attorneys general, and administrative agencies have issued a flood of hostile legislation, litigation, and regulation. Some of these impose beneficial supports for the corporate system, mandating grievance and review, financial solvency, and quality monitoring mechanisms that enhance accountability and legitimacy. Others, however, target the very engine of innovation, impeding or prohibiting new methods of payment, utilization management, benefit design, network contracting, capital financing, and organizational affiliation. Lessons of Utility Regulation and Deregulation No nation has ever unleashed the forces of market competition and corporate organization on its health care system. Insights are available from the experiences of the transportation, communication, energy, and banking industries. For decades, these industries have been opened to competition and its consequences. Despite differences in physical technology, geographic concentration, and consumer demand, the experiences of the utility industries under partial and total deregulation have been broadly similar. There is now a substantial body of research from the airlines, trucking, railroad, banking, and natural gas industries (as well as from telecommunications, electric power, and cable television). While the experiences from these sectors do not precisely replicate that of health care, they can provide useful guideposts and standards of comparison. Indeed, the utility industries are potentially more relevant to the emerging health care system than the oft-cited experiences of health care in other nations, which evolved in different cultural contexts and under different political institutions. The deregulation of the utility industries has been remarkable for the breadth of the industries affected and the depth of the changes effected, but also because it was so unanticipated. Scholars and industry observers have diverged widely in their assessment of the economic desirability of regulation but converged in their assessment of its political durability. Liberals often interpreted regulation as an efficiency-enhancing response to market failure and as an equity-enhancing means of subsidizing the poor. Conservatives often denounced utility commissions as captured by the regulated industries, and hence as conducive to inefficiency and inequity, but by this very token despaired of mobilizing a political constituency for change, since the beneficiaries of regulation are concentrated and committed while the losers are dispersed and apathetic. CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 15 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care However, over the course of the 1960s and 1970s, during the era of its apparent invincibility, utility regulation was subjected to a sustained critique from both the left and the right that created an intellectual quasi-consensus and prepared the way for sweeping change in the following decades. The new consensus, shared in diverse ways by consumer activists and Nobel laureates, by Democrats and Republicans, is that utility regulation exacerbates rather than attenuates economic inefficiencies and social inequities. The inefficiencies stem from incentive distortions induced by particular rules and from the general climate of a protected, non-competitive industry. Regulatory pathologies were identified in the airline industry, where price floors stimulated cost-increasing competition through amenities and flight frequency;1 in the electric power industry, where rate-of-return limits induced a substitution of capital for labor and the construction of overly large generating facilities;2 in the railroad industry, where restrictions on track abandonment led to excess capacity, under-maintenance, and demands for public subsidy;3 in the banking industry, where constraints on product and market diversification limited the number and type of financial instruments and protected inefficient and poorly managed firms;4 and in the natural gas industry, where uniform rates prevented conservation-enhancing seasonal and time-of-day pricing.5 Barriers to market entry, product diversification, and corporate mergers protected incumbent firms against the rigors of competition, fostered managerial slack, financed abovemarket wages, and discouraged innovation in methods of production, supply, and marketing. The distributional impact of regulation derives from its attentiveness to mobilized political constituencies and its insulation from the larger but less vocal majority. Simplistic theories of agency capture by regulated industries failed to acknowledge the full complexity of regulatory politics, in which consumer groups, legislators, and litigators all play important roles, but did succeed in dispelling even more simplistic interpretations of regulation as a means to tax the rich and help the poor.6 The greatest defenders of continued regulation often have been not the disenfranchised but the regulated firms themselves, backed by their investors, bankers, labor unions, executives, and employees. Deregulation is not a one-time event but a process that unfolds in different ways across industries and geographic markets. It generates instability and stress, and it is threatened continually by political reaction and re-regulation. Based on the industry experiences and research evidence to date, four basic impacts can be identified.7 First, deregulation in the utility industries has stimulated productivity and performance, with significant reductions in cost and improvements in service. Second, it has led to differentiation among product features and prices depending on the purchaser, the geographic market, the season, and other characteristics of supply and demand. Third, the relaxation of restrictions on new entry has led to dramatic changes in market structures, organizational forms, distribution networks, and methods of purchasing. Finally, deregulation has engendered countervailing pressures to slow the pace and reverse the direction of change, to dampen the instability and impede the innovation, to 16 CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 65 66 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care cushion the blow to previously favored constituencies, and in some cases to re-regulate in whole or in part the behavior of the industry. Utility Deregulation: Cost and Quality The most visible impact of deregulation has been to lower prices and improve service to consumers.8 After adjusting for economy-wide inflation, deregulation has reduced fares per mile traveled by 33% for airlines, 35% for less-than-truckload freight, 75% for full-truckload shipping, and 50% for railroads. Natural gas prices have fallen 30% for both residential and industrial users. Service frequency has increased substantially in air transportation, due to lower fares and higher demand; service times have declined substantially for less-than-truckload and full-truckload shipping; both the mean and standard deviation of railroad transit times have fallen by approximately 20%; banking is more convenient due to longer hours, automatic tellers, no restrictions on branching; and natural gas service is more reliable as shortages have been eliminated. Higher value to the consumer has derived from improved industry productivity, capacity utilization, and network configurations and from a virtuous cycle of lower costs, lower prices, increased demand, and further reductions in costs. The hub-and-spoke route configuration developed by the deregulated airline industry has raised rates of seat occupancy from 52% to 62% and thereby lowered costs per mile flown by 25%. Price wars have driven down air fares, dramatically increased business and leisure air travel, and permitted ever more frequent flights.9 The trucking industry has increased the percentage of full truckloads and reduced the number of empty return miles, thereby permitting price reductions that have attracted additional business from non-trucking firms that previously shipped on their own vehicles to avoid the costs of trucking regulation. Railroads have abandoned approximately one-third of their trackage, reduced operating costs, improved profitability, and thereby escaped from the regulation-induced death spiral of mandated excess capacity, high operating costs, high prices, declining demand, and need for ever-greater subsidy. Banks have lowered their operating costs through extended electronic and branch banking, raised interest rates above regulatory ceilings, and developed new financial products that better balance risk and return. Natural gas firms have restructured their transmission and distribution networks and improved pipeline capacity utilization, reducing overall operating and maintenance expenses by 35%. Utility Deregulation: Price and Product Differentiation A common characteristic of utility regulation was uniformity in products and prices in the face of great variability in consumer preferences and the actual costs of providing service. This one-size-fits-all approach led to services that were of excessive cost for some consumers and insufficient quality for others, impeded the use of price flexibility to enhance capacity utilization, and CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 17 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care juxtaposed overcapacity and low load factors in some industries with undercapacity and shortages elsewhere. It generated cross-subsidies from consumers for whom the cost of service was low to consumers for whom the cost of service was high. Shippers on heavily traveled routes subsidized shippers on remote routes and long distance telephone users subsidized local callers. Deregulation has spurred an outpouring of new services that incur different costs and impose different prices, permitting a better match between supply and demand. Air travelers can obtain substantial discounts if they purchase tickets in advance and stay for the weekend, but must pay the full cost of standby capacity if they want to delay their decisions to the last minute. Shippers can obtain low rates if they allow their freight to be combined with others’ and be routed over less direct but more heavily traveled corridors, or they can choose to pay the full cost of less-than-truckload delivery. The increased variability in price and service results in part from the deregulation of contracting between buyers and sellers. Rail and road regulation, for example, often prohibited shippers from negotiating with transporters for volume discounts, flexibility factors, multimarket or multiyear agreements, or other variations from uniform price and service standards. Now half of rail freight moves at specially contracted rates, allowing better track utilization for the railroads and better coordination of production, inventory, and distribution for the shippers. Deregulation permits the contractual flexibility that allows buyers and sellers to explore potential gains from new electronic and Internet technologies, thereby accelerating the adoption and diffusion of innovation. Utility Deregulation: Market and Organizational Structures Deregulation stimulates competitive entry into previously protected industries and local markets. Startups challenged the most prominent firms in airlines, trucking, electric power, and telecommunications and even have appeared in specialized niches of the railroad industry. After an initial turbulent phase, however, deregulated industries undergo a process of concentration through merger, acquisition, market exit, and bankruptcy. Airlines, railroad, and banking firms are almost all larger now than prior to deregulation, and there has been a similar wave of consolidation in the electric power and telecommunications sectors. Deregulation has spurred exit from particular product and geographic markets as firms have pulled out, sold out, or gone under in the face of new entry. Much of this was overdue, since regulation protected incumbents from more efficient and innovative outsiders. Large scale is not incompatible with the most intense competition, as much growth has occurred through product and market diversification. Some firms have grown by developing broader networks that better fit the needs and preferences of customers. Airlines have thickened their regional nets by servicing more communities around their hubs and have developed joint venture and contractual arrangements to service global demand. Railroads have merged end-to-end to more efficiently link ports to mines to manufacturing 18 CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 67 68 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care centers, and have purchased or contracted with maritime shipping firms and trucking companies to offer intermodal transport services. Many mergers and acquisitions are designed to penetrate new geographic markets, as in branch banking and local service telecommunications, or to penetrate new product markets, as in linkages between commercial banks and investment banks. Substitution stimulates rivalry for traditional services and their producers. Mutual funds, corporate lenders, life insurers, and other financial intermediaries now compete with savings and loan institutions for deposits. Of course some consolidation is designed to reduce rather than increase competition. While end-to-end mergers increase rivalry in the railroad industry, parallel mergers decrease it. Airlines dominant at particular hubs can exploit the shortage in airport capacity to exclude rivals and raise rates. All in all, however, the utility industries have become increasingly competitive as the deregulatory process has unfolded, even in what were formerly considered natural monopolies such as electric power and telecommunications. The strategy of full service diversification—driven by the heterogeneity of preferences, technology, and geography—leads to the creation of large firms competing fiercely across many products and many markets. Utility Deregulation: Political Backlash Deregulation has exerted a major impact on the political climate of the utility industries, in some cases stimulating a backlash that finds sympathetic ears in legislatures and the courts. Formerly subsidized consumers deplore market-level price and quality. Airline pilots, unionized teamsters, stock brokers charging fixed commissions, employees of power companies with cost-plus rate structures, and domestic crews on American flagships all have experienced the reduction in industry costs as a reduction in personal incomes. Consumers as a whole are winners, with more choices, better service, and lower prices, but significant subgroups find themselves to be losers. Everyone appreciates price decreases and quality increases in services where regulation offered neither subsidy nor shelter. They lament, however, similar effects in industries where they were protected and pampered. The consumer and producer backlash against utility deregulation has found sympathetic ears in Congress, state legislatures, and executive agencies due to the structure of political incentives and institutions. Legislators look not to the aggregate social impacts of deregulation but to the costs and benefits accruing to their local constituents. They seek to slow, stop, and reverse adverse impacts, such as the abandonment of little-used railroad trackage, competitive threats to hometown truckers, and the transfer of jobs to distant communities. Elected politicians and appointed administrators are concerned with short-run rather than long-run effects and are uncomfortable with the instability created as deregulation opens long-protected industries to entry and innovation. All three branches of government are under continual pressure to do no direct harm, to minimize adverse impacts on the visible and vocal at the expense of CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 19 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care the invisible and inarticulate, thereby upholding perceived standards of due process while rewarding politically powerful interests. The process of deregulation has generated considerable friction, but almost without exception it has not been reversed. Indeed, the deregulatory process has spread to previously untouched industries and previously unconvinced nations, as local phone service sees the first glimmerings of competition, global maritime and airline regulations are loosened, and European nations reexamine their telecommunications and transportation policies. Over time, moreover, deregulation creates a constituency in its own support, as producers, consumers, and communities advantaged by the changes mobilize against reregulatory initiatives. Nevertheless, the process is fragile and always endangered. Utility deregulation depends on the political as well as the economic marketplace, on the temporal and geographic incidence of costs and benefits, on the comparative salience of winners and losers, and on the likelihood that political entrepreneurs will find in the turbulence of change the opportunity to pursue other agendas. Comparing Health Care to the Utility Industries No exact analogies can be drawn between the changes sweeping through health care and the revolutionary transformations spurred by deregulation in the transportation, communication, energy, and finance industries. Health care was never subjected in such an explicit and comprehensive fashion to the dictates of a utility commission. However, the performance of the traditional health care system so closely resembled a regulated utility, and health care competition has affected performance in ways so similar to utility deregulation, that significant commonalities must be acknowledged and important lessons can be learned. Many states experimented with price controls covering a subset of insurers, and all imposed certificate-of-need entry barriers for at least some services and facilities and a few states imposed rate regulations affecting all hospital patients. The Medicare program imposed a uniform administered pricing system for its patients on the nation’s hospitals, and many states imposed Medicaid payment rates that were based on budgetary politics rather than an analysis of the cost of care. Economic theory looks to market failure and income redistribution to explain the pattern of regulation and deregulation across industries. The most commonly cited market failures include natural monopoly (which can lead to excess profits and distortion of resource allocation) and imperfect information (which can expose consumers to exploitation by better-informed producers). Distributional motives include the efforts by producer or consumer groups to convince legislators and regulators to impose taxes, rules, or other mechanisms that generate special benefits for special interests. Health care includes rural communities too small to support more than one hospital or a few physicians, but the mainstream of the system is structurally so competitive and has so 20 CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 69 70 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care many providers that it is implausible that public policy can be an efficiencyenhancing response to natural monopoly. Imperfect information is a more important feature of health care and one to which has been attributed most of the system’s unusual organizational and normative characteristics.10 It is difficult to believe, however, that the asymmetry of health care information between consumers and producers has changed in an exogenous fashion over the past three decades and thereby spurred the tumultuous changes in ownership, finance, and payment mechanisms. The amount of health care information possessed by consumers is likely to be the result rather than the cause of changes in the economic and political environment. It therefore is most enlightening to examine distributional motives, cross-subsidies, and the creation of rents as the underlying source of similarity between the processes of regulation and deregulation in health care and the utility industries.11 Many of the traditional institutional and normative features of health care served to restrict entry, comparison-shopping, price competition, and other features of a deregulated industry.12 Professional licensure, judicial acquiescence in physician boycotts of prepaid group practice, and exemption from antitrust statutes created economic rents for physicians that could be spent providing charity care for the indigent or by enjoying a more generous personal lifestyle. State “corporate practice of medicine” statutes outlawed the creation of vertically integrated delivery systems that would employ physicians to provide services on a salaried basis. “Any willing provider” statutes prevented insurance companies from negotiating volume discounts with subsets of physicians, pharmacies, or other provider entities. Community-rating regulations limited the ability of insurers to offer low premiums to healthy subscribers, thereby increasing revenues potentially available for subsidizing premiums for unhealthy subscribers. Hospital rate regulation programs directly imitated utility commission pricing policies, imposing price floors as well as ceilings to generate the operating surpluses necessary to subsidize charity patients. Certificate of need regulations limited entry and dampened the non-price competition that would dissipate operating surpluses. A particularly important feature of the health care industry, less prevalent in the utility sector, is the moral hazard generated by widespread insurance. Indemnity and Blue Cross insurance buffered consumers from the cost consequences of the physicians’ decisions and thereby fueled an openended demand for quality-improving and service-enhancing new technologies and process of care. Certificate of need and rate regulation in the hospital industry was consciously designed to moderate the inflationary aspects of this “medical arms race,” in a manner analogous to that of the Civil Aeronautics Board in its campaign against amenity competition and low load factors in the airlines industry. Some of the competition-limiting features of the health care system were designed in part to effect the spreading of insurance risk and subsidy of the ill through indirect means, as an alternative to creation of a national health insurance system analogous to those in European nations. Here again the health care system bears comparison to the utility and transportation industries, which CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 21 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care were put under regulatory tutelage during the New Deal era in part to forestall demands for nationalization on the then-prevalent European model. Most economic discussions of the politics of deregulation focus on the tendency for the cross-subsidies underlying utility regulation to grow over time and to become ever more complex and unpredictable in incidence. These changes gradually undermine the political support for the regulation, creating new coalitions that eventually accumulate sufficient power to partially or completely remove the regulatory edifice.13 The accelerating medical care inflation of the 1970s and 1980s spurred the principal purchasers of health care, including private employers, state Medicaid agencies, and the federal Medicare program, to attack the institutional barriers to competition in health care. The removal of the antitrust exemption, abandonment of most Certificate of Need and hospital rate-setting programs, and removal of limits on price-based negotiations between insurers and providers embody experiments in moving the health care system towards a more competitive market. The phenomenon known as managed care—comprising various combinations of volume purchasing (“selective contracting”), prepayment (“capitation”), monitoring and oversight (“utilization management”), creation of preferred provider panels, and other mechanisms—attempts to limit moral hazard and stimulate cost-conscious decision making. Health Care: Cost and Quality Market competition and corporate organization have demonstrated a remarkable ability to moderate the inflationary trajectory.14 The development of medical groups, health care systems, multi-product insurers, capitation contracting, and utilization management during the 1990s held the growth in health care costs to the lowest levels in 50 years, confounding the skeptics and contributing to the strong economic performance of the decade. It is difficult to ascertain the influence of corporate organization on health care quality, due to the inherent difficulties in measuring outcomes and to the lack of pre-existing baselines for comparison. The overall quality of care is improving, but this is due primarily to longer trends in laboratory research, physician training, and technology diffusion than to recent changes in markets and organization. The record on customer service is decidedly mixed. Cost pressures have led to a shortening of physician visits and oversight of utilization patterns that patients resent, while the new emphasis on satisfaction surveys and enhancement has induced providers to offer longer office hours, 24-hour telephone advice, and other consumer conveniences. The short-term success against health care cost inflation does not imply that the long-term battle for stable expenditures has been won. On the contrary, America is poised to enjoy the clinical benefits but rues the budgetary implications of an outpouring of new drugs, devices, tests, and treatments that prevent infection, dispel uncertainty, enhance functional ability, and generally contribute to a healthier and more long-lived citizenry. This technological dynamic opens 22 CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 71 72 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care diagnostic and therapeutic opportunities that are hard to ignore, but it is less important perhaps than the revolution of rising expectations. It is clear that as the population gets healthier, it demands more—not less—from its medical care system. We embrace treatments for old ailments that once were merely suffered, from childhood viruses and rashes through migraine headaches and springtime allergies to the impotence and arthritis of our golden years. We open our hearts and our wallets to medical breakthroughs that benefit victims of the great scourges of our time, from childhood cancer through AIDS to Alzheimer’s. We take gains in longevity for granted, expect that full physical, social, and intellectual functioning will continue to the now more distant end, and insist that these advances are for all to share. The corporate system of health care does not seek to stop the development of quality-increasing technology or to quell the revolution of consumer expectations, both of which inevitably accompany the growing wealth of society. It does, however, create significant changes in economic incentives and organizational structures that will temper the rate of inflation and enhance the overall value of health care services in a manner analogous to the gains in efficiency and quality in the deregulated utility industries. Four dimensions are particularly worthy of note. The shift from the professional guild to integrated organization, from indemnity insurance to managed care, and from non-price rivalry to price competition creates strong economic rewards for the diffusion of cost-decreasing clinical innovations. The medical arms race rewarded the development of technologies that raised quality—real or perceived—but not ones that reduced costs. Now firms and individuals at every point along the health care value chain— from bench scientists to clinical researchers, pharmaceutical manufacturers, hospital managers, multi-specialty medical groups, single-specialty networks, and primary care physicians—can increase their status and income if they discover, develop, or adopt interventions that reduce the overall expense of care. The corporate system is rapidly restoring the normal economic relationship between supply and demand, between market disequilibrium and price changes in health care. The United States has inherited an excess supply of acute care hospitals and physician specialists, analogous to the excess capacity generated by entry and exit regulation in many utility industries. In the now-passing system of guild organization and indemnity insurance, excess capacity stimulated cost-increasing non-price competition analogous to that experienced by the rate-regulated airline industry. Health services researchers delighted in discovering ever-new economic pathologies, from Roemer’s Law that a built bed is a filled bed, to the medical arms race of duplicative clinical technology, to supplier-induced demand in response to physician fee reductions. Henceforth, facilities and services that are in excess supply will receive lower, rather than higher, prices than otherwise comparable facilities and services that enjoy excess demand. The painful recalibration of relative incomes within the profession CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 23 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care and across the industry will continue, redirecting investments and career choices towards areas of need rather than areas of excess. The original demand placed on the corporate system by public and private purchasers was to reduce the cost of care, not to improve quality and service, and the system responded accordingly. The greatest emphasis in the early years has been on methods of payment, network contracting, utilization management, benefit design, and organizational structure that promise to restrain the inflationary spiral. Considerable success has been achieved in this endeavor. However, the distinctly American question remains: What have you done for me lately? Patients are worried lest the emphasis on cost control reduce the quality of the care they receive. Consumers are annoyed with every obstacle to obtaining what they want when they want it. The corporate system is shifting its emphasis to developing methods for measuring and improving service, in a manner analogous to the process pursued in the utility industries after deregulation. For the first time, the health care industry is being subjected to systematic monitoring of quality and service levels, with the intent of promoting clinical comparisons and quality-conscious consumer choice. The road to be traveled in a difficult one, since almost all the monitoring tools need to be invented. A salient feature of the professional guild was reliance on unmonitored trust and opposition to quantitative, validated measures of performance. Purchasers, plans, and provider organizations now experiment with satisfaction surveys, indicators of preventive services utilization, tracers for appropriate clinical processes, and risk-adjusted measures of patient outcomes. The new monitoring mechanisms hold great potential to enhance as well as simply measure the quality of care, since statistical and epidemiological methods always outperform badapple approaches to quality improvement. Deregulation has not universally improved quality and service in the utility industries. We all bemoan the paucity of empty seats on the airlines or the ubiquity of small fees for banking services that once were offered free. Some forms of regulation imposed a uniformly high-cost, high-quality style of service by forbidding firms from developing economy options. Without the ability to attract customers through lower prices, airlines added flights that they knew would be half-empty and financial institutions offered white-glove service to those customers who could come in during bankers’ hours. Deregulation in these contexts led initially to a reduction in service as a byproduct of an even greater reduction in price. However, the value offered to the customer, defined as including both service and price, increased. Most of us are willing to put up with strangers in adjacent seats in order to obtain economy fares and, for those who are not, the airlines offer business class service. Similarly, the corporate system of health care will experiment with different combinations of price and service to find the mix that offers best value in the mind of the consumer. There are tradeoffs to be made between broad and narrow provider networks, stringent and loose utilization management, thick and thin benefit coverage, high deductible and first dollar cost sharing, and, of course, between connoisseur 24 CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 73 74 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care class and economy prices. The tradeoffs are more controversial in health care than in the utility industries since the benefits of gold card service accrue to the patient while the benefits of low cost often accrue to the employer or taxpayer. Health Care: Price and Product Differentiation Generations of reformers have sought to overcome the variability in health care demand and supply through uniform benefits, premiums, and prices that do not vary according to incomes, preferences, health, location, employment, or other characteristics of consumers and producers. In the absence of strong governmental controls, however, the heterogeneity among consumers (in what they are willing to buy) and among providers (in what they are willing to sell) is driving price and product differentiation in health care. Benefit coverage and network design, premiums and prices, and method of marketing and distribution now are highly variegated and promise to become ever more so. The defeat of President Clinton’s Health Security Act spelled the demise of the uniform benefit package as the foundation of health care policy in the United States. Simply put, those who currently enjoy rich benefits and low premiums—due to good subsidies, good health, or good luck—are unwilling to sacrifice so that the less endowed, less healthy, or less fortunate can come up to their level. A uniform benefit package sufficiently rich to be politically acceptable to the quality-conscious voter would be economically unacceptable to the cost-conscious taxpayer. The unstandardized marketplace is responding to the diversity in incomes and preferences though a wide variety of benefit packages, cost-sharing provisions, network configurations, and methods of utilization management. Self-employed individuals and small firms now can shop from a menu of options—with inclusion, exclusion, or partial coverage for prescription drugs, mental health services, rehabilitation therapy, and complementary medicine; with different levels of cost sharing; and with combinations of deductibles and co-payments for particular services. Large public and private purchasers demand idiosyncratic benefit configurations, reminding the health plans and providers that he who pays the piper calls the tune. Network designs are proliferating at an equally astonishing rate, mixing and matching PPO and HMO components, gatekeepers and self-referral, prior authorization and retrospective profiling, out-of-network wraparounds and out-of-area expansions. The threeletter acronyms that once anchored our understanding of health insurance alternatives are rapidly becoming untethered as the industry crafts hybrid strains in a dizzying display of product-engineering. Premiums and prices have lost whatever uniformity they once possessed, with community-rating and standard methods of capitation and fee-for-service being swept aside by the market imperative to vary prices according to underlying variations in costs. Consumers choosing rich benefit packages, loose network designs, and patrician physician practices find themselves paying substantially more than those content with thinner benefits, more tightly managed access, and community-based practitioners. Public and private sponsors are continuing CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 25 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care their slow and painful transition from defined benefits to defined contributions, paying a fixed dollar amount rather than encouraging costly choices through higher subsidies. In a competitive market each product must be priced to be self-supporting, since cross-subsidies invite new entry that appeals to the overcharged customers. The diverse options in benefit and network design are reflected in actuarially sound, and hence diverse, price levels. Insurance premiums and provider payments will increasingly reflect the health status and cost of care required by the individual enrollee and patient. Risk-adjusted prices are desirable since they remove incentives to cherry-pick the healthy and avoid the ill. They are essential for the continued economic viability of safety-net providers who attract the sickest patients due to their geographic location or open-door policy. In the absence of risk-adjusted subsidies, market competition will shift the economic burden of illness onto the ill while allowing the healthy to pay for only their modest medical needs. The United States currently maintains a tattered fabric of risk-adjusted subsidies, with employer-paid benefits, government entitlement programs, and the health insurance tax deduction allocating greater sums for sick than for healthy citizens. However, the system has many loopholes and exceptions. Competitive markets and corporate organizations in health care would benefit from a well-designed and well-financed system of risk subsidies, since this would eliminate the pressure to deny coverage and would convert charity cases into paying customers. However, steps in this direction are difficult since they would violate the ban on new taxes, which is one manifestation of the “do no direct harm” principle in contemporary politics. The marketing of health care is increasingly differentiated and methods of branding, distributing, and selling are becoming key competitive skills for health plans and provider organizations. It is increasingly hard to imagine that all Americans one day will pick up their health insurance at the local Social Security office or be channeled through a uniform open enrollment process. Consumers obtain their information and options through insurance brokers and websites, private and public employers, state insurance pools and Medicaid agencies, federal Medicare and military programs, and myriad other options. The industry is pioneering ever-new ways of connecting buyers and sellers, including print and electronic media, direct mail and the Internet, community organizations and consumer cooperatives. Through it all, the American consumer reigns sovereign over a complete menu of choices, chaos of opportunities, and cacophony of salesmen promising a product as unique as the individual and as affordable as the alternative. Health Care: Market and Organizational Structures We are witnessing massive changes in the structure of health care markets and organizations. Many of today’s most prominent organizational forms, such as Independent Practice Associations and physician-hospital organizations, were difficult to find 20 years ago.15 Multi-specialty medical groups have a long and illustrious history in some communities but have been thoroughly 26 CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 75 76 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care transformed by the marketplace shift towards managed care. Preferred provider insurance has displaced indemnity and the network HMOs have displaced their staff model progenitors only in the recent decade. Forms of contracting are in a state of ferment, with payment methods that borrow from both capitation and fee-for-service and methods of utilization management that compromise between arm’s-length review and full delegation. Organizations are becoming larger and more complex through merger, acquisition, and product diversification. However, increased scale is stimulating competition rather than cartels, as local barriers fail to impede entry by multi-product, multi-market firms. The most visible feature of the corporate system of health care is ceaseless acquisition and divestiture, integration and outsourcing, and combination and recombination. Medical groups, hospital systems, and health plans are coming together and then coming apart, substituting contract for joint ownership, creating diversified conglomerates and refocused facilities, and experimenting with ever new structures of ownership, finance, governance, and management. After decades in which medicine was frozen into a cottage industry of solo physician practices, freestanding community hospitals, and single-state Blue Cross insurers, incumbents and upstarts are pushing boundaries in ways once not merely infeasible but unthinkable. They are exploring potential economies of scale, the advantages offered by large size in insurance risk bearing, administrative efficiencies, and vendor contracting as well as the diseconomies that accompany the attenuation of individual incentives and accentuation of influence politics. Firms are exploring the economies and diseconomies of scope, the tradeoffs between conglomerate versus staff-and-line organization, broad-spectrum versus niche positioning, transfer versus market pricing, diversification versus product focus, coordination versus clinical specialization. They seek some middle ground between the extremes of vertical integration and spot contracting, some balance of coordinated and autonomous adaptation in the face of ever-new challenges. This process of trial and error is generating a diversity rather than uniformity of organizations and contracts. The heterogeneity of regional providers and purchasers, technologies and transactions, economics and demographics, popular cultures and political institutions supports an enduring variety in the health care marketplace. There are striking cross-market and within-market differences in methods of payment, medical management, data reporting, and quality accountability. Some physician communities are characterized by multi-specialty medical groups, others by more loosely structured IPAs, and others by a continuing Diaspora of unaffiliated practices. For-profit hospital chains hold a strong position in some communities, while others are dominated by large nonprofit systems and the remainder cling to hometown facilities. Different regions favor different mixes of HMO, PPO, and hybrid insurance products. This heterogeneity stems both from enduring regional characteristics and from transient differences in each community’s place on the health care learning curve, as experiments that succeed in one locality are copied in others. CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 27 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care Medical groups, hospital systems, and health plans want to avoid the rigors of competition by acquiring or merging with their rivals, seeking oligopoly and ultimately monopoly power to dictate prices and protect profits. However, accomplishment seems ever to lag behind aspiration, as purchasers, suppliers, substitute services, and entrepreneurial outsiders compete for their share of those potential monopoly profits. The organizational diversification of health plans and providers has created a ravenous crowd of well-financed and battlehardened competitors able to jump into new products and new markets when revenue opportunities arise. Entry barriers are lower, not higher, than in the bygone era when the professional guild boycotted group practices, fixed prices, restricted advertising, enforced any-willing-provider laws, and banned the corporate practice of medicine. The cottage industry structure of yesteryear lent itself well to the most thoroughgoing anti-competitive practices, while the large corporate organizations, consolidated industry structures, and complex contractual relationships of today lend themselves to the most vigorous competition ever observed in health care. Health Care: Political Backlash The political backlash against competitive markets and corporate organization in health care has far exceeded the reaction against deregulation in the utility industries. The success against cost inflation has produced large savings for employers and governmental programs but little visible benefit to individual employees and taxpayers. Had the rate of inflation that prevailed in the five years prior to the defeat the President Clinton’s Health Security Act continued for the five years following that landmark event, health care costs and premiums at the end of the decade would have been twice their actual levels, creating dire personal hardships, acrimonious tax politics, and contentious labor relations. However, the transition to a market-driven health care system coincided with an acceleration of trends away from paternalistic employment policies and welfare state politics. Many employees experienced the decline in overall premiums as an increase in their paycheck deductions and compared unfavorably the network restrictions and utilization oversight of managed care with the halcyon days of first dollar indemnity insurance. Consumer concerns have been accompanied and encouraged by a producer backlash against the changing market and organizational structures in health care. Hospital employees and their labor unions are dismayed to note the shift in jobs from unionized inpatient settings to often nonunion ambulatory, sub-acute, and home health settings. Medical specialists resent the tilt in status and income towards primary care. Physician earnings have continued to rise, but at a slower pace and in a much more uneven pattern than in the era of costunconscious consumer demand. Medical groups and hospital systems impose a degree of administrative oversight, peer review, and public accountability that feels foreign and uncomfortable to clinical miracle-workers. Caregivers resent the budgetary constraints necessary for financial solvency as unwarranted 28 CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 77 78 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care incursions on their clinical autonomy. Specialty societies, labor unions, device manufacturers, and all the other constituents of the medical-industrial complex have mobilized in defense of their economic self-interest, naturally explaining their behavior as a defense of patient rights and the quality of care. The number and variety of new laws and regulations concerning the corporate health care system is remarkable. While debate over the federal legislation (including imposition of liability on insurance plans and exemption of physicians from antitrust law) has gained the greatest attention, most of the activity has been at the state level. In the 1999-2000 legislative session, over 10,000 pieces of health care legislation were introduced at the state level.16 For example, 38 states imposed timelines on claims payment, 31 mandatory disclosure of pharmacy formularies, 27 banned various payment incentives for physicians, 21 required insurers to include “any willing provider” in their contractual networks, 19 mandated “point of service” options on HMO products, 7 imposed new tort liability on insurers, and one exempted physicians from state antitrust statutes. The numbers rise rapidly when bills are counted that did not reach the governor’s desk, including 21 state bills to exempt physicians from antitrust law and 32 state bills to increase insurer tort liability. Needless to say, measures of regulatory backlash that include regulations in addition to new statutes would be substantially larger. Social Benefits of Partial Re-Regulation Market economies need well-conceived and well-implemented political institutions just as much as democratic polities need vibrant economic markets. Utility commissions and statutory compulsions were not replaced by laissez faire in the transportation, communications, and finance industries but by a mix of disclosure mandates, safety standards, financial reserve requirements, and other safeguards that protect the public interest with a hand somewhat less visible than before. By analogy, some mechanism of oversight and accountability are beneficial and indeed essential for the corporate system of health care. A salient characteristic of medicine is the clinical uncertainty of each individual’s diagnosis and appropriate treatment. It is essential that administratively efficient and socially acceptable mechanisms be developed for reviewing, adjudicating, and appealing differences concerning benefit coverage, experimental treatment, and medical necessity. These mechanisms must be not only sufficiently close to the clinical interface to produce informed and timely outcomes, but sufficiently independent to claim a broader legitimacy. The system will need to grope to some workable mix of mediation, arbitration, and litigation to resolve differences in what is an inherently stressful and complex decisionmaking arena. Health insurance involves the collecting of premiums and subsequent paying of claims in a manner that invariably raises the possibility of overextension and insolvency. State insurance departments traditionally regulated CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 29 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care indemnity, Blue Cross, and HMO carriers but have been outstripped by the geographic expansion, product diversification, and capitation contracting of the industry. The locus of administrative control and the incidence of risk is no longer clear in health plans that operate in multiple states, offer multiple network designs, and sell every form of insurance, partial insurance, and reinsurance. Private employers and public agencies with self-insured fringe benefits programs escape state regulatory oversight altogether. Medical groups, practice management firms, and physician-hospital systems cover capitated populations larger than the enrollments in some insurance companies yet are often exempt from formal insurance regulation. The emerging system needs to revisit the nuts and bolts of tangible net equity, liquidity ratios, and other means for ensuring that the money paid at the beginning of the year is still available to cover the stream of claims that trickle in at the end. The emerging health care system has pioneered new methods for the collection, dissemination, and comparison of data on customer service and clinical quality. The progress to date has been frustratingly slow but has laid the foundation for more specific, severity-adjusted, and outcomes-oriented measures in the future. This is an arena with important roles for public agencies that can mandate participation, for nonprofit organizations that can develop the instruments, and for health plans and providers who can cooperate on data collection and compete on quality results. The proliferation of print, television, and internet avenues for the dissemination of quality and service data repeats the experience of the deregulated utility industries, where the rise of choice and competition created a new demand and thereby spurred a new supply of information to consumers. The Corporate Practice of Medicine The corporate system of health care has produced ever-larger organizations and ever more intense performance competition among them. However, its sustainability has not thereby been assured. The very dynamism of the corporate system disrupts established social norms and disadvantages powerful political constituencies. American health care will never go back to professional dominance, which lost its political power as well as its organizational basis in the transition to managed care. It will not proceed to the complete consolidation, the full vertical and horizontal integration embodied in the principles of managed competition. However, corporate health care is threatened by a new form of regulation. This will not be the entry barriers and rate setting of the utility commission, but will come through myriad small rules, requirements, and judicial precedents designed to protect the purportedly helpless consumer against the hazards of choice and competition. Individually, each new regulation will limit only modestly the discretion of health care purchasers and providers. Cumulatively, however, they could strap down the corporate Gulliver through 30 CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 79 80 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care a thousand small impediments on innovation, taxes on efficiency, and litigious disputes over clinical uncertainties. Despite the serious challenges facing the emerging health care system, it is possible to conclude on a cautiously optimistic note.17 Political backlash followed the growth of large diversified firms in the American economy but did not reverse its course, due to the remarkable gains in efficiency and quality generated by market competition and corporate organization. Capacity investment, market entry, product price, and service specifications have been opened to competition in the transportation, communication, energy, and finance industries after decades of utility regulation. The competitive corporate system has been sustained because it proposes not incremental improvements in cost or quality for the pre-existing set of goods and services but, rather, revolutionary changes in the basic organizational and market structures of the economy. Similarly, the corporate system does not offer incremental reforms to the framework of professional dominance in medicine but has swept it away completely, along with fragmented physician practice, arm’s-length indemnity insurance, and costunconscious consumer demand. In the final analysis, it is not incremental improvement in price and quality that counts, but rather the radical competition from the entirely new product and service, the new technology, the new source of supply, and the new type of organization—competition that strikes not at the margins of the profits and the outputs of the existing organizations but at their foundations and their very lives. This is the corporate practice of medicine. Notes 1. D.W. Douglass and J.C. Miller, “Quality Competition, Industry Equilibrium, and Efficiency in the Price-Constrained Airline Market,” American Economic Review, 64 (1974): 657-669; E.E. Bailey, D.R. Graham, and D.P. Kaplan, Deregulating the Airlines (Cambridge, MA: The MIT Press, 1985); the classic paper on the costincreasing effects of competition in the presence of rate regulation is G.J. Stigler, “Price and Non-Price Competition,” Journal of Political Economy, 76 (1968): 149154; R.H.K. Vietor, Contrived Competition: Regulation and Deregulation in America (Cambridge, MA: Harvard University Press, 1994). 2. H. Averch and L. Johnson, “Behavior of the Firm under Regulatory Constraint,” American Economic Review, 52 (1962): 1052-1069; P.L. Joskow and R. Schmalensee, “Incentive Regulation for Electric Utilities,” Yale Journal on Regulation, 4/1 (1986): 1-49; P.L. Joskow, “Regulatory Failure, Regulatory Reform, and Structural Change in the Electric Power Industry,” Brookings Papers: Microeconomics (1989), pp. 125-199. 3. A.F. Friedlander and R.H. Spady, Freight Transport Regulation: Equity, Efficiency, and Competition in the Rail and Trucking Industries (Cambridge, MA: The MIT Press, 1981); T.E. Keeler, Railroads, Freight, and Public Policy (Washington, D.C.: The Brookings Institution, 1983); A.F. Friedlander, E.R. Berndt, and G. McCullough, “Governance Structure, Managerial Characteristics, and Firm Performance in the Deregulated Rail Industry,” Brookings Papers: Microeconomics (1992), pp. 95-183. 4. A.N. Berger, A.K. Sashyap, and J.M. Scalise, “The Transformation of the U.S. Banking Industry: What a Long Strange Trip It’s Been,” Brookings Papers on Economic Activity, 2 (1995): 55-218. CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 31 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care 5. A. DeVany and W.D. Walls, “Natural Gas Industry Transformation, Competitive Institutions, and the Role of Regulation,” Energy Policy, 22/9 (1994): 755-763; K.W. Costello and D.J. Duann, “Turning Up the Heat in the Natural Gas Industry,” Regulation, 1 (1996): 52-59; R.H.K. Vietor, Contrived Competition: Regulation and Deregulation in America (Cambridge, MA: Harvard University Press, 1994). 6. G.J. Stigler, “The Theory of Economic Regulation,” Bell Journal of Economics and Management Science, 2 (1971): 22-50; S. Pelzman, “Toward a More General Theory of Regulation,” Journal of Law and Economics, 19 (1976): 211-240; G. Becker, “A Theory of Competition among Pressure Groups for Political Influence,” Quarterly Journal of Economics, 98 (1983): 371-400; S. Pelzman, “The Economic Theory of Regulation after a Decade of Deregulation,” Brookings Papers: Microeconomics, (1989), pp. 1-41; A.E. Kahn, The Economics of Regulation: Principles and Institutions (New York, NY: John Wiley, 1971, second edition 1988); P.L. Joskow and R.C. Noll, “Regulation in Theory and Practice: An Overview,” in G. Fromm, ed., Studies in Public Regulation (Cambridge, MA: MIT Press, 1981); M.W. White, “Power Struggles: Explaining Deregulatory Reforms in Electricity Markets,” Brookings Papers: Microeconomics (1996), pp. 201-267. 7. A.E. Kahn, “Deregulation: Looking Backward and Looking Forward,” Yale Journal on Regulation, 7 (1990): 325-354; C. Winston, “Economic Deregulation: Days of Reckoning for Microeconomists,” Journal of Economic Literature, 31 (1993): 12631289; J.R. Meyer and W.B. Tye, “Toward Achieving Workable Competition in Industries Undergoing a Transition to Deregulation: A Contractual Equilibrium Approach,” Yale Journal on Regulation, 5 (1988): 273-297; R.H.K. Vietor, Contrived Competition: Regulation and Deregulation in America (Cambridge, MA: Harvard University Press, 1994). 8. These quantitative estimates are derived from the literature survey in C. Winston, “U.S. Industry Adjustment to Economic Deregulation,” Journal of Economic Perspectives, 12/3 (1998): 89-110. 9. Fare ceilings imposed by Civil Aeronautics Board had stimulated non-price competition through more frequent flights, reducing occupancy rates and raising average costs per passenger mile, and it was anticipated that deregulation would reduce frequency by stimulating price competition. However, the increase in demand stimulated by the lower prices more than compensated for the frequency-reducing impact of higher seat occupancy rates. 10. K.J. Arrow, “Uncertainty and the Welfare Economics of Medical Care,” American Economic Review, 53/5 (1963): 941-973. 11. D.A. Banks, S.E. Foreman, and T.E. Keeler, “Cross-Subsidization in Hospital Care: Some Lessons from the Law and Economics of Regulation,” Health Matrix Journal of Law-Medicine, 9 (1999): 1-35. 12. For an overview of the economics of professional dominance, see J.C. Robinson, The Corporate Practice of Medicine: Competition and Innovation in Health Care (Berkeley, CA: University of California Press, 1999), Chapter 2. 13. R.G. Noll, “Economic Perspectives on the Politics of Regulation,” in R. Schmalensee and R.D. Willig, eds., Handbook of Industrial Organization (Amsterdam: Elsevier Science Publishers, 1989). 14. K. Levit, C. Cowan, B. Braden, et al., “National Health Expenditures in 1997: More Slow Growth,” Health Affairs, 17/6 (1998): 99-110. 15. For an overview of organizational innovation in physician group practice, see J.C. Robinson, op. cit., Chapters 5-8. 16. The BNA Health Plan and Provider Reporter provides a weekly summary of federal and state anti-managed care legislation and regulation. The figure on 10,000 bills was derived from analyses by the Health Insurance Association of America 32 CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 81 82 Harvard Business School Service Management Articles Deregulation and Regulatory Backlash in Health Care © The McGraw−Hill Companies, 2004 Article Deregulation and Regulatory Backlash in Health Care and National Conference of State Legislatures. Bureau of National Affairs, BNA Health Plan and Provider Reporter, June 28, 2000): pp. 758-759. 17. The cognoscenti will recognize the debt of this paragraph to J.A. Schumpeter, Capitalism, Socialism, and Democracy (New York, NY: Harper and Row, 1942). CALIFORNIA MANAGEMENT REVIEW VOL. 43, NO. 1 FALL 2000 33 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care Article © The McGraw−Hill Companies, 2002 Finding a Lasting Cure for U.S. Health Care Perspectives Harvard Business Review Reprint 94512 83 84 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care Article © The McGraw−Hill Companies, 2002 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care 85 © The McGraw−Hill Companies, 2002 Article HarvardBusinessReview SEPTEMBER-OCTOBER 1994 Reprint Number PETER F. DRUCKER THE THEORY OF THE BUSINESS 94506 H. KENT BOWEN, KIM B. CLARK, CHARLES A. HOLLOWAY, DOROTHY LEONARD-BARTON, STEVEN C. WHEELWRIGHT SPECIAL SECTION: REGAINING THE LEAD IN MANUFACTURING DEVELOPMENT PROJECTS: THE ENGINE OF RENEWAL HOW TO INTEGRATE WORK AND DEEPEN EXPERTISE MAKE PROJECTS THE SCHOOL FOR LEADERS 94501 94502 94503 ARTEMIS MARCH USABILITY: THE NEW DIMENSION OF PRODUCT DESIGN 94507 JOHN A. QUELCH, DAVID KENNY EXTEND PROFITS, NOT PRODUCT LINES 94509 STAN DAVIS, JIM BOTKIN THE COMING OF KNOWLEDGE-BASED BUSINESS 94505 REGINA FAZIO MARUCA HBR CASE STUDY CAN THIS BRAND BE SAVED? 94508 WILLIAM G. BOWEN SOCIAL ENTERPRISE WHEN A BUSINESS LEADER JOINS A NONPROFIT BOARD 94504 PERSPECTIVES FINDING A LASTING CURE FOR U.S. HEALTH CARE 94512 RICK YAN WORLD VIEW TO REACH CHINA’S CONSUMERS, ADAPT TO GUO QING 94511 ALAN M. WEBBER BOOKS IN REVIEW SURVIVING IN THE NEW ECONOMY 94510 86 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care Article © The McGraw−Hill Companies, 2002 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care © The McGraw−Hill Companies, 2002 Article P E R S P E C T I V E S Can health care reform in the United States achieve longterm cost reductions and maintain quality of care? Finding a Lasting Cure for U.S. Health Care In “Making Competition in Health Care Work” (July-August 1994), Elizabeth Olmsted Teisberg, Michael E. Porter, and Gregory B. Brown consider a question that has been conspicuously absent from the current national debate on health care reform: How can the United States achieve sustained cost reductions over time? The authors find the answer in the powerful lessons that business has learned over the past two decades about the imperatives of competition. In industry after industry, the underlying dynamic is the same: competition compels companies to deliver constantly increasing value to customers. The fundamental driver of this continuous quality improvement and cost reduction is innovation. Without incentives to sustain innovation in health care, short-term cost savings will soon be overwhelmed by the desire to widen access, the growing health needs of an aging population, and the unwillingness of Americans to settle for HARVARD BUSINESS REVIEW September-October 1994 anything less than the best treatments available. The misguided assumption underlying much of the debate about health care is that technology is the enemy. By assuming that technology drives up costs, reformers neglect the central importance of innovation or, worse yet, attempt to slow its pace. In fact, the authors argue, innovation driven by rigorous competition is the key to successful reform. A lasting cure for health care in the United States should include four basic elements: corrected incentives to spur productive competition, universal insurance to secure economic efficiency, relevant information to ensure meaningful choice, and vigorous innovation to guarantee dynamic improvement. Eleven experts examine the current state of the health care system in the United States and offer their views on the shape that reform should take. Teisberg, Porter, and Brown then provide a brief response. Copyright © 1994 by the President and Fellows of Harvard College. All rights reserved. 87 88 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care I. Steven Udvarhelyi Vice President, Medical Services The Prudential Insurance Company of America Executive Vice President The Prudential Center for Health Care Research Philadelphia, Pennsylvania As Elizabeth Teisberg, Michael Porter, and Gregory Brown argue, the failure of U.S. medicine to produce cost innovation has contributed significantly to the difficulty we have in controlling health care costs. And cost innovation is critical if we want to succeed at reducing costs and improving quality in a world of fixed resources. However, the authors fail to emphasize some important issues and do not present others in their full complexity. The assertion that payers try to deny payment on claims whenever possible is just such an oversimplification. As the authors point out, The Prudential Insurance Company of America has demonstrated through its Institutes of Quality Program that incentives can be aligned to produce cost savings and improve quality. And our case is far from an isolated one. Health maintenance organizations cover and pay for more comprehensive preventive care than traditional fee-for-service plans do. Some HMOs actually pay expectant mothers on Medicaid to come in for care. HMO managers understand that an HMO is responsible for the health of a defined population, rather than for a series of individuals with individual health problems. If we are to solve the problems of the health care system, we must start thinking in these same terms. Indeed, the use of new health care technologies requires just such an approach. The authors are correct to say that we should not slow technological innovation in health care, especially innovation that can reduce costs. But the diffusion of technologies into widespread medical practice prior to an adequate assessment of their risks, benefits, and appropriate relative roles should be slowed. The push for rapid dissemination of new technologies is most prevalent 6 © The McGraw−Hill Companies, 2002 Article “On the road to innovation, let us not forget to develop the tools that allow physicians, payers, and patients to make better decisions.” I. Steven Udvarhelyi where current therapies are limited in their effectiveness. While it is understandable that individuals may wish to try new, unproven technologies in such situations, as a society we must collect data that demonstrate the effectiveness of new technologies rather than submit a large number of individuals to unknown risks for unknown benefits. Gathering information on whether or not a new technology produces better health outcomes – or equal health outcomes at a lower cost – is almost impossible if the technology has become practice before data are collected and analyzed. The argument that we will improve innovation by providing consumers, specifically individual patients and other purchasers, with better information on health outcomes is true but again oversimpli- fied. In the financial services markets, we have seen the development of bond ratings as aggregate measures of performance, partly because individual investors cannot make use of detailed, individual financial reports on bond stability and projected yields. Why should medicine be different? Many individual consumers will have difficulty interpreting outcome data on complex medical treatments and procedures and weighing the risks and benefits associated with different approaches to treatment. We should anticipate the equivalent of an aggregate “bond rating” in medicine that allows the lay public to evaluate competing physicians, hospitals, and health plans. In addition, we should expect individuals to get better advice from physicians who are better informed than most physicians are today. To that end, extensive research that develops better outcome measures must be undertaken quickly; however, that research should not simply focus on measures that are important to individual patients or to group purchasers, such as employers. The information needs to be useful to physicians, and the outcome data need to be coupled with a better understanding of which clinical processes produce the best outcomes. It is critical that the foundation of clinical decision making be improved. The health care system of the future will place less emphasis on the decision-making abilities of individual physicians and more on the decision-making abilities of a team of individuals working together – a team that should include the patient. This new system of health care delivery will require new ways of supporting and making decisions in order to improve medical outcomes. Information and outcome data should be available to all decision makers so that better informed, and better coordinated, recommendations can be made about treatment options. Such data should permit physicians to improve their own performance, permit each decision maker to understand the relationship of outcomes to the performance of other team members, and provide patients with information that HARVARD BUSINESS REVIEW September-October 1994 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care points out the pros and cons of different treatment options. On the road to innovation, let us not forget to develop the tools that allow physicians, payers, and patients to make better decisions. Arnold S. Relman Professor of Medicine and of Social Medicine Harvard Medical School Editor-in-Chief Emeritus The New England Journal of Medicine Boston, Massachusetts The authors are largely correct in their description of the inefficiencies and skewed incentives of the present health care system in the United States, but their suggested remedy can’t work. They prescribe a strong dose of “productive competition,” as if health care were simply a business in which competition has not been allowed to work its usual magic. A lifetime of involvement in the practice, teaching, and study of medical care has convinced me that this view, so commonly held by businesspeople and economists, is misguided. Health care is not a product or a simple service that can be standardized, packaged, marketed, or adequately judged by consumers according to quality and price. The authors correctly recognize that “informed purchasing decisions” have, to date, had little influence on supply and demand in health care. But they are wrong if they believe that health care can be made to behave like other parts of the U.S. economy through the stimulation of competition and the use of “meaningful outcome measures.” Medical care is a highly personal and individualized service, the value and success of which can be fully assessed only with respect to a particular individual in particular circumstances. Yes, it is true that narrowly defined “outcomes” of certain procedures can be measured and reported in statistical, probabilistic terms, but such data cannot capture the almost infinite variety of personal circumstances that determine the value of these procedures to a particular patient. There is an enormous and HARVARD BUSINESS REVIEW Article “Health care is not a product or a simple service that can be standardized, packaged, marketed, or adequately judged by consumers according to quality and price.” Arnold S. Relman rapidly growing literature on the probable effects of given procedures in particular medical conditions, but judgments on the quality of care in a given patient rarely can be based on such information. Business managers don’t understand why they shouldn’t be able to get reliable information about quality of care, which they can weigh against the prices charged. The fact is that the measurement of quality is in a primitive state and will probably remain so for the foreseeable future. Here is the best definition of highquality medical care that I can come up with: It is the care given to a particular patient under particular circumstances by a compassionate and competent physician who has access to consultants and the best current information, who is not influenced by economic incentives to do more September-October 1994 89 © The McGraw−Hill Companies, 2002 or less than is medically appropriate, and who is committed to serve the patient’s best interests guided by the latter’s wishes and medical needs. This definition emphasizes the physician’s key role in allocating medical resources and preserving standards of quality. Now, if what I have said about the measurement of quality and the role of physicians is correct, how likely is it that market competition can solve the present problems of our health care system? What we need instead is a reorganization of medical practice to emphasize community-based not-for-profit group practices, and the development of new incentives for physicians and other health care providers to act as prudent counselors for their patients. Unlike ordinary markets, health care needs some overall limitation of expenditures. A national health insurance system could provide a rational and equitable basis for establishing spending limits, subject to public approval. However, the use of available resources within agreed-upon national limits should be the responsibility of health care professionals working with their patients. The authors envision a competitive, market-driven health care system in which for-profit investorowned companies take responsibility for providing care and expect financial rewards in exchange for risking capital. What happens to the doctorpatient relationship in that kind of market? If sick patients are not likely ever to function as independent price-and-quality-sensitive consumers do in ordinary markets, how do we ensure that the economic incentives of investors do not compromise the quality and availability of care? Caveat emptor is the rule in most markets. Who would want to be cared for in a health system built on that principle? Gordon M. Binder Chairman and CEO Amgen Thousand Oaks, California The biotechnology industry offers living proof of Teisberg, Porter, and 7 90 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care Article © The McGraw−Hill Companies, 2002 P E R S P E C T I V E S Brown’s forceful argument: Decades of basic research into the genetic code are now paying off in effective treatments and potential cures for illnesses that have long eluded medical researchers. New drug therapies for heart disease, diabetes, leukemia, cancer, and kidney disease are available to patients, and biotech researchers are determined to eradicate AIDS, Parkinson’s disease, and even cancer. Biotechnology drugs offer patients better and more cost-effective therapies, and they often help avoid surgery and hospitalization. For example, a biotechnology drug we developed at Amgen, Neupogen, is given to patients undergoing chemotherapy to decrease their risk of infection. In clinical trials at Duke University Medical Center, Neupogen has helped reduce the cost of bone marrow transplantation for women with breast cancer from $140,000 two years ago to $65,000 today. Many women who had to receive treatment as hospital inpatients can now receive treatment virtually on an outpatient basis. Yes, this medical care is still expensive, but lives are saved and extended, and quality of life is improved. This kind of progress can continue only in an atmosphere of free and competitive markets. Innovation and investment are two sides of the same coin. Before Amgen sold its first product, more than $400 million had to be raised to fund research. The scientific discoveries that will create today’s medical miracles can evolve only in an environment that rewards the enormous risk that entrepreneurial companies assume in conducting research. The United States is on the brink of stunting this progress. Under the threat of price controls, investor interest in the health care industry is drying up. The biotech industry raised only $1.6 billion in the public market in 1993, down from $3.7 billion in 1991, according to Montgomery Securities, an investment bank based in San Francisco. Under threats of the price controls and added regulation that the Clinton administration has proposed, the number of new biotech companies 8 dropped from 120 in 1987 to 40 in 1993. Sixty percent of the companies that planned to raise capital in 1993 either missed funding targets or canceled stock offerings. An astonishing 100% said that investor concern about price controls has been harmful to their ability to raise funds. Clearly, the threat of price controls is already having a negative impact on medical research. Some members of Congress have worried that if a cure for AIDS is developed, it may be too expensive. But the most cost-effective health care is a cure – or, better yet, a vaccine. For example, in 1952, more children died of polio than of any other infectious disease, and polio was much feared as the great crippler of children. After a concerted campaign to fund many millions of dollars of research, the Salk vaccine was “The scientific discoveries that will create today’s medical miracles can evolve only in an environment that rewards the enormous risk that entrepreneurial companies assume in conducting research.” Gordon M. Binder developed, virtually eliminating polio as a threat. Who can estimate the value of the lives saved and the children who were not crippled because they received the vaccine in time? While we have made dramatic strides in medical research, the way health care is financed and delivered in the United States today needs to be changed. Too many people go without the medical treatment they need, and too many others face catastrophic medical expenses when they have a major illness. But shortsighted efforts to control prices are self-defeating and undermine scientific progress. It is imperative that public-policymakers respect the vibrant connection between innovation and investment. The genius of medical research goes hand in hand with the genius of the competitive market. The cure for the ailments of the U.S. health care system is not increased government regulation, price controls, and mandates but a healthy, vibrant market that offers ever more effective and ever more cost-effective treatments and cures. Rina K. Spence President RKS Health Ventures Corporation Cambridge, Massachusetts Former CEO Emerson Hospital Concord, Massachusetts The authors have accurately identified many of the barriers to successful competition and therefore to sustained cost savings. I would add yet another barrier: the complexity of medical culture and politics. Innovation and competition may appear to be stifled by regulators and legislation, but in fact the conservative nature of much of the health care industry itself – hospitals and insurers included – contributes significantly to the problem. The medical community is fundamentally risk-averse. While clinically sound, this stance poses a real problem when it comes to implementing change in the structure of the health care system. And the problem is only exacerbated by political forces that generally promote the self- Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care Article 91 © The McGraw−Hill Companies, 2002 P E R S P E C T I V E S preservation of existing medical practices and community institutions. Risk-averse behavior manifests itself in all areas of health care delivery, and much of the payment structure that exists today was put into place precisely to limit the level of risk undertaken by practitioners, hospitals, and insurers alike. Today’s innovative and cost-effective forms of service delivery will necessarily involve taking risks, including acceptance of nonphysician caregivers, nontraditional modes of care, and less costly sites for service delivery. Indeed, the new payment scheme, capitation, is fundamentally risk based. Physicians, hospitals, and other providers will receive a fixed dollar amount per patient based on an educated guess concerning the total cost of providing care for their populations. Because of the financial risk involved in serving a population under capitation, these entities will have to become more efficient and find new ways of delivering high-quality care without exceeding their operating budgets. Given these new dynamics, an industry that has been risk-averse will have to change its culture to achieve success. I believe that there is room for successful niche approaches to health care. After ten years as a hospital CEO, I changed paths in order to see if one could create innovative service delivery by stepping outside the existing culture and politics of a traditional institutional setting. Could one build a more cost-effective staffing structure, purchasing systems, and equipment based only on cost and quality, and offer services based on consumer demand? RKS Health Ventures, my answer to that question, is a private outpatient network of consumer-oriented women’s health facilities. These services will be delivered cost-effectively with an ability to incorporate riskbased reimbursement. The private, for-profit sector is also seeking new business opportunities through different management of old structures. Large hospital corporations are purchasing hospitals, and those corporations may be better able to consolidate services and regionalize care because they are not party to the old politics and culture. They are also rapidly developing lower-cost alternatives for health care delivery, such as subacute-care and rehabilitation centers. The health care industry can achieve sustained cost-effectiveness. To that end, the system must be reengineered, breaking down the current paradigm of who, how, and where health care is delivered. Edward M. Kennedy Senator, Massachusetts Chairman, Committee on Labor and Human Resources Washington, D.C. “Making Competition in Health Care Work” is a powerful prescription for reform. The authors’ analysis is fundamentally compatible with the Health Security Act pro- “The medical community is fundamentally risk-averse. While clinically sound, this stance poses a real problem when it comes to implementing change in the structure of the health care system.” Rina K. Spence posed by President Clinton and recently approved in modified form by the Committee on Labor and Human Resources. Everyone’s first priority in Congress is to unleash the forces of competition in order to achieve long-term cost reductions, continuous quality improvements, and innovation. But the real challenge is how to do it. The Health Security Act addresses the problems and will foster the innovation that Teisberg, Porter, and Brown identify as the key to longterm cost control. A solution to the cost problem, as the authors rightly emphasize, requires universal coverage. The Health Security Act ensures that every citizen will have incentives to choose the highest-value health plan from among a number of different plans. Employees choosing more expensive plans will pay more; those choosing less expensive plans will pay less. And they will receive a cash rebate if they choose a plan that costs less than the employer’s contribution. Coverage will be comprehensive and standardized so that people can compare plans on price and quality without the subtle distortions introduced when benefits vary among plans. The program also improves the negotiating power of citizens by reducing fragmentation. Employers with fewer than 500 employees, as well as the self-employed and the unemployed, will purchase coverage through community-rated pools, and they will be able to exert considerable market power to curb costs. Employers with more than 1,000 employees will purchase coverage outside the pools. Companies with 500 to 1,000 employees will have a choice: they can purchase coverage directly or participate in pools. The plan gives citizens still another choice by making the Federal Employees Health Benefits Program available to nonfederal employees. The Health Security Act is also consistent with a number of the other recommendations made by Teisberg, Porter, and Brown. It recognizes that good infor mation on quality of care is an essential part of making health care work. A consumer report card on each health 9 92 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care plan must be developed and made available, using the most up-to-date and comprehensive information on medical outcomes. A major additional investment must be made in outcomes research and the development of practice guidelines. The Health Security Act simplifies the content of health insurance policies, outlawing balance billing and providing for patient cost sharing in the standardized policies. By substantially expanding funds for medical research and academic health centers, the act sends a message that cost savings should be achieved by developing and disseminating new cures for diseases, rather than by restricting the availability of new products. Indeed, our proposal carefully avoids the micromanagement and regulation of the price of specific products and services, new or old, which the authors rightly caution could stifle innovation. Instead, each health plan will have strong incentives to balance the value of a product or service against its cost. In addition, each plan will allow subscribers to decide whether or not that provider has struck the right balance by deciding where to take their business. The main area in which our program differs from the authors’ recommendations is in its fallback premium limits in areas where competition alone is not fully effective or does not work fast enough. In my view, these premium limits are not incompatible with competition. Instead, they are a safety net to ensure that costs do not continue out of control. Excessive inflation is so deeply embedded in today’s system that the availability of such limits may be the “stick in the closet” that is essential to let real competition take hold. The experts we heard from in our committee hearings generally felt that managed competition alone might not be sufficient to restrain rising prices in the short run. The goal is to find the best way to manage competition. Just as antitrust laws are the wise restraints that make competition free in other sectors of the economy, so the right kind of managed competition can work well in health care. 10 © The McGraw−Hill Companies, 2002 Article “Just as antitrust laws are the wise restraints that make competition free in other sectors of the economy, so the right kind of managed competition can work well in health care.” Edward M. Kennedy Jerome H. Grossman Chairman and CEO New England Medical Center Boston, Massachusetts We health care providers must change the elements of practice that are within our control if we are to realize the true benefits of new marketplace incentives. Consider outcome measures. The marketplace, the delivery system, and patients are best served by attending to four categories of outcomes: clinical health (traditional biomedical and physiological health status); functional health (quality of life and general well-being); satisfaction (the consumer’s attitudes and responses to the experience of seeking and receiving care); and cost (the costs of care to achieve the desired level of health outcomes). Fortunately, we are making rapid strides in our ability to measure all four categories. Developments in the field of psychometrics are making it possible to utilize patient- and consumerbased survey instruments of great reliability and accuracy. Essential to adopting outcome measures in health care settings is installing appropriate state-of-theart information systems. The health care system has lagged behind other industries in its use of computers and information systems. Only recently have we begun looking in a methodical way at the bigger picture of how structure, process, and outcomes are intertwined and how operations can be adjusted to improve results. Today we are creating a new generation of decision-support systems to help clinicians and managers make the most efficient use of resources while delivering the most effective health care services. The development of health-care-information systems may prove to be the most significant innovation of all. The health care system is already changing dramatically because the marketplace, led by powerful payers, is transforming itself in ways that the authors would endorse. This evolution will continue, regardless of the actions of Congress. Many of us who are directly responsible for providing health care see an opportunity to improve the health of the population and at the same time enhance our own professional satisfaction. The fact is that we physicians have grown increasingly frustrated with a system that imposes micromanagement by payers, dictating what we can and cannot do for our patients. The alternative: pay us for what we accomplish, not what we do. Provide us with a predetermined and appropriate capitation rate to care for an enrolled population, make us accountable for delivering necessary care within the limits of this budget, and help us measure and monitor the outcomes to ensure that we don’t sacrifice quality for profits. If we succeed in improving outcomes at reduced costs, we stand to gain by increasing our margins and securing market share. HARVARD BUSINESS REVIEW September-October 1994 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care Physicians and providers are responding to this evolving shift to a health care system based on “covered lives” rather than “covered services” by building organized and integrated delivery systems, reviewing and amending practice patterns, and controlling expenditures. Under capitation, providers will make smart purchasing decisions, so that innovations that make sense will be rewarded. This, in turn, sets the context for pharmaceutical and medical device companies to produce costeffective, labor-saving advances that truly improve the outcomes of care. In this way, we will structure an industry and a marketplace to achieve our goals of high-quality and affordable health care. Henri A. Termeer Chairman, President, and CEO Lisa J. Raines Vice President for Government Relations Genzyme Corporation Cambridge, Massachusetts The pharmaceutical marketplace provides a microcosm for Teisberg, Porter, and Brown’s critique of the U.S. health care system’s self-contradictory incentive system. Prescription drugs are usually the most cost-effective way of treating a disease, but neither Medicare nor half of all private insurance policies cover outpatient drugs. As a result, patients are sometimes tempted – or forced by economic circumstance – to forgo filling a $50-per-month prescription that significantly reduces the probability of a more debilitating and expensive heart attack or stroke. And Medicare’s policy of covering inpatient – but not outpatient – drugs has led many oncologists to admit cancer patients to the hospital at a substantial cost to Medicare for the purpose of qualifying the patient’s chemotherapy for reimbursement. The Clinton administration’s health-care-reform plan recognizes the foolishness of a system that will pay for a $20,000 surgical procedure but will not pay for a $2,000 drug that eliminates the need for surgery. The plan proposes to remedy this situation by requiring all public and HARVARD BUSINESS REVIEW Article “The fact is that we physicians have grown increasingly frustrated with a system that imposes micromanagement by payers, dictating what we can and cannot do for our patients.” Jerome H. Grossman private payers to cover outpatient prescription drugs. Yet the details of this proposal, particularly the Medicare portion, could be improved if made more consistent with the authors’ suggestions. Under the Clinton plan, if two brand-name drugs are therapeutically equivalent but one drug costs twice as much as the other, Medicare would pay for whichever drug a physician prescribes. The plan has no meaningful mechanism for encouraging the physician to use the less expensive but equally effective product. In contrast, HMOs and pharmacy-benefit managers direct physicians to prescribe the least expensive therapeutically equivalent product. Furthermore, the administration’s proposal would pay pharmacists a $5 dispensing fee for each Medicare prescription – almost twice the average fee September-October 1994 93 © The McGraw−Hill Companies, 2002 negotiated by managed care organizations – and would prohibit some of the types of discounting and product bundling arrangements that allow manufacturers to either cut the cost or increase the value of their products in ways dictated by an increasingly competitive marketplace. Perhaps most ominously, the administration’s Medicare proposal would authorize the secretary of health and human services to “negotiate” a rebate for new drugs if she “believes the manufacturer’s retail price may be excessive.” It seems obvious that if Medicare can demand a rebate of unlimited size, it has the absolute right to set the product’s price with respect to the Medicare market. For drugs that are used primarily or exclusively by elderly patients – such as those for Alzheimer’s, arthritis, and many cancers – Medicare would control the price for the entire U.S. market. Diseases of the elderly account for about half of all health care costs, and that amount will increase as our nation ages demographically. Our only hope for a sustained reduction of those costs is to create new methods of treatment that reduce the need for hospitalization, surgery, and nursing home care. The structure of the administration’s Medicare proposal undermines these incentives by imposing price controls that would make drug development unattractive to investors who have a myriad of non-price-controlled investments from which to choose. A better approach to a Medicare drug benefit would be to allow pharmacy-benefit managers and HMOs to administer the program. Such private-sector organizations have demonstrated success in containing prescription drug costs through the use of generic substitution, therapeutic substitution, and price negotiations with drug manufacturers, while avoiding the regulations, price controls, paperwork, and inefficiency that would likely accompany a government-run program. As the authors note, the federal government can make an intellectual contribution to such a program through expanded outcomes research and technology-assessment studies that 11 94 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care Article © The McGraw−Hill Companies, 2002 P E R S P E C T I V E S provide payers, providers, and patients with relevant information about the relative merits of various therapeutic approaches. Beyond assessing the merits of individual products and services, however, we need to achieve a social consensus that recognizes the value of innovation. The debate about whether innovation drives costs up or down, whether it improves medical outcomes or not, will continue in the absence of a meaningful evaluation of these issues. Elizabeth Marincola Executive Director The American Society for Cell Biology Bethesda, Maryland It is curious that innovation, and in particular biomedical research, has not figured more prominently in the national health care debate. This omission may be a function of the contrast between the short-term pressures of politics and the longterm ones of science. As the authors point out, longer-term changes in health care are needed, requiring new insights at the most basic level. In the current climate of perverse economic incentives, those who are most vocal in the health care debate – elected officials and advocacy groups representing people with diseases – can be the unintentional enemies of economic efficiency. According to these officials and advocates’ biased view of innovation, federal appropriations for biomedical research are defined as being for the social good. They are not measured in terms of economic returns. Biomedical research should be considered primarily an investment in the national economic wellbeing with additional humanitarian benefits. Like the Japanese, we should consider federal funding of biomedical research to be an investment in R&D for the health care industry, just as electronics research is the R&D for the computer industry. Resistance to investing in research also comes from the misleading but popular public claim that although technological innovation increases the quality of health care, 12 it also always increases costs. In fact, cost increases are often not caused by the technology per se but are rather artifacts of the suboptimal use of diagnostic equipment, such as the nonconsolidation of expensive high-tech capital investments like magnetic resonance imaging. As the authors correctly claim, there must be some regionalization of specialized services so that patients can benefit from state-of-the-art technology free of incentives that encourage its overuse because too many owners need to recoup their investment in expensive machines. The authors also make a good case that the manipulation of incentives for payers, consumers, and providers should result in the actual reduction of health care costs, not just in their redistribution. Economic incentives and regulatory reforms can and “Biomedical research should be considered primarily an investment in the national economic wellbeing with additional humanitarian benefits.” Elizabeth Marincola should be improved – but they can only produce savings on the margin. In an economic climate that seeks to optimize value, we can expect that fundamental research will lead to better-quality treatments at less cost. The only mechanism for significant change in the cost of treating disease is basic biomedical research, which presently consumes a very small fraction (less than 2%) of the health care budget. Unfortunately, analysis of the economic impact of such research is incomplete. Nevertheless, ample evidence exists demonstrating the dramatic returns of successful biomedical research. Hepatitis B vaccine is estimated to save as much as $94.7 million per year by preventing acute and chronic disease. The development of genetic screening techniques for neonatal hypothyroidism allows 97% of infants with congenital hypothyroidism to be identified early enough to avoid the mental retardation that otherwise results from this condition. Any single breakthrough of basic biomedical research could alone produce more savings in health care costs in one year than the entire federal budget for the National Institutes of Health, which funds most biomedical research in the United States. The emphasis on innovation driven by biomedical research, which has been shamefully ignored so far, must be a central element in the reformulated debate on health care reform. Although it is complicated to measure accurately the cost savings produced by biomedical research, federal policy that uncouples such research from the economics of health care delivery undervalues what will ultimately prove to be our most direct avenue to both increasing the quality of health care and lowering its costs. Thomas O. Pyle Managed Care Manager and Policy Analyst Metropolitan Life Insurance Company Westport, Connecticut The authors have provided us with a compelling description of the Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care Article 95 © The McGraw−Hill Companies, 2002 P E R S P E C T I V E S problems in health care economics and practices. Solutions, however, are harder to find. The view that incentives are needed and that competition is good is repeatedly asserted. But these icons of market-driven systems, of which I am a firm advocate, are not easy to implement in health care. Moreover, the authors never tell us how they would do it. The problems are myriad. For instance, since health care coverage is a futures contract, it is inherently speculative. The desire to participate in advantageous aggregations by either buyer or seller is called adverse selection and skimming, respectively. It is the Achilles’ heel of competition in health care. The inability to identify inherent risk in population groups only compounds the problem and prevents large employers in the United States from comparing performance between the various HMOs and indemnity plans it offers; it stymies any simple comparison of outcomes. The problem of gaming extends from health care insurance into the delivery system. Gaming, of course, is characteristic of all businesses, but it’s rarely defended in other industries with the degree of sanctimony and professional weight that is thrown around in health care. All incentive systems have side effects that must be monitored or offset. Even a pure salary system, described in the article as “volume neutral,” is, in fact, not volume neutral. While it will not stimulate the volume of procedures, a pure salary system will tend to reduce access and decrease productivity. The proposals for managed competition, largely the work of Alain Enthoeven and Paul Ellwood, and also known as the Jackson Hole proposals, have a good deal more merit than the article suggests. (I admit to bias, since I was chairman of the Jackson Hole Group from 1991 to 1993.) The main purpose of the proposals is to create a workable market. The Jackson Hole proposals call for the development of HMO-like organizations called accountable health plans (AHPs). These AHPs would assume full responsibility for cost and quality in any individual’s care and would publish performance data. They would compete on the basis of the full array of service attributes, with consumers periodically selecting a new plan if they were dissatisfied or felt a new plan offered a more satisfactory package. For smaller employers, a health store would help the choice process. These health stores would be nonregulatory entities that would facilitate the distribution of AHPs to promote availability and competition and handle the accounting (admittedly primitive) for risk adjustment. Each AHP would compete in a medical market, roughly defined as an area of variable size in which a high percentage of the medical transactions occur for both the population and the set of institutions located within. Plans might be single-market, like the Harvard Com- “While one can envision a time when medical standards and performance data would permit competition on individual types of services, the present state of the art does not allow meaningful competition.” Thomas O. Pyle munity Health Plan in Greater Boston, or multimarket, like Kaiser Permanente, serving markets nationwide. Each market, however, would essentially be a stand-alone business. These organizations would have a strong incentive to improve performance both individually and by developing consortia with others to sponsor research. While the possibility exists that a high-quality provider might be excluded, market incentives would encourage including the providers who offer the best value. And the AHP would have greater capabilities to distinguish high-quality providers than would any individual. The idea that all providers need to be included means including many bad providers and undermining cost-effectiveness. While one can envision a time when medical standards and performance data would permit competition on individual types of services, the present state of the art does not allow meaningful competition in such a model. And who would the decision maker be: the employer, the patient, or the insurer? How would we link payment responsibility with authority to choose? We buy most of our products, such as automobiles, assembled with the named manufacturer taking competitive responsibility for component quality and cost. In the arcane world of health care and health care financing, to do otherwise would perpetuate the gaming so well described in the first part of the article. Ben L. Holmes Vice President General Manager of Medical Products Group Hewlett-Packard Company Andover, Massachusetts It is true that innovation, best attained through healthy competition, is critical to the success of comprehensive and sustained health care reform. The interests of the three primary links in the health care chain – patients, providers, and payers – are still largely conflicting, resulting in inefficient, costly, and sometimes ineffectual care. However, we are beginning to see their interests meld as 13 96 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care © The McGraw−Hill Companies, 2002 Article P E R S P E C T I V E S a result of health-care-industry changes already under way. Regardless of when a health care bill is passed on Capitol Hill, market dynamics have already begun to initiate changes to the system, as shown by health-care-system consolidations and the movement to managed care. Legislators and other government agencies should resist instituting unnecessary, and potentially damaging, policies that could result in additional layers of bureaucracy, diluting competition and interfering with innovation. The shifts occurring in our health care system should not be ignored or underestimated. Well before health care reform became an important topic in Washington, there were signs that the health care industry recognized the need to restructure itself. One of the most dramatic changes – the movement from a fee-for-service to a managed care system – is causing ripple effects throughout the entire industry. The goal of the fee-for-service system was to manage sick people – which meant competing for patients, performing tests of perhaps unknown effectiveness, or having uncertain and unfair guidelines for compensation. In contrast, the goal of managed care is to keep patients healthy within a certain budget. This goal cannot be achieved without all parties assuming more responsibility for health care than they have done under the old system. Indeed, we risk achieving the goals of reform if we focus more on cost – particularly if we implement only short-term tactical measures. Cost containment cannot be separated from quality of care and outcomes. Indeed, the three are inextricably linked and should be considered collectively. The need to lower costs is already well documented. With health care running at 14% of the GNP even while 38 million Americans are uninsured, we’re spending too much Elizabeth Teisberg, Michael Porter, and Gregory Brown Respond: It is heartening that the respondents accept our diagnosis of the problems with incentives in today’s health care system in the United States, problems that have driven up health care costs substantially. Even more encouraging is their general endorsement of our argument that innovation, driven by rigorous competition, is essential to successful reform – particularly given that the principle of innovation has been conspicuously absent from the national debate on health care reform. Rina Spence underscores the importance of incentives for innovation in her critique of the medical culture and the politics that have discouraged new forms of and facilities for health care delivery. Henri Termeer, Lisa Raines, Elizabeth Marincola, and Gordon Binder each provide powerful examples of innovative therapies that not only yield dramatic cost reductions but also improve the quality of life for patients. These commentators share our view of the innovation-stifling effects of price controls and the need to support both basic and applied research. Of all the respondents, only Ar nold Relman argues that 14 health care is a special case and cannot rely on competition. Relman asserts, “Caveat emptor is the rule in most markets. Who would want to be cared for in a health system built on that principle?” Actually, the current system in the United States is built on that principle. Our argument is that all “buyers” in the health care system – patients, doctors, payers, and employers–will make better choices with a combination of more appropriate incentives and improved information. The main debate raised by the respondents centers on just how to restructure incentives and improve information. Two issues concerning how incentives should be changed emerge. First, Ben Holmes and Relman raise the issue of spending caps. Holmes holds that industry-initiated reforms should be sufficient. Relman, in contrast, asserts that overall spending caps are necessary. In our view, health care reform should be implemented and given a chance to work before instituting measures like overall spending caps. Such measures are apt to introduce new distortions in incentives, like biases against new treatments and procedures. Second, Relman and Thomas Pyle raise the issue of physicians’ incentives. Relman agrees with us that salaries create incentives that are preferable to either traditional fee-for-service reimbursement, which provides incentives to overtreat, or the new capitation system, which provides incentives to undertreat. On the other hand, Pyle argues that salaries reduce access and decrease productivity, presumably because salaried doctors will work less or not perform all necessary procedures. Pyle’s argument seems to assume that salaries must be low and fixed. Of course, underpaying doctors makes no sense. Incentives for salaried physicians will stem not only from their commitment to patients but also from the possibility of bonuses, raises, and advancement. A doctor’s salary should reflect the demand for his or her services, which in turn will reflect both the quality of care and the quality of outcomes that patients experience. There is little disagreement about the need for improved information. Holmes, for example, underscores the dangers of reform efforts that try to reduce costs HARVARD BUSINESS REVIEW September-October 1994 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care Article 97 © The McGraw−Hill Companies, 2002 P E R S P E C T I V E S and seeing too few results. Yet isolating expenditures also ignores how better methods of care, from prevention to treatment, would not only control costs but also contribute to better health. Without understanding what treatments work and how to achieve expected and desired medical outcomes, it is virtually impossible to deliver efficient care. We cannot, and should not, tackle the system of cost without considering a total solution involving quality of care and better outcomes. A key tenet of managed care requires all parties to make informed decisions based on knowledge of basic treatments, costs, and expected outcomes. Unfortunately, while health care is one of the most information-rich industries, we are sorely unprepared to aggregate patient data and assess the most successful treatment methods. Technology can and should play a stronger role in the collection and utilization of clinical and administrative data. Technology manufacturers and providers are being charged with developing and utilizing technologies that provide more information about patients, leading to better outcomes. HewlettPackard, for one, is committed to bringing to market products that achieve those goals. Health care providers are learning that in order to survive, they need to operate more as businesses, providing their customers with the best medical service, competitively priced with maximum efficiency. By the time legislation is approved, industry-initiated reform measures will have cured much of what ails health care, resulting in more reasonable costs while improving quality and enhancing outcomes. But this success relies heavily on developing concomitant interests among those with the most to lose or gain from a health care solution – those who receive it, those who provide it, and those who pay for it. Reprint 94512 “Bold reform that includes universal coverage is needed.” without paying adequate attention to the effect of quality. The questions center on how better information will be used and by whom. Steven Udvarhelyi agrees that better information and improved outcome measures should be developed rapidly but argues that only physicians should have access to specific information; the lay public can understand only aggregate ratings of providers. Relman goes a step further, claiming that even physicians are often unable to base judgments on outcome data. Improved, accessible data on medical outcomes are first and foremost needed for physicians. Those data – in addition to knowledge about the individual patient and professional expertise – will allow doctors to make better professional judgments. In addition, corrected physician incentives will guard against the overuse and underuse of treatments. Doctors’ judgments should not be replaced by practice guidelines developed by insurance managers or government bureaucrats. Moreover, the benefits of medical outcome data will be amplified if anyone who wants those data has access to them. HARVARD BUSINESS REVIEW Senator Edward Kennedy, a central player in shaping health care reform, comments that “everyone’s first priority in Congress is to unleash the forces of competition.” We agree with the Senator that bold reform that includes universal coverage is needed. (Indeed, in view of the current debate, it is notable and encouraging that none of the respondents question our argument that universal coverage is necessary for reasons of economic efficiency as well as equity.) And we support the Senator’s efforts, not mentioned in his response, to demonstrate more convincingly the value of research and innovation. But three aspects of the Health Security Act remain troubling. First, as Kennedy points out, “fallback premium limits” are a form of price control. Price controls will distort incentives and re-create health care inefficiency. Second, the employer mandate is expedient but inefficient and unnecessary. Providing health coverage at the employer level creates an unnecessary level of bureaucracy. A better long-term solution is to require everyone to have health insurance, mandate a onetime salary adjustment to September-October 1994 cover the cost of forgone employer benefits, provide subsidies to those who need them, and require age-adjusted community ratings by insurers. Coverage must remain intact when someone moves or changes jobs, and insurers and buying groups must be required to accept all comers to protect people with higher risks or preexisting conditions. Third, a consumer report card is too narrow a vision of outcome measures. In addition to “consumer” information, reform must encourage the rapid development of sophisticated outcome measures that compare specific treatments and specific providers. As Jerome Grossman and Holmes point out, outcome measures and information-technology tools are already improving in anticipation of reform. The fastest way to spur further advancement is via the widespread dissemination of measures currently in use. Hopefully, the consensus among the respondents regarding the importance of innovation can begin to be reflected in the political debate about the direction of health care and, ultimately, in the plans for its reform. 15 98 Harvard Business School Industry and Competitive Strategy Articles Finding a Lasting Cure for U.S. Health Care Article © The McGraw−Hill Companies, 2002 Harvard Business Review HBR Subscriptions Harvard Business Review Subscription Service P.O. Box 52623 Boulder, CO 80322-2623 Telephone: U.S. and Canada (800) 274-3214 Outside U.S. 44-85-846-8888 Fax: (617) 496-8145 American Express, MasterCard, VISA accepted. Billing available. HBR Article Reprints HBR Index Harvard Business Review Operations Department Soldiers Field Boston, MA 02163 Telephone: (800) 545-7685 Fax: (617) 496-8145 HBR Custom Reprints Inquire about HBR’s custom service for quantity orders. Imprint your company’s logo on reprint covers, select articles for custom collections or books. Color available. Telephone: (617) 495-6198 Fax: (617) 496-2470 Permissions For permission to quote or reprint on a one-time basis: Telephone: (800) 545-7685 Fax: (617) 495-6985 For permission to re-publish please write or call: Permissions Editor Harvard Business School Publishing Corporation Soldiers Field Boston, MA 02163 (617) 495-6849 Harvard Business School POM Cases Deaconess−Glover Hospital (A) 99 © The McGraw−Hill Companies, 2004 Case Harvard Business School 9- 601-022 Rev. September 19, 2000 Deaconess-Glover Hospital (A) Hospitals are filled with contradictions. You come to them because you’re sick and need care, but hospitals are places where infections, uncertainty, and errors might actually worsen your condition. Yet, miracles happen so routinely that we’ve come to expect them. Broken bodies are fixed, illnesses are cured, and spirits are repaired because of the hospitals’ caregivers. Unlike many business organizations, hospitals don’t wrestle with the problem of an uncommitted workforce. You will never see a more motivated group: nurses, doctors, technicians, and administrators. They are infused with and exude a single-minded desire to comfort and heal, above all else.1 -- Paul O’Neill, Chairman, Alcoa Chairman, Working Together Healthcare Initiative of Western Pennsylvania Since August 1999, John Carter, a vascular surgeon, had been working with John Dalton, President of Needham Massachusetts-based Deaconess-Glover Hospital (DGH); Julie Bonenfant, Deaconess-Glover’s Vice President for Patient Services; and members of the hospital’s staff (See Exhibit 1 for DGH’s organizational chart). They were seeking an appropriate location within the hospital where they could test the applicability of the Toyota Production System2 to the health care setting. The idea was that once a prototype model line or learning unit was tested for functionality and its benefits were verified, lessons from the learning unit could be taught throughout the rest of the hospital. The longer-term hope was that once benefits were verified within Deaconess-Glover, lessons from DGH could be applied within the CareGroup health care system of which DGH was part (See Exhibit 2 for CareGroup’s organizational chart). Now, in November 1999, Carter was sharing his initial recommendation for the model line. As he waited in Dalton’s office for Bonenfant’s arrival, he mentally rehearsed his presentation of findings and supporting data and anxiously anticipated Dalton and Bonenfant’s reaction. The stakes were high for all concerned. Carter had a twenty-year career as a vascular surgeon and as a surgical practice manager in Washington state. However, his experience as a patient proved to be an epiphany. While vacationing with his family, he chased his son up a tree, slipped on a branch, and fell, breaking the 2nd cervical vertebra in his neck. As a practitioner, he had often wrestled with “the system” to ensure that his patients received 1 Quote taken from e-mail correspondence, January 1999. 2 For reference: “Decoding the DNA of the Toyota Production System” by S. Spear and K. Bowen, Harvard Business Review, September/October, 1999. Visiting Scholar John Kenagy, M.D. and Professor Steven J. Spear prepared this case as the basis for class discussion rather than to illustrate either effective or ineffective handling of an administrative situation. Names and financial numbers have been disguised. Copyright © 2000 by the President and Fellows of Harvard College. To order copies or request permission to reproduce materials, call 1-800-545-7685, write Harvard Business School Publishing, Boston, MA 02163, or go to http://www.hbsp.harvard.edu. No part of this publication may be reproduced, stored in a retrieval system, used in a spreadsheet, or transmitted in any form or by any means—electronic, mechanical, photocopying, recording, or otherwise—without the permission of Harvard Business School. 1 100 Harvard Business School POM Cases Deaconess−Glover Hospital (A) Case 601-022 © The McGraw−Hill Companies, 2004 Deaconess-Glover Hospital (A) the care they needed, when they needed it. As a patient, Carter found that the system was filled with people who were as highly committed to patient care as he was, if not more so. Time and again, nurses, doctors, aides, technicians, and administrators went to heroic lengths to make sure that he was well treated. Yet, able to see his situation as a patient from the perspective of a trained clinician, Carter knew he had experienced many, uncomfortable close calls. Carter returned from his hospitalization and recovery, looking for a better way to manage health care. He spent the next five years -- now as an executive in a health care delivery system -- pursuing better top-down management approaches such as incentive alignment through integrated management systems and exploring public policy options for oversight and regulation. Yet, for all his effort and that of those with whom he worked, he saw no lasting changes. Finally, he decided to look outside of health care for proven management methods, spending two years in a largely self-funded quest. The work at Deaconess-Glover was his chance to demonstrate the opportunity generated by his two previous years of intellectual prospecting. Dalton and Bonenfant had significant stakes in this process too. Deaconess-Glover was a 41-bed community hospital that had lost $2.7 million in the previous 12 months (See Exhibit 3 for DGH’s summary statements of operations). CareGroup, the 1,500 bed system of which DGH was part, had lost nearly $100 million in the same period (See Exhibit 4 for CareGroup’s summary statements of operations). CareGroup’s CEO, James Reinertsen, M.D., had enlisted Deaconess-Glover to be CareGroup’s test site, the first facility to learn how to interpret Toyota Production System principles for the health care context. Reinertsen and his senior management team had been persuaded that if CareGroup mastered Toyota Production System principles, then it might provide higher quality care at lower cost relative to its rivals, just as Toyota had demonstrated sustained and superior quality, cost, and lead-time over several decades in automobile manufacturing. If Deaconess-Glover met success, it would become both a showcase and the source of teachers for the rest of the CareGroup system. There was an added imperative. After volunteering Deaconess-Glover as the pilot, Dalton and Bonenfant agreed to have a portion of their incentive compensation tied to the experiment’s outcome. Reinertsen and Dalton invited Carter into CareGroup and Deaconess-Glover because he brought two useful perspectives to the exercise. His many years of experience as a vascular surgeon and as a health care manager meant that the Deaconess-Glover and CareGroup environments were familiar to him. In addition, Carter had worked closely with TPS experts over the previous year. They had helped him view the Toyota Production System as more than a collection of specific production tools. Rather, he had begun to understand TPS as an integrated approach to designing and improving the work of groups of people engaged in collaborative effort. Carter could now test his understanding of the theory in actual practice. It was time to see if Carter’s investment of time and Dalton and Bonenfant’s willingness to take a significant professional risk were going to pay off. Deaconess-Glover Hospital Glover Memorial Hospital began serving the Needham community as a general-purpose, town-owned facility in 1909. In the 1980s, Glover began to encounter financial difficulty, as did much of the rest of the health care industry due to the switch from cost-plus payments to “Diagnostic Related Groups” which put a cap on the amount hospitals would be compensated per treatment. While medical science and technology had created many more, increasingly complex, and ever more costly tests and treatments, and while demand on the 2 Harvard Business School POM Cases Deaconess−Glover Hospital (A) Case Deaconess-Glover Hospital (A) 101 © The McGraw−Hill Companies, 2004 601-022 system had increased with a gradually aging, growing population, public and private reimbursement rates weren’t keeping pace with rising costs.3 To control expenses, the Town hired the Hospital Corporation of America to provide professional management. Despite pioneering efforts in Deming-inspired Continuous Quality Improvement, Glover’s financial situation had not improved sufficiently, however. Two weeks after joining Glover as its administrator in 1991, John Dalton learned that the Town of Needham wanted to privatize the hospital. Since Glover lacked access to needed capital, and because Glover retained strong support from its staff, its affiliated physicians, and the surrounding community, a merger between Glover and a larger hospital seemed most promising. This was especially true because the health care market in the greater Boston area was consolidating. In 1994, Deaconess Hospital, a large, Harvard-affiliated teaching and research institution purchased Glover, agreeing to keep it open for at least five years as part of Deaconess’s community-based, clinical network. Two years later, Deaconess merged its system with that of the Beth Israel Medical Center, another large, Harvard-affiliated teaching hospital. The combination, named CareGroup, was a 6-hospital network based in Eastern Massachusetts, which employed 13,000 people, and had a 2,000 person medical staff. Reinertsen, who became head of CareGroup in June 1998, and his senior management team were working diligently to make CareGroup the premier system. Yet, it was caught in a sea of external and internal problems that became more intense with almost daily revelations in the media about the financial tribulations of the US health care system. Finding A Model Line In the first several weeks of his engagement, Carter’s primary objective was to identify a site within Deaconess-Glover that had high potential for a model line. Just as DeaconessGlover was to be a test site within CareGroup, the model line would be a place where small tests in applying TPS to health care could be performed. These tests would be the basis for propagating these discoveries throughout Deaconess-Glover. Carter examined several areas within the hospital including the Radiology and Emergency Departments, the Pharmacy, and the Ambulatory Surgery, Gastrointestinal, and the “South Two” medical-surgical inpatient units. In each, he spoke to members of the staff for a broad overview of what they did individually and what their unit did overall before making detailed observations of how work was done in practice. Gastrointestinal Unit In the Gastrointestinal unit (GI), Carter met with Dr. Greg Stoller, the gastroenterologist who performed endoscopies and colonoscopies, Anita Hansen the unit’s senior nurse and manager, Janice Gibb, a staff nurse, and Hannah Seltzer, an endoscopy nurse. Beyond talking to the GI staff, Carter directly observed the work of the group by following patients through a medical procedure. In one case, on August 24th, Carter met a patient, Edward Bennett, in the admitting area at 8 AM. Mr. Bennett had been having trouble swallowing food and Dr. Stoller was going to use an endoscope to investigate for 3 For reference: “The Structure of the Health Care Industry,” Harvard Business School Publishing, 9-196-049, by Ann Winslow and Regina Herzlinger, 1995 and “The Financing of the U.S. Health Care Industry,” Harvard Business School Publishing, 9-196-095, by Winslow and Herzlinger, 1995. 3 102 Harvard Business School POM Cases Deaconess−Glover Hospital (A) Case 601-022 © The McGraw−Hill Companies, 2004 Deaconess-Glover Hospital (A) abnormalities in Mr. Bennett’s esophagus and stomach that might explain his symptoms.4 Carter followed Mr. Bennett in the prep room, stayed with him during the GI procedure in the examination room, and joined him in the recovery area where Bennett rested until the anesthesia wore off by 11 AM. Throughout, Carter noted who was doing what and when, trying to record both the physical activities that were occurring and also the information exchanges that were taking place among the different members of the GI staff and the patient, on a minute-by-minute basis. Carter saw that much of the information was situational. For example, some weeks before, Mr. Bennett had had a similar procedure performed at a nearby, non-CareGroup hospital. Due to the physical discomfort, uncertainty about the procedure, fear of the pain he might experience, and concern about his condition, based on his previous experience with the procedure, the 53-year old father of three was extremely anxious on the morning of his Deaconess-Glover examination. Mr. Bennett’s anxiety caused the medical team to be concerned with more than his physical condition. His emotional condition was an equally pressing concern, affecting the amount of Valium-like sedative he would need and the amount of agitation for which the team had to be prepared. After Stoller completed Mr. Bennett’s procedure, Carter observed Hannah5 preparing the examination room and equipment for the next patient and noted Anita’s procedures for admitting, discharging, and record keeping. Carter generated a profile of the mix of procedures that were performed in the unit and the frequency with which each had been performed over the course of that day and that week. The purpose of this was to understand better the actual needs of the unit’s patients and the demands these needs placed on the work group. This was one of several ways in which Carter’s process of making observations reflected the professional norms of those with whom he was working. Within the hospital, patient care was repeatedly held up as the primary priority. Similarly, Carter’s TPS mentors routinely observed the work done in factories by starting at the shipping dock. They started there to understand the mix, volume, and timing with which customers expected to receive deliveries. Understanding customer expectations served as a prelude to studying how and how well the processes within the plant met customers’ expectations. South Two Medical/Surgical Inpatient Care Unit During his initial study across several areas in the hospital, Carter familiarized himself with the South Two inpatient care unit. Just as he had tried to understand the working of the GI unit on a representative day, he approached South Two in the same way. South Two patients were either being treated for an illness (medical patients) or were recovering from an operation (surgical patients). The unit had 34 beds. By reviewing unit records, Carter learned that over the previous month, the “census” had varied between 19 and 31 with an average count of 24. Patients could be admitted by one of the more than 100 doctors who had full staff privileges. Physicians with privileges were allowed to admit patients to the hospital and to provide and to prescribe active care. Though some of the doctors who had privileges were employed by the hospital directly, most were part of professional practices independent of the hospital. A large portion of these doctors had privileges at more than one hospital so could admit and treat patients where they saw most fit. 4 An endoscope is a long, narrow, rubber coated instrument with camera lenses on one end and controls and video monitor connections on the other. 5 The narrative in this case follows the hospital’s convention by which nurses go by their first names, doctors by their professional title and surname, and patients by their title and surname. 4 Harvard Business School POM Cases Deaconess−Glover Hospital (A) Deaconess-Glover Hospital (A) Case 103 © The McGraw−Hill Companies, 2004 601-022 On August 24th, Carter arrived at Deaconess-Glover at 6:45 AM so that he could observe the end of the night shift (11 PM - 7 AM) and the beginning of the day shift (7 AM 3 PM). He joined the nurses in their break room from 7 AM to 8 AM. There, the three nightnurses reported on patient conditions to the five day-shift nurses. Carter learned from the nurses that while they were in the hospital, patients were usually visited by their doctors twice in a day, during morning rounds and during evening rounds. The bulk of the patients’ 7-day, 24-hour ongoing care was provided by South Two’s nurses. Organized in three shifts, the nurses assessed patients’ conditions, developed care plans, and administered medications and other treatments. They also evaluated results, responded to emergencies, changed dressings, helped with meals, bathed patients, and provided the support and information patients and their families needed during what was a stressful experience. According to the unit’s staffing charts, the typical day shift (7 AM to 3 PM) had five nurses, the evening shift (3 PM to 11 PM) had four, and the night shift (11 PM to 7 AM) had three. Carter saw that staffing levels on each shift had been adjusted based on the number of patients and the severity of each patient’s condition. Because of days off, part time work loads, vacations, and sick days, the number of nurses associated with South Two was actually double to triple the daily staffing level. The day shift began when Arlene Wassel, the day-shift “charge nurse,” assigned each of the 26 patients to one of the five day-nurses. (“Charge nurse” was not an official managerial position. Rather, responsibility for making assignments was circulated among the more senior nurses on an informal basis.) Working from a patient roster and from her own knowledge of each patient’s condition, Arlene assigned patients to nurses based on each nurse’s skill and interests and based on the acuity of each patient’s needs. For instance, some nurses tended to be more comfortable with medical patients while others preferred to work with surgical cases.6 Arlene explained that she knew many of the patients because they had been on the unit the previous day (average stays were about 4 1/2 days). However, before making assignments, she gathered information about those who had been admitted during the evening and night shifts. After Arlene made assignments, the night nurses began to exchange information with the day nurses for the purposes of assessment and treatment. While the patients’ medical charts contained quantitative information, there were unique anecdotal factors that were not communicated on standardized forms. For example, two nurses discussed Mr. Howard’s situation. A veteran of World War II, Howard had run a family-owned hardware store in Needham for thirty-seven years, raised a family, and was a long time Boy Scout leader. Recently, suffering from progressive dementia, the nursing home resident had been having trouble eating. This had left him weak, dehydrated, and in need of more active care than the nursing home could provide. In addition to his medical issues, the night-nurse, Diane, explained to her day-shift replacement that Mr. Howard kept misplacing his box of TicTacs®, and this caused him anxiety and mild distress. Furthermore, Diane had realized that he only had one candy left. She tried the vending machine, but it didn’t sell the mints. Diane called a day-shift colleague who bought a supply on her way to work. Diane explained that she had put the Tic-Tacs® under Mr. Howard’s pillow so that he could find them easily. Carter saw that during the hour, nurses repeatedly left and returned to the room in which report was being given. He followed several nurses and realized that even during 6 Before Dalton joined Glover Memorial, the surgical care unit and the medical care unit had been separate entities. 5 104 Harvard Business School POM Cases 601-022 Deaconess−Glover Hospital (A) Case © The McGraw−Hill Companies, 2004 Deaconess-Glover Hospital (A) report, they continued to care for patients. In one instance, a day nurse, Cindy, responded to an equipment buzzer. A pump that provided painkiller intravenously to a postoperative patient, Mrs. Gould, had stopped and needed to be reset. After the night-shift finished its report, the day nurses reviewed the specific needs for each patient in the KARDEX, a loose-leaf binder containing a sheet for each patient that outlined treatment requirements such as dressing changes, special feeding instructions, etc. Each nurse made notes on a “cheat sheet” that she carried as reference throughout the day.7 After the morning report, Carter spent 30 minutes observing the front desk nurses’ station. Here, doctors and nurses reviewed and modified patients’ charts, Denise -- the unit secretary -- took calls, social workers reviewed records, and doctors phoned in instructions that had not been communicated during rounds. For example, after making her own rounds, a nurse had phoned the admitting-physician with questions about a patient’s treatment. Carter watched as the receptionist received the return call from the physician and found the nurse who had made the request. On a second visit to South Two, Carter observed activity in the five-foot by seven-foot Medication Room. Each patient had an individual drawer or cassette in which a day’s worth of medication was kept. Each cassette was stored in one of two cabinets on wheels, and with each cabinet was a loose-leaf binder that contained the Medication Administration Record (MAR) for each patient. Carter saw that nurses would come to the “med room,” transfer information from the MAR to their cheat sheets, and then stage dosages of several medications that had to be administered at the same time in a disposable paper cup. For instance, when asked what she was doing, one nurse explained that she was putting together all the medications that had to be given at 9 AM in one cup, and all those for 1 PM in another. While nurses were “pouring meds,” as this activity was called, other nurses would look in, and if the room was crowded, they would move onto another activity before returning to do their own medication staging.8 The Pharmacy Carter also made observations in the pharmacy as he initially familiarized himself with Deaconess-Glover. On September 8th, at 8 AM, he met Denise, the pharmacy technician, Carol -- one of the registered pharmacists, and Dan Carpenter, also a registered pharmacist and the unit’s manager. Carter started by watching Denise prepare intravenous medications for patients in both South Two and also in the Intensive Care Unit. Denise reviewed medication orders sent to the pharmacy on “Green Sheets.” She explained that each Green Sheet was the 3rd copy of an order written by a doctor during rounds or by a nurse after discussing a patient’s condition with a doctor on the phone. The Green Sheet had information for a new or modified prescription. For those who had been at Deaconess-Glover the day before, Denise modified the Pharmacy’s Patient’s Medication Record (PMR) for intravenous medications. For those admitted during the evening or night shift, Denise created a new PMR. Using each patient’s PMR for reference, Denise labeled 7 On a separate visit, Carter observed another shift-change activity, counting the narcotics locked in South Two’s medication room. A nurse completing a shift and a nurse starting on the next shift reviewed the entire narcotics inventory and compared that to the narcotics-use record. No nurse could leave until all narcotics issues were reconciled and verified. Once the counts were reconciled, a “White Sheet” was completed and sent to the pharmacy. 8 Carter noted variation in this activity. Some nurses staged medications for the entire day, whereas others returned to the Medication Room every two hours for the next round of doses. 6 Harvard Business School POM Cases Deaconess−Glover Hospital (A) Case Deaconess-Glover Hospital (A) 105 © The McGraw−Hill Companies, 2004 601-022 the medications and staged them on a cart for delivery that day. As she took the IVs from the freezer, refrigerator, or cabinet where they were stored, she noted those for which the inventory was running low so that a replenishment order could be made later that day. After watching Denise perform her work, Carter observed Carol do her work. She started by updating a separate set of Patient Medication Records based on Green Sheets that had been delivered to the pharmacy during the evening and night shifts. Then, at 10 AM she left the pharmacy and went to South Two’s medication room to reconcile her PMRs with the Medication Administration Records kept there. After returning to the pharmacy, she began withdrawing dosages for each patient from one of the 600 containers that were kept on three shelves -- each fifteen feet long, and placed these blister-pack wrapped pills and tablets in the patient’s cassette along with other prescribed medications such as eye drops and syrups. In several cases, Carol had to inform nurses that a particular medication needed special attention. For example, in watching Carol do her work, Carter learned that the pharmacy had 20 mg tablets of a certain drug, but the physician had prescribed a 10 mg dose. Carol affixed a red adhesive label to the pill’s blister pack so that the nurse would know she had to divide the tablet in half before giving half to the patient and disposing of the other half. Carol said that she was trying to complete the filling of all the cassettes by 1:00 PM so that she could wheel two cassette carts to the medication room in South Two and another to the intensive care unit and collect the previous day’s carts.9 Medication Administration on South Two After this overview of the hospital, Dalton, Bonenfant, and Carter decided to focus their efforts. They chose not to concentrate on a particular department or unit -- Radiology for instance -- but instead opted to test the application of the Toyota Production System to a specific process, medication administration, in the South Two inpatient-care unit. Medication administration was the process that delivered pharmaceuticals to patients on a seven-day, 24-hour per day basis. Carter noted that on October 28 South Two’s 23 patients required as few as three and as many as 17 medications (See Exhibit 5 and Exhibit 6). The drugs varied by physical form (pills, tablets, intravenous solutions, topicals, etc.), by administration timing (every 2, 4, 8, 12, 24, or 48 hours or on an as needed basis), and by other criteria (i.e., with or without food). Carter had learned from his earlier observations that several people were involved in the prescription, delivery, and administration of the drugs, and in the pre-treatment and post-treatment evaluation of the patients. These included nurses, doctors, pharmacists, and technicians with various specialties. Though medication administration crossed the boundary of two areas of the hospital -the pharmacy and the medical/surgical recovery unit, it offered several advantages for the purposes of the TPS implementation experiment. Medication administration directly affected the quality and cost of patient care. Mis-medication could delay or compromise a patient’s well being, yet the process didn’t automatically work well. National studies estimated that getting the prescribed medication to patients in the correct form and 9 The pharmacy delivered several classes of medications. One group included those supplied on a patient by patient basis, such as those just described. Second were narcotics delivered in response to “White Sheet” orders. Other medications were supplied on a restock basis, and were ordered on “Pink Sheets,” department by department. In South Two, for instance, certain saline solutions were stocked in the medication room so they would be available immediately as needed. 7 106 Harvard Business School POM Cases Deaconess−Glover Hospital (A) Case 601-022 © The McGraw−Hill Companies, 2004 Deaconess-Glover Hospital (A) quantity, and at the right time, had error rates in the parts per hundred. 10 To reduce the error problem, computerized prescription tracking and drug dispensing technologies were being installed across the country, and CareGroup was an early adopter of these in some of its facilities. Material and Information Flows: Day-Shift Once South Two had been picked as the site for the learning unit, Carter studied the medication administration process more closely. His TPS mentors had emphasized repeatedly that before he made any changes he had to understand the “current condition,” how the process actually worked. As a first step, he had to know what goods and services were provided to the patient, and how the organization produced and delivered each of these goods and services. To gain this information, Carter waited at a patient’s room until the patient’s nurse came to administer medication. After the patient received the various doses, Carter asked the nurse how she had been supplied. He learned that the nurse had taken two medications from the patient’s cassette which was stored in the medication cart in the medication room. A third medication had been delivered directly to the nurse by the pharmacist an hour earlier. Since he had already observed the pharmacy’s work during the earlier portion of his study, Carter knew that the medication cart was delivered once per day to South Two and that throughout the day, the pharmacy made additional deliveries because of changes in patient medications created by new prescriptions. Having made observations that established from whom to whom and from where to where medication was transferred on its journey from the pharmacy to patient, Carter then began a second step in grasping the current condition. He had determined the basic flows of material characteristic of the medication administration process. Now Carter tried to determine the basic information flows characteristic of the process, trying to determine how people knew what to transfer, to whom, when. Therefore, as his second step in grasping the current condition, Carter followed an order from when it was prescribed until when it was delivered. He did this by following a doctor during rounds until the doctor revised a patient’s prescription. This first occurred at 8:10 AM. Carter continued to follow the doctor through the rest of her rounds and to the nurse’s station. There, she wrote the new orders into the patient’s chart. 11 Next, Carter watched how that specific medication order was actually picked up and delivered. The patient’s nurse saw the physician fill out the medication order sheet, so she went immediately to the chart and separated the medication order into its three parts. The 10 According to the report To Err Is Human: Building a Safer Health System, medical errors k i l l 44,000 to 98,000 people in U.S. hospitals each year, a total greater than the deaths attributed to highway accidents, breast cancer or AIDS. Medication errors specifically are responsible for 7,000 deaths per year, more than those due to workplace injuries. -- From the press Release for To Err Is Human: Building a Safer Health System; L. Kohn, J. Corrigan, and M. Donaldson, Editors; Committee on Quality of Health Care in America, Institute of Medicine; 2000 11 The patient “chart” was a large, maroon, three ringed binder and served as a primary medium through which doctors and other health team members communicated. For example, if the doctor examined a patient and decided the patient needed to get a particular medication every four hours, the doctor would write that instruction in this three-ring binder and would then put the binder back on the shelf. 8 Harvard Business School POM Cases Deaconess−Glover Hospital (A) Deaconess-Glover Hospital (A) Case 107 © The McGraw−Hill Companies, 2004 601-022 top copy remained in the chart, the middle copy was pasted into the MAR, and the third copy, the Green Sheet, was sent to the pharmacy. 12 Carter observed that the Green Sheet for this particular order was placed in the nursing station’s outbox, and a few minutes later, it was collected by Denise, the pharmacy technician. At the same time, another nurse reminded Denise of a different patient who had a change in medication requirements. Carter trailed Denise to the Intensive Care Unit, and then back to the pharmacy where she gave the Green Sheet at 9 AM to Carol who was in the midst of dispensing medications. Since the drug was needed before the filled medication cart was to be delivered to South Two’s medication room, Carol placed the requested drug dosage in a plastic bag that was labeled with the patient’s name and the drug’s names. She gave this bag to a community volunteer who came to the pharmacy at 10:15 AM to take it back to nursing station inbox at South Two. There, the nurse collected the medication from the inbox at 10:30 AM and gave it to the patient at 10:35 AM. Having followed one medication from when it was prescribed at the patient’s bedside until it was administered to the patient, Carter followed a second prescription. Mrs. Donaldson, one of Dr. Whestney’s patients, was complaining of gastrointestinal symptoms, for which Whestney prescribed a 20 milligram dose of Prisolec. Whestney did this by completing an order sheet and adding it to the chart. A few minutes later, Mrs. Donaldson’s nurse, Arlene, read the new instructions and placed the Green Sheet copy in the outbox and also started to add the order to the patient’s Medication Administration Record. As she was recording this information in the MAR, she realized -- based on her considerable experience -- that Prilosec was no longer part of the hospital’s formulary and that it been replaced by Previcid, which was available in 15 milligram doses. 13 Though the Green Sheet had been collected, Arlene found Miriam, another pharmacist, who had come to South Two to reconcile the pharmacy’s Patient Medication Record with South Two’s Medication Administration Record. Miriam offered to return with two tablets of Previcid so that if Dr. Whestney wanted either 15 mg or 30 mg given to Mrs. Donaldson, Arlene would be prepared. In the meantime, Arlene called Dr. Whestney, confirmed that 15 mg was sufficient, and so was able to administer the drug to the patient at 9 AM when Miriam returned to South Two. Summary of Findings After watching how the medication administration process occurred in actual practice, Carter summarized his findings in a hand-drawn diagram (the version for South Two’s day shift is replicated in Exhibit 7). He started by indicating the different participants in the process: the patient, the doctor, the nurse, the pharmacist, and the volunteer. Then, he indicated who communicated with whom and the way in which information was communicated. For example, his diagram captured the observation that doctors learned about patients’ conditions by direct examination during rounds or from information 12 Carter observed several ways in which nurses knew that something has been changed in t h e chart. The doctor “flagged” the chart by flipping the color tag on its spine from green to red; t h e doctor verbally told the patient’s nurse that a change had been made; or the nurse went to check i f there was anything new in the book even if the flag-color had not been changed. 13 The medications kept in stock comprised the hospital’s “formulary.” Because identical drugs existed with different brand names, and because different drugs might have had identical uses, i t was possible for a doctor to prescribe a medication that was not in the formulary, and so was not available in-house. 9 108 Harvard Business School POM Cases Deaconess−Glover Hospital (A) Case 601-022 © The McGraw−Hill Companies, 2004 Deaconess-Glover Hospital (A) gathered by nurses and communicated in medical charts, by face to face verbal communication, or by phone. Carter included in his diagram his observations that information about prescriptions was communicated from doctors to nurses through information in the chart, in face to face conversation, or over the phone. He added the different ways in which the pharmacy learned that a patient needed medication. These included the various forms such as Green Sheets for specific prescriptions, White Sheets for narcotics orders, and Pink Sheets for medications kept in stock in South Two. He added the face-to-face and phone conversations that he had noted, and also the PMR/MAR reconciliation done by Carol, the pharmacist, each morning and the calls the pharmacy made to South Two for clarification of a hard-to-read Green Sheet entry. Having indicated how requests were communicated between those who needed something and those who would provide it, Carter then showed how suppliers responded. His diagram showed that medications arrived to South Two from the pharmacy in the medication cart, through the efforts of a volunteer, or when a pharmacist came to the floor, as Miriam had done with Mrs. Donaldson’s Previcid. Carter’s illustration showed the complete loop by indicating that it was the nurse who administered each medication. Carter’s detailed description of South Two’s medication and information flows showed who was involved in the medication administration process, what each person was exchanging/communicating with the other, where these exchanges took place, and how they were exchanging medications and communicating information. Because these information flows contained instructions of what to do, the diagram suggested why people did certain activities. The final element of the diagram indicated the time element, when events occurred. Carter indicated when the doctor examined the patient, when the prescription was entered in the chart, when the Green Sheet was detached and placed in the outbox, when the sheet was picked up and delivered to the pharmacy, etc. on the drawings he made for each specific medication administration observation. Medication Administration: Evenings and Nights For both the evening and night shifts, Carter repeated the process of following a medication from when it was prescribed until when it was administered. He discovered differences in the nature of orders made during these shifts and how orders were communicated to the pharmacy and how a delivery was made back to South Two. The nature of the orders differed in the following way. During the day, the pharmacy prepared the patient-cassettes with a day’s worth of medication. During the evening and night shifts prescriptions were for newly admitted patients or were adjustments in the medication for a continuing patient. In both cases, medication delivery was for several hours, not for an entire day. The form in which orders were handled differed because the pharmacy was not staffed during evening and night shifts. Therefore, it was the responsibility of the shift’s nursing supervisor to bring Green Sheets to the pharmacy and distribute the ordered medications to South Two. The Green Sheets were left until the next day, at which point the information was transferred into the PMR. The medication was carried back to South Two by the nursing supervisor so that it could be administered to the patient. Beyond the description just given, these differences are not detailed further in this case. However, as part of Carter’s effort to understand the medication administration process, he generated a separate set of summary diagrams and analysis. Observing the Work of a Nurse In tracking medications from when and where they were prescribed to when and where they were administered, Carter identified each person who had played a role. Therefore, he 10 Harvard Business School POM Cases Deaconess−Glover Hospital (A) Case 109 © The McGraw−Hill Companies, 2004 Deaconess-Glover Hospital (A) 601-022 was able to document the particular pathway over which specific prescriptions traveled. He was also able to observe how information and materials were exchanged among the members of the health care team. In an additional set of observations, Carter sought to learn about the work of the specific people who played a role in the process as part of his larger effort to grasp the current condition of medication administration. He approached this portion of the study by following an individual nurse for 60 minutes and recording -- on a minute by minute basis -- where she was, what she was doing, with whom she was working, and what was being said. (Exhibit 8 displays the table Carter generated from observing one nurse on the day shift). To be sure that his observations were representative, Carter repeated this activity with another day-shift nurse and with nurses on the evening and night shifts. He then shared his findings with the nurses he observed and with other members of the nursing staff to confirm the validity of his observations and the way he had represented them. Carter’s impression, which was confirmed when he reviewed his detailed records of his observations, was that the nurses were blizzards of activity. For example, the nurse whose work is documented in Exhibit 8, cared for five patients in three rooms during her shift. In the hour that Carter observed her, Cindy worked in eight locations (patient rooms 237, 238, and 239; the hall phone, the kitchen area, the nurses’ station, the medication room, and the supply closet). In the hour, she moved among these 8 locations 22 times, and she spoke inperson or on the phone with 15 different people. For example, she spoke with the five patients for whom she was caring, both to assess their condition and to provide information and reassurance. Cindy discussed the condition of an elderly patient with the patient’s daughter, explaining the follow up home care the mother would need after being discharged from the hospital. Cindy traded information with five other South Two nurses, a hospice nurse, and a nursing aide. She also spoke by phone with two doctors and their receptionists in order to get clarity on the treatment two patients were to receive. Carter asked the South Two nursing staff to define the function of a nurse and they uniformly described it as “assessing a patient’s needs, developing a care plan, implementing the care plans, administering treatments, evaluating the results, and otherwise attending to the care of the patient.” In reviewing his minute by minute observations, Carter noted that in the hour he had recorded, the nurse had spent two thirds of her total time locating information and gathering the materials necessary to do the value-adding nursing work that was described as a nurse’s job. Carter found that all the nurses he observed spent between one-half and two-thirds of their time occupied by other activities that were necessary to do value added nursing. To communicate these findings to other people, Carter summarized his observations in hand-drawn diagrams that are reproduced in Exhibit 9. Completing the Current Condition: Who Cares for Whom? In his first step at understanding the current condition of the medication administration in South Two, Carter had traced specific pathways over which prescriptions and medications traveled, documenting flows of information and medication among those making requests and those generating responses. That resulted in the diagram in Exhibit 7. In his second step at understanding the current condition, Carter studied the work of individuals who performed activities on the pathway over which prescriptions and medications traveled.15 In the third and final step of understanding the current condition, Carter tried to determine the number of distinct pathways over which prescription requests and medications traveled. To do this, he obtained the sheet on which nursing assignments were recorded. This document, reproduced in Exhibit 10, showed each patient (indicated by room number), the patient’s doctor, and the nurse on each shift -- day, evening, and night 15 Activity studies were done in the pharmacy, though they are not reproduced in this case. 11 110 Harvard Business School POM Cases Deaconess−Glover Hospital (A) Case 601-022 © The McGraw−Hill Companies, 2004 Deaconess-Glover Hospital (A) -- who was assigned to that particular patient. Carter re-expressed that document diagrammatically, as in Exhibit 11. He did this to show, pictorially, who had to speak with whom about a patient’s condition, not only during a shift but across shifts as well. Recommending a Next-Step Carter had consolidated his findings on an 11x17 sheet of paper for the meeting with Dalton and Bonenfant. He included background information about the underlying business case for CareGroup, Deaconess-Glover, South Two, and the medication administration process, and included the three summary diagrams he had developed. (See Exhibit 12) Carter used this document to explain to Dalton and Bonenfant how he had studied medication administration and what he and the front line team had observed. He explained that he had confirmed his observations with members of the nursing and pharmacy staff. Though the presentation was punctuated by questions, neither Dalton nor Bonenfant took exception to Carter’s description of how this critical patient-care process actually occurred. Carter was bolstered by their evident interest in what he had done and their obvious agreement with his findings. After thirty minutes, Carter concluded the first portion of the presentation. He then drew in his breath and began explaining the next step he and the TPS experts had designed. Eager to learn Dalton and Bonenfant’s reaction, Carter presented the diagram for the “target condition,” the first step for implementing the Toyota Production System in South Two’s medication administration process. 12 Pharmacy Emergency Department Safety and Risk Mgt. Medical Records Volunteers Clinical Education Occupational Health Intensive Care Rehabilitation Services Cardio-pulmonary services Diagnostic Imaging (Radiology) Infection Control Medical day care Telecommunications Materials Mgmt. Facilities Information Srv Budget and Reimbursement Food Srv/Housekeeping Managed Care Contracts In-house MDs Anesthesia Patient Registration Patient Acct. Marketing/Planning Community Development General Acct. Laboratoy Accounts Payable Treasurer/CFO Case Cont. Quality Imp. Utilization Review/ Quality Assurance Medical Library Hospital Aid Association Medical Staff Office Social Service Oper. Rm./ Post Anesthesia Care/ Same Day Surgery Joint Committee on Accreditation Medical Staff President and CEO John Dalton Deaconess−Glover Hospital (A) Ambulatory clinic Medical/Surgical Unit Vice President Patient Services Julie Bonenfant Human resources Vice President Board of Trustees President and CEO John Dalton Exhibit 1: Organizational Chart - Deaconess-Glover Hospital 601-022 -13- Harvard Business School POM Cases © The McGraw−Hill Companies, 2004 111 Beth IsraelDeaconess Medical Center DeaconessGlover Hospital DeaconessWaltham Hospital General Council Chief Financial Off. Chief Medical Off. Chief Med. Info. Off. SVP-Development SVP-System Development and Communications SVP-Human Resources EVP-External Affairs Deaconess−Glover Hospital (A) DeaconessNashoba Hospital New England Baptist Hospital CareGroup CEO Harvard Business School POM Cases Mt. Auburn Hospital Exhibit 2: Organizational Chart - CareGroup 601-022 -14- 112 Case © The McGraw−Hill Companies, 2004 Increase in unrestricted net assets Transfers from (to) affiliates Change in net unrealized gains on investment $1,068 3,800 (4) (2,728) 88 26,285 14,196 9,936 1,122 874 69 Deaconess−Glover Hospital (A) Deficiency of revenue over expenses Expenses Salaries and benefits Supplies and other expenses Uncompensated care Depreciation Interest Restructuring expenses Year 2000 Expenses Twelve months ended: Sept 30, 1999 (in thousands) Unrestricted revenue, gains and other support Net patient service revenue $22,416 Research Revenue Contributions, investment income, gains 103 Other revenue 1,038 $23,557 Exhibit 3: Consolidated Statements of Operation: Deaconess-Glover Hospital 601-022 -15- Harvard Business School POM Cases Case © The McGraw−Hill Companies, 2004 113 ($89,718) ($104,121) (20,054) 403 (50,134) (34,336) Case Decrease in unrestricted net assets Transfers from restricted funds 5,354 2,129 Net assets released from restrictions used for purchase and sale of property and equipment Extraordinary loss on advance refunding of long-term debt 2,746 Change in net unrealized gains on investment (99,947) 1,235,734 638,170 376,229 85,606 95,506 40,223 Deaconess−Glover Hospital (A) Deficiency of revenue over expenses 711,868 406,471 76,958 97,633 40,723 18,486 14,763 1,366,902 Harvard Business School POM Cases Expenses Salaries and benefits Supplies and other expenses Uncompensated care Depreciation Interest Restructuring expenses Year 2000 Expenses Twelve months ended: Sept 30, 1999 Sept 30, 1998 (in thousands) Unrestricted revenue, gains and other support Net patient service revenue $987,871 $963,626 Research Revenue 105,114 88,169 Contributions, investment income, gains 63,188 69,447 Other revenue 110,782 80,156 $1,266,955 $1,201,398 Exhibit 4: Consolidated Statements of Operation: CareGroup 601-022 -16- 114 © The McGraw−Hill Companies, 2004 Patient 229 A 233 A 236 C 244 A 230 B 231 A 233 B 234 B 237 A 239 A 232 A 232 B 234 A 235 B 240 B 241 A 238 239 C 241 243 243 B 244 B 242 B Nurse RN A RN A RN A RN A RN B RN B RN B RN B RN B RN B RN C RN C RN C RN D RN D RN D RN E RN E RN E RN E RN E RN E RND MD MD 1 MD 5 MD 7 MD 13 MD 2 MD 3 MD 6 MD 4 MD 1 MD 9 MD 4 MD 7 MD 1 MD 2 MD 2 MD 12 MD 8 MD 10 MD 11 MD 1 MD 9 MD 5 MD 9 Med 1 A S ii c1 D P UU YY tt I U EE VV H s1 b2 ww r1 r1 l2 I I f2 Med 3 C KK ll F F R ZZ vv l1. W FF I ff t1 d2 b1 n1 y1 m2 p2 d3 h2 Med 2 B BB jj z2 E Q Y uu k1 V E1 WW G I c2 AA AA f1 b1 s2 rr g2 bb xx mm Y HH W hh v1 e2 d1 p1 a2 o2 t2 e3 j2 I nn b3 H T LL mm a3 G S aa ww d X GG XX gg u1 P c1 o1 z1 n2 d1 M i2 Med 5 Med 4 AA Z JJ RR e1 r1 q2 v2 f3 p1 HH w1 X q1 p2 u2 p1 h1 r2 w2 f1 x2 g1 BB L PP rr Med 9 f1 h1 CC M QQ RR Med 10 AA j1 DD N G ss Med 11 y2 O RR gg Med 12 p1 VV SS 5 others Med 13 TT Med 14 Deaconess−Glover Hospital (A) x1 ee a1 K J dd zz OO qq Med 8 NN pp Med 7 cc yy. AA B II MM oo c3 I Med 6 Exhibit 5: Medications prescribed for each patient in South Two on October 28th, 1999 601-022 -17- Harvard Business School POM Cases Case © The McGraw−Hill Companies, 2004 115 a2 trimacinalone cream b2 Zestril 5 c2 Glyburide 2.5 d2 Toprol XL 200 e2 Diltiazem CD 300 f2 Gentamycin 240 IV g2 Cosyn 3.375 IV h2 Demerol 50 IM I2 Vistaril 25 IM j2 Ventolin 1 puff l2 Acuolate 20 m2 Solumedrol 60 j1 Compazine 5 IM k1 Vasotec 15 l1 Levoxyl 0.112 m1 Cardizem 120 n1 Lopressor 25 o1 Darvocet p1 APAP 650 q1 Motrin 450 r1 Nitroglycerine SL s1 Thiamine t1 Effexor 37.5 u1 Nadolol 20 v1 Casopt ophth w1 Aphagan ophth x1 Dexicidin ophth y1 Kefzol 500 IV z1 Clotriamzole cream a1 Vanceril 2 puffs b1 Zoloft 25 c1 Lanoxin 0.125 d1 Metoprol 25 e1 Quinine SO4 f1 KCL 20 mEq g1 Hydralazine 10 h1 Ambien 5 a3 Gentamycin 120 IV b3 Kefzol 1 gm IV c3 Metronidazole 500 d3 Gentamycin 160 IV e3 Clindamycin 600 IV f3 Dakins solution n2 Humabid 1200 o2 Zithromax 250 p2 Heparin 5000 SQ q2 Albuterol nebulizer r2 Xanac 1 s2 Vitamin C 500 t2 Capoten 37.5 u2 Hydralazine 25 v2 Prednisone 30 w2 Ampicillin 1 gm IV x2 Erthromycin ophth y2 KCL 40-80 mEq z2 ZnSO4 220 Deaconess−Glover Hospital (A) ll Zinc 50 mm FeSO4 325 nn Colace 100 oo Lactulose 300 pp Folate 1 mg qq Vancomycin 750 rr Zosyn 2.25 IV ss Percocet tt Prinivil 40 uu Gylburide 10 vv Lasix 80 ww Synthroid .075 xx Lipitor 10 yy Reglan 5 zz Coumadin 5 & 7.5 aa Flagyl 250 bb Zyprexia 5 cc Naprosyn bid dd Valium 5 ee Xyprexia 25 ff Compazine 10 IM gg MgSO4 hh Tylenol #3 ii Epogen 12,000 u IM jj Nephrocaps NN Nuerantin 500 mg OO Vit C 500 mg PP Megace 40 QQ Clindamycin 600 RR Ativan .5 mg PO SS Chlorazepam .5 TT Gentamycin 300 UU Morphine IV drip VV Atenolol 25 WW Dilantin 200 XX Folic acid 1 gm YY Corgard 20 ZZ Plavix 75 Harvard Business School POM Cases AA Lasix 20 mg BB Ducolax supp CC Timoptic .5 ophth DD Robitussen AC 5cc EE Zestril 20 mg FF Hydrochlorthiazide 12.5 mg GG NS flush IV HH Darvocet II Phenobarbital JJ Ativan O.5 IM KK Zoloft 50 LL ZnSO4 220 mg MM Nuerantin 400 mg A Prednisone 20 B Prednisone 10 C Prednisone 15 D Destin oint E Zantac 150 F Lopressor 50 G APAP 650 H Heparin 5000 SQ I MVI IV J Flagyl 500 K Risperdol .5 mg L Risperdol 1.0 mg M Zantac 50 mg IV N Cephazalam 1 gm O Zosyn 3.375 mg P Imdur 30 mg Q KDUR 20 mg R Lasix 40 mg S MOM T Percolace U Amiodarone 200 V Tamoxyphen 10 mg W ELASA 8 mg X Coumadin variable Y Prevacid 15 mg Z Bisonprolol 5 mg Exhibit 6: Medications prescribed in South Two: Identification Key 601-022 -18- 116 Case © The McGraw−Hill Companies, 2004 Med Cart Doctor 2x/day physician exam 24hr/7day nursing care Medication deliveries Information: Requests, clarifications Patient 10:35 AM 10:30 AM Medication given Nurse takes medication from to patient in-box Drug given according to prescription Chart Elapsed time for responses 10:15 AM Medication left in South Two in-box South Two Nurse Verbal Phone Verbal Chart Phone Phone Receptionist 8:10 AM Prescription written Case 10:00 AM Volunteer Volunteer receives medication Medication Special Delivery Verbal Phone Verbal Phone Green Sheet White Sheet Pink Sheet Patient Medication Record/ Medication Administration Record Reconciliation Elapsed time for requests Deaconess−Glover Hospital (A) Pharmacy Information 9:00 AM Green sheet delivered to pharmacist Exhibit 7: Medication Administration - South Two - Day Shift: Flows of Medication and Information - 601-022 -19- Harvard Business School POM Cases © The McGraw−Hill Companies, 2004 117 Nurse’s Station 9:40 Call another office Talk to MD Call MD help rolling patient Washes hands Starts referral forms and process Answers phone observe site for bleeding wash hands, get MAR sheets for transfer, hunt for chart MD receptionist 1 MD at other office Aide Hospice RN Aide Aide with patient in 237 receptionist 2 find MD explain hospice concerns phone call concerns about patient’s status and meds, Family has worries gets suggestion for new med Where’s chart? Help rolling patient NA finds out it is not Cindy’s patient, apologizes Explains flu shot, and IV removal, answer questions about discharge Case 9:45 Supply & Med Room Nurse’s Station Room 239 9:35 Wash hands, get flu shot and supplies, give flu shot, remove patient’s IV Deaconess−Glover Hospital (A) Supply & Med Room Room 237 Many questions from patient. isolation precautions?, going home, meds, bath when, etc. “Did you use your inhaler?” Using MAR? Greeting, give med, receive request Saying what Is this vaccine ok? Is this vaccine ok? Harvard Business School POM Cases 9:30 Exhibit 8: Example: Day-Shift Nursing Activities - November 3, 1999, 9:15 - 10:15 Time Where What Who 9:15 Hallway phone Phonecall Pharm, hunt med Medication Room look for syringe, draw label vaccine Arlene, Rosie Room 239 look for patient Nurse’s Station label syringe Medication Room put syringe in fridge. Find 10 meds 9:20 pull MAR Sheets for discharge RN 1 Room 238 give med with patient in 238 kitchen get juice Room 238 deliver juice with patient in 238 leaves med, finish bath, change 9:25 bed, straighten room, etc Asks questions of patient 601-022 -20- 118 © The McGraw−Hill Companies, 2004 Remembers something on discharge form Check chart Gives med Room 237 Nurse’s Station 10:15 Room 237 10:10 Get above med from floor stock Give above med Find chart, review order, check lab to see if dose appropriate, check discharge order Discovers new med order on the transfering patient, change form, sign off order, records med “given” phone call Medication Room Room 237 Nurse’s Station Nurse’s Station Medication Room Find’s patient’s chart, starts write orders, intercom again, finish order, replace chart Post new order observe “wastes” narcotic Back to transfer chart form Excuse me, asks about new med, waste narcotic? apologize for keeping her waiting Where’s chart? does intercom work? get new med order by phone with patient in 237 with patient in 237 with patient in 237 Answers many questions, convinces patient that it is ok to take med Reasure Many questions about this med patient believes dosage incorrect Aide “You have phone call” Pt’s daughter - concerns from hospice, clarification, reassurance Pharmacist RN 2 RN 3 Intecom - call another RN to the phone Aide Aide Deaconess−Glover Hospital (A) 10:05 10:00 9:55 9:50 Answers phone 601-022 -21- Harvard Business School POM Cases Case © The McGraw−Hill Companies, 2004 119 Patient Rm 237 Rm 238 Rm 239 Hall Phone In one hour . . . • 8 locations • 22 location changes • 15 conversation partners • 25 topics • 5 patients in 3 rooms Med Room Nurses’ Station Storage Room Kitchen Deaconess−Glover Hospital (A) South Two Nurse • Assess Condition • Searching for • Plan Care and transmitting • Treat information and • Evaluate material • Other care 100% Exhibit 9: Summary of one-hour of nursing activity 601-022 -22- Harvard Business School POM Cases Activity Assessment 120 Case © The McGraw−Hill Companies, 2004 Exhibit10: Patient/Nurse/Doctor Assignments in South Two Bed # MD Day RN Evening RN Night RN 229A Duane Cindy Susan Bob 230B Guzman Joan Susan Bob 231B Duane Joan Susan Bob 232A Weiss Diane Susan Bob 232B Hayden Diane Susan Bob 233A Whestney Cindy Susan Bob 233B Whestney Joan Meg Bob 234A Peters Diane Meg Alice 234B Weiss Diane Meg Alice 235A Guzman Arlene Meg Alice 236C Michaels Cindy Sarah Alice 237A Peters Diane Sarah Alice 238 McAndrews Amy Sarah Alice 239A Frick Joan Sarah Alice 239C Larenzo Amy Sarah Alice 240B Hayden Arlene Sarah Fran 241A Larenzo Amy Meg Fran 242A Bose Amy Chris Fran 242B Ferber Amy Chris Fran 243A Peters Arlene Chris Fran 243B Frick Cindy Chris Fran 244A Brooks Joan Chris Fran 244B Whestney Arlene Chris Fran Arlene Alice Bob Fran Night RN Meg Sarah Susan Chris Evening RN Arlene Diane Cindy Joan Amy Day RN 233A 233B 244B 234B 232A Whestney Weiss Peters 238 234A 237A 243A 241A 239C 236C 239A 230B 235A 232B 240B The Patient in Room: 242A 244A 229A 231B 242B 243B McAndrews Michaels Larenzo Hayden Guzman Frick Ferber MD Bose Brooks Duane Deaconess−Glover Hospital (A) Diane Cindy Joan Amy Day RN For simplicity, (MD-EveningRN, MD-NightRN, & Pharmacy links not shown) Exhibit 11: Who communicates with whom 601-022 -23- Harvard Business School POM Cases Case © The McGraw−Hill Companies, 2004 121 Medication Pharmacy • Patient Searching for and transmitting information and material Rm 237 Rm 238 Rm 239 Hall Phone In one hour . . . • 8 locations • 22 location changes • 15 conversation partners • 25 topics • 5 patients in 3 rooms Med Room Nurses’ Station Volunteer Med Cart Special Delivery Verbal Phone Phone Verbal Green Sheet Pink Sheet White Sheet Doctor 2x/day physician exam 24hr/7day nursing care Drug given according to prescription Chart Elapsed time for responses South Two Nurse Verbal Phone Verbal Chart Phone Phone Receptionist Elapsed time for requests Patient Medication Record/ Medication Administration Record Reconciliation Alice Bob Fran Night RN Meg Sarah Susan Chris Evening RN Arlene Diane Cindy Joan Amy Day RN Rationale: Michaels Larenzo Hayden Guzman Ferber Frick MD Bose Brooks Duane Weiss Whestney McAndrews Peters Recommended Next Step: Arlene Diane Cindy Joan Amy Day RN 234B 232A 233A 233B 244B 243A 241A 239C 236C 238 234A 237A 242A 244A 229A 231B 242B 243B 239A 230B 235A 232B 240B The Patient in Room: Around the clock Pathway: Who works with whom Case Medication deliveries Storage Room Kitchen Information: Requests, clarifications Patient Medication and Information Flows Nurse • Assess Condition • Plan care • Treat • Evaluate • Other care 100% •Med Administration • South Two Nursing Activity • Glover • CareGroup Deaconess−Glover Hospital (A) Information Background: Medicine Administration Process - South Two Medical/Surgical Ward - Current Condition as of November ‘99 Exhibit 12: Current Condition - 11 x 17 single page presentation 601-022 -24- Harvard Business School POM Cases Activity Assessment 122 © The McGraw−Hill Companies, 2004 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work Article © The McGraw−Hill Companies, 2002 Making Competition in Health Care Work by Elizabeth Olmsted Teisberg, Michael E. Porter, and Gregory B. Brown Harvard Business Review Reprint 94408 123 124 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work Article © The McGraw−Hill Companies, 2002 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work 125 © The McGraw−Hill Companies, 2002 Article HarvardBusinessReview JULY-AUGUST 1994 Reprint Number CHRIS ARGYRIS GOOD COMMUNICATION THAT BLOCKS LEARNING 94401 ROBERT H. WATERMAN, JR., JUDITH A. WATERMAN, AND BETSY A. COLLARD TOWARD A CAREER-RESILIENT WORKFORCE 94409 ROSABETH MOSS KANTER COLLABORATIVE ADVANTAGE: THE ART OF ALLIANCES 94405 PAUL KRUGMAN DOES THIRD WORLD GROWTH HURT FIRST WORLD PROSPERITY? 94406 GARY HAMEL, C.K. PRAHALAD COMPETING FOR THE FUTURE 94403 ELIZABETH O. TEISBERG, MICHAEL E. PORTER, AND GREGORY B. BROWN MAKING COMPETITION IN HEALTH CARE WORK 94408 HBR CASE STUDY MEDIA POLICY – WHAT MEDIA POLICY? 94407 PERSPECTIVES THE CHALLENGE OF GOING GREEN 94410 SOCIAL ENTERPRISE EFFECTIVE OVERSIGHT: A GUIDE FOR NONPROFIT DIRECTORS 94404 SANDI SONNENFELD REGINA HERZLINGER BENJAMIN GOMES-CASSERES WORLD VIEW GROUP VERSUS GROUP: HOW ALLIANCE NETWORKS COMPETE 94402 126 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work Article © The McGraw−Hill Companies, 2002 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work © The McGraw−Hill Companies, 2002 Article Incentives throughout the health care system are so skewed that the normal rules of competition do not apply. Making Competition in Health Care Work by Elizabeth Olmsted Teisberg, Michael E. Porter, and Gregory B. Brown Health care reform in the United States is on a collision course with economic reality. Most proposals focus on measures that will produce onetime cost savings by eliminating waste and inefficiency. The question at the heart of the current political debate is whether these savings will be large enough to pay for the added costs of universal coverage. But this is the wrong question to ask if reformers are serious about achieving a lasting cure for U.S. health care. The right question, and one that is conspicuously missing from the health care debate, is how to achieve dramatic and sustained cost reductions over time. What will it take to foster entirely new approaches to disease prevention and treatment, new ways to deliver services, and more cost-effective facilities? The answer lies in the powerful lessons business has learned over the past two decades about the imperatives of competition. In industry after industry, the underlying dynamic is the same: competition HARVARD BUSINESS REVIEW July-August 1994 compels companies to deliver increasing value to customers. The fundamental driver of this continuous quality improvement and cost reduction is innovation. Without incentives to sustain innovation in health care, short-term cost savings will soon be overwhelmed by the desire to widen access, the growing health needs of an aging population, and the unwillingness of Americans to settle for anything less than the best treatments available. Inevitably, the failure to promote innovation will lead to lower quality or more rationing of care – two equally undesirable results. Elizabeth Olmsted Teisberg and Michael E. Porter are associate professor and professor, respectively, at the Harvard Business School in Boston, Massachusetts. Gregory B. Brown, a former surgeon, is a vice president of Vector Securities International in Chicago, Illinois. The three have recently completed a three-year study that examines the competitive dynamics of health care, Innovation, Information, and Competition: A Lasting Cure for U.S. Health Care. Copyright © 1994 by the President and Fellows of Harvard College. All rights reserved. 127 128 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work © The McGraw−Hill Companies, 2002 Article HEALTH CARE COMPETITION The misguided assumption underlying much of the debate about health care reform is that technology is the enemy. By assuming that technology drives up costs, reformers neglect the central importance of innovation or, worse yet, attempt to slow its pace. In fact, innovation driven by rigorous competition is the key to successful reform. Although health care is unique in some ways, in this respect, it is no different than any other industry. The United States can achieve universal access and lower costs without sacrificing quality, but only by allowing competition to work at all levels of the health care system. What’s Wrong with Competition in Health Care? More health care competition exists in the United States than in any other industrial nation. The puzzle confounding reformers is that while competition has been enormously successful at producing quality-enhancing innovation, it appears to have failed on the crucial dimension of cost. A closer look suggests not that competition is failing, but that incentives throughout the system have been so skewed that the normal rules of competition simply do not apply. Prices remain high even when there is excess capacity. Technologies remain expensive even when they are widely used. Hospitals and physicians remain in business even when they charge higher prices for equal quality or fail to provide high-quality service. Until recently, incentives existed only for innovations that raised costs or increased quality regardless of cost. Successful reform must begin with a clear understanding of how the current system creates incentives for unproductive competition. services; and doctors, who determine or advise on the tests and treatments for patients. These customers have different interests. The employer is concerned with paying the lowest premiums while providing enough insurance to retain employees or meet contractual obligations. The third-party payer is concerned with spending less on patient care than was received in premiums. The insured patient is concerned with finding the best quality care regardless of cost. And the advising doctor often has incentives to order more services. Since payers do not have the final legal responsibility for insured patients’ bills, patients are the payers of last resort. The conflict of interest between payers and patients creates incentives for payers to compete on the basis of creative and complicated methods of denying coverage to people who might need expensive care. The payer becomes the patient’s adversary, rather than advocate, denying payment on claims whenever possible. The incentives not to pay claims also set the payer in opposition to the provider by requiring the provider to Until recently, incentives existed only for innovations that raised costs or increased quality regardless of cost. Payers’ Incentives Make Payers Adversaries of Patients and Providers In most industries, the consumer makes the purchasing decision and pays for the product or service. In health care, the purchasing decision, payment, and receipt of services are separated. As a result, there are multiple tiers of customers: employers, who purchase health care coverage for their employees; third-party payers, such as insurance companies and health maintenance organizations (HMOs), which collect premiums and then pay providers for services rendered to their subscribers; patients, who ultimately receive the health care 132 assume the costs that neither payer nor patient has paid. As a result, providers expend scarce resources on bill collection and avoid patients whose insurance companies may deny claims. These skewed incentives lead to behaviors that get in the way of genuine cost reduction. However, the conflict among payers, patients, and providers is unnecessary. Payers should be able to profit only from actually improving the quality of medical outcomes and reducing costs, not from shifting payment responsibility onto patients or providers. They should concentrate on identifying high-quality providers with good medical outcomes and negotiate lower prices for their services. Studies show that better quality care is often lower in cost due to the efficiency of experienced medical teams, fewer complications, and better long-term results.1 For example, The Prudential Insurance Company of America estimates that it saves more than 20% in costs with its Institutes of Quality Program by directing bone-marrow transplant patients to high-quality providers, which are screened on HARVARD BUSINESS REVIEW July-August 1994 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work Article the basis of the limited available data on facilities, staff, credentials, processes, and past outcomes. Recent programs like this one are productive responses to new pressures to find ways to reduce costs, not just avoid paying claims. Patients’ Incentives Discourage Cost Sensitivity In life-threatening or urgent situations, patients and their families are rarely price sensitive. But even when it comes to receiving routine and discretionary services or choosing a health plan, most patients have had little incentive to consider cost. Patients rarely have access to relative price information; they rarely comparison shop; and they often feel uncomfortable asking about prices for fear of offending the physician on whom they rely. In fact, most employees choose insurance plans without considering price. Sometimes employees do not pay at all for their health benefits. Other times the prices of competing plans are equalized by the employer, who pockets the difference, removing the incentive for employees to choose a lower priced plan. More efficient health plans or insurers have little incentive to reduce prices if lower prices do not help them gain market share. And once a person has insurance, the current system makes patients insensitive to price even for decisions such as where to undergo elective surgery, fill a prescription, or obtain diagnostic tests. Copayments and deductibles can compensate only to the extent that the patient can make choices about which provider to use. Even under the current system, the patient has no choice when it comes to many types of decisions. Usually, once a patient chooses a doctor, health plan, or hospital, decisions such as which laboratory, imaging facility, or specialist to use are predetermined. This is especially true in managed care organizations and provider networks. One choice all patients make is the frequency of visits for routine concerns. Copayments help make price a factor in these decisions. One of the results of the greater attention to health care costs in recent years has been increasing the use of copayments to reduce premiums and to discourage the overuse of primary care visits. Fragmented Customers Have Little Negotiating Power Well-functioning competition is characterized by demanding customers with enough clout to push providers to improve quality while at the same HARVARD BUSINESS REVIEW July-August 1994 129 © The McGraw−Hill Companies, 2002 time reducing costs. But when customers are fragmented, as they are in health care, their power is greatly diminished. The United States has 1,500 different third-party payers, such as insurance companies and HMOs, with roughly 200 serving a given region. Typically, 3 to 12 payers – the number varies by region – represent significant purchase volumes to a given hospital, doctor, or other provider, while the rest of the payers and individual patients have little bargaining power. Moreover, under the current system, patients have little bargaining power with their insurance companies or other payers. This fragmentation of patients and payers not only limits competitive pressure but also drives up transaction costs since many of the payers have different policies, procedures, and forms for provider reimbursement. The long, customized forms, different reporting requirements, and bureaucracies developed to handle the forms and requirements contribute to high administrative costs, which account for nearly 25% of health care expenditures.2 Providers, Patients, and Payers Lack Information Health care customers also lack access to information that would improve decisions and in turn pressure providers to ameliorate medical outcomes and reduce costs. In most industries, customers can compare product performance and price with competing products. Buyers of automobiles, for example, can go on test drives, compare prices at different dealers, draw on their own and friends’ past experiences, and consult publications that provide information on costs, margins, ratings of quality and reliability, and used-car values. Health care could hardly be more different. Patients, payers, and referring physicians do not have readily available measures of quality or of the relationship between price and quality for a given physician, procedure, course of treatment, or hospital. Data from the Pennsylvania Health Care Cost Containment Council reveal that both referring physicians and patients continue to recommend and use the services of providers that have poorer outcomes and higher costs than nearby rivals. 3 Since many health care purchases are onetime events, patients cannot draw on past personal experiences. They usually receive only the expert opinion of one doctor (or sometimes two if the patient obtains a second opinion), and they frequently have difficulty judging the quality of that advice. Even under managed care, in which a gatekeeper physician makes supposedly informed choices 133 130 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work © The McGraw−Hill Companies, 2002 Article HEALTH CARE COMPETITION about how a patient is treated, good information about the best type of care and provider for a given patient is lacking. Worse still, physicians must often refer patients within a network of approved providers, which are selected by administrators. These administrators base their selection primarily on price negotiations because they have little information about quality of care or outcomes. Without adequate quality measures and information, the dangers are that the network may either exclude high-priced providers that deliver better quality care or include substandard providers in spite of the good intentions of administrators and physicians. This lack of relevant, comparative information based on meaningful medical outcome measures – not the complexity of medicine itself – prevents informed purchasing decisions. Customers in other complex, highly technical fields, such as aerospace and computer software, require competitive bidding on products or services and delineate precise criteria against which products are evaluated. In contrast, the poor comparative information and lack of meaningful outcome measures in health care create incentives for hospitals and physicians to compete based on what is observed: the hospital’s pleasing physical environment, high-tech equipment, or wide array of services; the physician’s comforting bedside manner; even high prices. Measures of customers’ satisfaction are inadequate quality measures. The right information concerns short- and long-term outcomes of treatments As health care moves increasingly toward provider capitation (a fixed dollar amount per patient in the plan per period of time), the need for meaningful information is more crucial than ever. Historically, the attitude of the U.S. health care system was, “If it might work, try it.” Today the equally risky bias is, “If we’re not sure, don’t do it.” This kind of thinking can only stifle innovation and erode quality. Better information is the antidote to either bias, allowing decisions to be based on expected outcomes. Providers’ Incentives Increase Costs In a well-functioning competitive market, producers’ desires to raise prices or create more demand are counterbalanced by buyers who purchase only what they need and can afford. Demand rises when prices fall or when quality at a given price increases. These simple economic laws do not apply to health care providers in the United States because the health care system skews their incentives in a number of ways. Hospitals and Outpatient Facilities: Incentives to Maximize Reimbursement. Beginning in the post-World War II period, hospitals were reimbursed on a cost-plus basis, which in turn produced rapidly escalating hospital costs. The Medicare Prospective Payment System, implemented in 1983, granted hospitals a fixed fee based on the diagnosis that resulted in the patient’s admission to the hospital. (Changes in Medicare carry particular significance because other players tend to follow Medicare and implement the same rules.) This diagnosis-related group (DRG) reimbursement created incentives to reduce hospital stays and treatment costs. In the decade following its introduction, DRG reimbursement rules reduced the average length of stay for an inpatient by half a day, and the number of inpatient hospital stays dropped by 20%. Corrections needed to be made to the cost-plus system, which created incentives for providers to overtreat. But fixed-price reimbursement skews incentives in the opposite direction, pressuring providers to undertreat and to discharge patients prematurely. These incentives create the risk that undertreatment or early discharge will raise overall costs by increasing the rate of recurrent or prolonged health problems. They also encourage hospitals to admit some patients unnecessarily and then quickly discharge them. Health care incentives will dramatically improve when customers can base decisions on relevant outcome measures. for particular diseases by specific providers, taking into consideration the patient’s general health. Health care is not a monolithic service, but a myriad of types of services. Reformers must develop information and outcome measures at the level of specific conditions and treatments instead of relying on aggregate comparisons of provider networks or payment plans. Buying treatment for cancer will never be like buying a car. But incentives in the U.S. health care system will dramatically improve when payers, patients, providers, and referring doctors can base decisions on comparisons of relevant outcome measures and prices. 134 HARVARD BUSINESS REVIEW July-August 1994 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work Article 131 © The McGraw−Hill Companies, 2002 Outpatient reimbursement has not yet changed to a DRG-like system. The cost-plus reimbursement combined with incentives for the earlier discharge of hospital patients has led hospitals and other providers to open many new outpatient facilities. Some of the resulting changes were productive. Effective outpatient treatment and surgeries are helping to reduce costs. However, there have also been unproductive results. For example, providers manipulated the DRG rules when they were first implemented by delaying admission of some patients and instead administering expensive drugs or treatments in the emergency room. While this specific practice has been forbidden, incentives for the overtreatment of outpatients remain. Physicians: Incentives to Increase Services. While the DRG rules encourage hospitals to undertreat, physicians currently have incentives to increase the volume of services they perform, even if those additional services do not lower costs or improve medical outcomes. Although physician capitation (a fixed dollar amount per primary care patient per period of time) aims to correct incentives, it may lead to undertreatment because physicians earn more by limiting care, including tests and referrals. Salary is also becoming more common, and its incentives are volume neutral. But most physicians still face an incentive structure in which they earn more by performing more tests or expensive procedures because they are paid for each service performed. The recently implemented ResourceBased Relative Value System (RBRVS) does lower reimbursement for technical procedures like surgery relative to cognitive services like office visits. But lower pay per procedure actually creates incentives for physicians to perform more procedures in order to maintain their incomes. We are not arguing that doctors unscrupulously take advantage of patients and payers. Medical practice is complex and requires professional judgment. Furthermore, many legitimate efforts to care for the patient increase the use of medical services. Physicians cannot in good conscience do less for a patient or pursue less costly treatments without evidence that these decisions improve outcomes or quality of life. But the complexity of medicine cannot explain why demand for physicians’ services is higher in areas where there are more physicians. Doctors with the time and facilities can increase demand by performing more tests and procedures, seeing patients more frequently, or operating on less severely ill patients. For example, the rate of open heart surgery on residents of Manchester, New Hampshire, doubled the year a local hospital opened an open-heartPHOTO BY BRUCE T. MARTIN 135 132 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work © The McGraw−Hill Companies, 2002 Article HEALTH CARE COMPETITION surgery service.4 Before the local service opened, 90% of bypass operations on patients from the community involved three or more arteries. Three years after the local center opened, over 50% of the bypasses involved only one or two arteries. But an appreciable improvement in coronary-heart-disease mortality did not accompany this surgical treatment of less severe coronary disease, and it is not clear whether other measures of health outcomes were improved. Cardiologists can debate the medical merits of operating on patients with less severe coronary disease. We simply use this example to il- Similarly, a University of Arizona study showed that physicians with diagnostic imaging equipment in their offices ordered four times as many imaging exams as physicians who referred patients for imaging tests. Congress passed the Stark bill, which became effective in 1992, forbidding physicians from billing Medicare patients for services performed in clinical labs in which the doctor has an equity interest. And other legislation has passed or is pending to limit self-referral further. But the more fundamental underlying problem, physicians’ incentives, remains unaddressed. If physician-owned labs are more efficient, then prohibiting their existence would be a mistake. Ideally, physicians should have incentives to promote and improve health rather than to increase the use of health care services. Physicians: Incentives to Increase Fees. As health care technologies evolved in the United States, high prices were placed on novel procedures, such as gastrointestinal endoscopy, because these procedures carried higher risk and were offered by relatively few, highly skilled physicians. In a competitive market, the diffusion of technology and increase in the supply of such services would drive down their prices over time. In health care, however, the fees did not decline because patients were not price sensitive and insurance payments to physicians were based on customary charges rather than on costs. In most industries, market forces determine how much a company can charge; prices need to be high enough to cover costs but low enough to attract customers. Companies can charge higher prices only for products or services that are differentiated, that is, products and services that provide more benefit to the customer. In health care, however, the normal rules do not apply. High prices have their roots in the “usual, customary, and reasonable charges” on which insurance companies traditionally based their payments to physicians. This structure made sense in the infancy of the health insurance industry in the United States, when most patients did not have insurance, paid for their own health care, and were price sensitive. At that time, doctors faced powerful constraints in setting their customary charges. As health insurance became more widespread, payers retained the “usual, customary, and reasonable” structure, even though a competitive market ceased to exist in physician services. With insurance the norm, doctors no longer attracted patients Physicians should have incentives to improve health rather than to increase the use of health care services. lustrate the point that doctors can increase demand for medical services without clear evidence of improving outcomes. This tendency for supply to create demand is part of the reason that the United States has a general shortage of primary care physicians compared with the number of specialists. In a competitive system, the income potential for specialists, now higher than that of primary care physicians, would fall with oversupply. But since the availability of specialists generates demand for specialized care, the oversupply perpetuates itself. The increasing debt burden of medical school graduates, which leads them to high-paying specialties, only serves to accentuate this tendency. Physicians: Incentives to Make Expensive Referrals. In addition to providing care, physicians also act as purchasing agents on behalf of their patients by ordering tests or making referrals. Referring physicians have traditionally had no incentive to choose a less expensive lab, ancillary service, or other provider since patients’ insurance paid the bills. Instead, convenience, established relationships, perceived quality, or direct financial rewards from equity interests in labs or facilities have determined referral patterns for independent physicians. The incentive to perform more tests and procedures is strongest when the physician has a financial interest in the facility or equipment. For example, a Florida State University study found that physician-owned laboratories in Florida performed twice as many tests per patient as independent labs. 136 HARVARD BUSINESS REVIEW July-August 1994 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work by setting lower prices. Indeed, patients with insurance came to view low prices as a signal of lower quality. Since any fee could become “usual, customary, and reasonable” as long as enough doctors charged it, physicians were able to boost their incomes by regularly increasing their fees so that future reimbursement calculations would be based on higher charges. Over the past decade, changes in physician reimbursement have limited the ability of physicians to increase fees. But piecemeal regulations can be circumvented. For example, when Medicare implemented a fee freeze in 1984 that lasted for two years, physician group practices responded by setting artificially high rates for new physicians in the group. Similarly, some payers have imposed fixedfee structures on physicians, but physicians have circumvented them with so-called balance billing: physicians simply bill patients for the difference between their “list charges” and the approved “fixed fee.” This strategy reduces the payers’ price sensitivity and their incentive to work for price reductions since they are no longer responsible for the entire bill. While balance billing may make patients more price sensitive, they often do not know in advance whether the bill will be significant. And when the balance is small, patients are often inclined to pay. Fortunately, an increasing number of insurance contracts now restricts doctors from balance billing patients. Physicians: Incentives to Practice Defensive Medicine. The threat of malpractice or the insistence of patients pushes even doctors paid by salary or capitation to practice defensive medicine by or- 133 © The McGraw−Hill Companies, 2002 Article problem and help retain good physicians in fields such as obstetrics. However, malpractice reform alone will not produce the dramatic changes that U.S. health care needs. Providers’ Incentives Encourage Overinvestment The U.S. health care system still supplies incentives for excessive capital investment by providers. Companies in a competitive market invest to enhance differentiation or to lower costs. Because they bear the costs and risks of investment, they invest only when they anticipate a reasonable return. Those that make inappropriate investments face declining profits and eventually go out of business. This has not been the case for capital expenditures in the U.S. health care industry. Until 1992, reimbursement by Medicare for capital investments was cost-plus. Thus, providers profited by building facilities and adding new equipment without the usual market constraint of needing to be sure that the capital investments would pay off. Regulators became aware of the resulting incentive to overinvest and tried to handle it by creating review boards to determine community needs. They did not attempt to correct the incentive itself. What’s more, the excess capacity of beds or equipment, such as imaging machines or medical helicopters, did not produce lower prices. Health care defied the usual laws of gravity for three reasons. First, reimbursement was not dependent on how fully a facility was used. Second, providers were protected from failure not only by cost-plus reimbursement but also by community interests in maintaining local health care facilities. Third, once facilities existed, there was a strong tendency to create demand to fill them. Ultimately, hospitals and outpatient treatment centers had incentives to overinvest in equipment and facilities because these investments attracted both doctors and patients. Without real measures of outcomes, state-of-the-art facilities became the focus of health care competition. In 1992, the Medicare capital reimbursement rules changed, limiting the rate at which major capital investments could be amortized. This change, coupled with increasing national attention to health care costs, substantially enhances incentives for improving the productivity of capital equipment. Cost-saving innovations in investment productivity will begin to emerge after a time lag. Companies in a competitive market invest only when they anticipate a reasonable return – not so in health care. dering more tests and procedures than are often necessary. The most widely cited study estimates the direct cost of defensive medicine to be about 1% of total health care expenditures.5 But such measures understate the problem because the threat of malpractice may also indirectly affect costs by coloring physicians’ judgments. Still, the popular notion that the threat of malpractice is the crux of the health care problem is oversimplified. Legal reform is essential to address the malpractice HARVARD BUSINESS REVIEW July-August 1994 137 134 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work © The McGraw−Hill Companies, 2002 Article HEALTH CARE COMPETITION But the benefits of this change are unnecessarily diluted by too many loopholes allowed in the new Medicare rules. These rules include significant adjustments, such as those for geographic location (regional, as well as urban versus rural), patient population (severity of illness, or “case-mix”), and reimbursement features (percentage of uninsured or indigent patients). Together, the adjustments make the system still effectively cost-plus. Exit Barriers Protect Substandard Payers and Providers Incentives for cost reduction will be fully effective only if lower quality, inefficient providers and insurance companies are allowed to fail. Any healthy competitive market forces the exit of substandard players, which are displaced by efficient ones. The net result is lower costs without compromising quality. The past two decades have witnessed dramatic reductions in the demand for hospital facilities, but relatively little capacity has been eliminated. The cost and quality penalty to the nation of too many facilities is high. Low volumes drive up costs, as fixed overhead must be spread over few patients. At the same time, quality suffers. For example, providers that perform fewer than 150 open heart procedures per year have higher death and complication rates. As a result, the American College of Surgeons has recommended that each cardiac surgery team perform at least 150 operations per year. Other studies show that hospitals that perform a higher volume of a given procedure have lower mortality rates and shorter inpatient stays.6 It is not beneficial to have reimbursement rules that guarantee any provider the ability to offer any service even if their quality and utilization rates are low. But in U.S. health care, there has been a surprising reluctance to force substandard providers to exit either by closing entire facilities or by dropping specific services. The idea that the closure of some hospitals and some services within hospitals would be good public policy is radical given the history of providing public incentives to open hospitals in every U.S. community. The U.S. hospital system developed at a time when the full range of medical care could be reasonably provided at a community hospital. Communities still benefit today from the ready availability of services like routine emergency care, routine obstetric care, and care for common disorders requiring hospitalization. However, for complex care such as high-risk obstetrics, trauma care, and organ transplantation, regionalization and ra138 tionalization could significantly enhance both quality and efficiency. While traveling to a preeminent regional facility may sound expensive and inconvenient, the savings in costs and the promise of better short- and long-term medical results can easily make it worthwhile for both patients and payers. Higher volumes of specialized treatments lead to better outcomes and lower costs, not only because physicians become more skilled with more practice but also because whole teams of medical professionals learn effective routines and develop expertise in protocols and problem spotting. As a result, facilities that have high volume in a specialized service also tend to have lower costs in that service. The current trends of consolidation into provider networks, however, could have detrimental effects on the cost and quality of specialized services. A managed care network is fine for primary care and relatively simple specialized care. However, the risks are that either high-quality providers will be excluded because they cannot conclusively prove cost-effectiveness or substandard providers of complex and highly specialized care will be hidden and protected within the networks. Although managers will not intentionally maintain clearly substandard services, measuring outcomes is difficult, and networks will be reluctant to lose their full-service status based on uncertain evidence of substandard care. The guaranteed patient flow to in-network providers, then, creates new exit barriers. Public policy should play a critical role in fostering competition. Although some consolidation is desirable to reduce excess capacity, it is important not to relax antitrust rules to the point of undermining competition. Excessive consolidation will risk creating very powerful providers with less need to respond to their customers. It will also limit the experimentation that is critical to stimulating new procedures and treatments. Piecemeal Solutions Treat Only the Symptoms The skewed incentives of the U.S. health care system are not the result of inattention. A great deal of regulatory effort has focused on fixing the problems. Unfortunately, much of this effort has aimed at treating symptoms rather than the underlying causes. In fact, new regulations make the system less efficient, while failing to improve quality. For example, when DRG reimbursement shortened hospital stays by encouraging earlier discharge, concerns surfaced that hospitals’ efforts to reduce costs might diminish the quality of care. So HARVARD BUSINESS REVIEW July-August 1994 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work the government added new regulations and expanded the bureaucracy to address the issues of quality and utilization. Hospitals responded to these quality regulations by creating parallel utilization review staffs. The net result was health care reduction, not cost reduction. Money previously spent on patient care was shifted to administration. Another result of such piecemeal solutions has been a complex collection of sometimes inconsistent rules that provide rewards to those who can figure out how to manipulate the system. Billing consultants have taught doctors and hospital administrators to maximize reimbursement. For example, when fixed fees were established for a given procedure, doctors learned the practice of unbundling: billing separately for the component parts of a procedure to increase fees. The rise of fixed-fee third-party payers and the increasing burden of the uninsured encouraged cost shifting – those patients with less restrictive payment plans absorbed the costs of caring for others. Only changes in incentives can close these loopholes. Additional layers of regulation will be circumvented and will create new administrative cost burdens. The failure to look at the health care system comprehensively and to focus on the long term has also raised systemwide costs. For example, many U.S. mothers receive little prenatal care, but the cost of universal prenatal care is almost negligible compared with the cost of intensive care for prema- 135 © The McGraw−Hill Companies, 2002 Article healthful behavior by making smoking expensive. But subsidizing tobacco and then taxing it is yet another example of complicated, piecemeal regulation that could be simplified if we looked at the systemwide costs and benefits of specific policies. Recent Progress on Cost Reduction Is Not Enough In response to national attention to rising costs and the DRG reimbursement system, a number of cost-reducing advances began to emerge by the late 1980s. Indeed, the results of the new, albeit incomplete, incentives for cost reduction have become noticeable at the national level. Although the medical component of the consumer price index is still rising faster than inflation, the rate of increase has dropped enough to shave $15 billion off expected U.S. health care expenditures in a single year. Specific examples of cost-reducing innovations span a wide range of treatments and procedures. Consider the antibiotic ceftriaxone. Until the mid1980s, advances in antibiotic development tended to deliver broader spectrum antibiotics. The 1988 introduction of ceftriaxone offered a drug with essentially the same spectrum as existing drugs of the same class, but at a lower cost due to the need for only one intravenous dose every 24 hours instead of every 3 or 4. Less frequent dosing means less nursing time and lower aggregate treatment costs, while providing equally good results; it also allows some patients to be discharged from the hospital and receive the injection on a daily outpatient basis. Because of these pharmacoeconomic advantages, ceftriaxone quickly became the top selling pharmaceutical product in hospitals. Other examples include new therapies and surgical techniques. Laparoscopy reduces the cost and recovery time from procedures such as cholecystectomies and appendectomies. Gene therapy is creating the potential for dramatic cost reduction by restoring normal function in congenital diseases like cystic fibrosis and ADA deficiency. Most pharmaceutical and biopharmaceutical companies are now consciously analyzing both the clinical and the economic advances of potential new products to decide which products to pursue and which research-anddevelopment investments to make. There are still other indications of the power of improved incentives to restore health to the U.S. health care system. Numerous private-sector initiatives have begun to ratchet down the rate of Some consolidation is desirable. Too much will risk creating powerful providers with little need to respond to customers. ture babies and the cost of long-term care for children with considerable health problems as a result of poor prenatal care. As improved outcome measures are developed, it is important to determine when apparently expensive care at one stage in an illness actually reduces overall costs or improves outcomes at subsequent stages. In addition, seemingly unrelated government policies contribute to rising health care costs. The most obvious example is the subsidization of tobacco. Given the demonstrated health risks of tobacco, the subsidies drive up health care costs. The Clinton administration’s suggested tax increase on tobacco products does strengthen incentives for HARVARD BUSINESS REVIEW July-August 1994 139 136 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work © The McGraw−Hill Companies, 2002 Article HEALTH CARE COMPETITION health care growth. Large employers are beginning to ask employees to pay more when choosing more expensive health care plans. Small-business coalitions are demanding and receiving greater value from insurers and providers. Employers are ferreting out information to empower their health benefit choices, and providers and insurers are learning to respond more effectively to informed buyers. These are positive signs, but they are not enough. The current trends should not be used as an excuse to avoid the real reform of incentives. Indeed, the anticipation of reform is itself driving cost reduction. And if weak and uncoordinated incentives can encourage such innovation, a systematic introduction of clear, competitive market incentives should be able to achieve dramatic results. Innovation in response to competitive forces will bring health care costs under control without rationing care or retarding the search for cures for currently untreatable diseases. Reform Can Cure Competition in Health Care Competition in U.S. health care has produced a breathtaking rate of advance in state-of-the-art treatments for a wide range of diseases and injuries. People come from all over the world for treatment by U.S. doctors in U.S. hospitals with U.S.-developed technologies. Reform should preserve this excellence and expand the scope of innovation. A lasting cure for U.S. health care should incorporate four basic elements: corrected incentives to spur productive competition, universal insurance to secure economic efficiency, relevant information to ensure meaningful choice, and vigorous innovation to guarantee dynamic improvement. Incentives for Productive Competition. Much of the health care debate is based on the premise that because competition has failed to control costs in the past, it will not be able to do so in the future. Paradoxically, competition, usually a powerful force for both quality enhancement and cost reduction, appears to be driving health care costs through the ceiling. But the problem, as we have seen, lies in the skewed incentives that allow providers, payers, and suppliers of drugs and equipment to prosper while costs escalate. “Managed competition” has been offered up as a solution. It encourages patients and employers to join large purchasing cooperatives, which will contract for health plans with large payers and organize providers and physicians into integrated delivery networks. But the pooling of customers and providers could create bilateral monopolies with lit140 tle incentive to innovate. More powerful payers could slow innovation by refusing to pay for new treatments in the effort to contain costs. More equal groups of customers and payers, without restructured incentives, could increase the mountains of paperwork generated by battles over who should pay the bills. Indeed, without restructured incentives, managed competition will only increase the power of the parties engaged in dysfunctional competition. Reform must eliminate the incentives that create dysfunctional competition. Rather than managed competition, reform must foster rigorous competition among providers and among payers to deliver value to customers. Providers and their suppliers should earn higher profits only when they make cost-effective advances in medical outcomes. Four conditions will help foster productive competition in health care: 䡺 Avoid overconsolidation. Providers must be forced to compete with one another on the basis of quality and price for specific services. 䡺 Maintain antitrust laws in order to ensure healthy rivalry. 䡺 Allow exit of substandard providers when regional competition is not restricted. The opportunity to prosper must be coupled with the risk of failure. In addition, a safety net must be set up to protect subscribers if their insurance plan fails. 䡺 Reject price caps because they will have devastating effects on innovation in new drugs and devices. Instead, competition among established products should be encouraged to push down their prices. Payers’ and patients’ incentives must also be aligned. Payers should profit when they negotiate good value for their subscribers. Patients should benefit when they seek good values. It is not enough to pool patients into purchasing groups or create streamlined provider networks. Unless incentives are changed, payers will continue in their attempts to shift costs rather than identify good values, and providers will continue to manipulate the reimbursement rules without necessarily improving quality. Four steps will help align patients’ and payers’ incentives and avoid the fruitless cost shifting that takes place today: 䡺 Align interests. Payers must have the legal responsibility for paying their subscribers’ bills. 䡺 Simplify the content of health insurance to reduce disputes over claims. 䡺 Outlaw balance billing. 䡺 Increase patient responsibility. Patients should bear some portion of costs through a noticeable copayment up to an income-graduated cap. HARVARD BUSINESS REVIEW July-August 1994 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work Insurance Coverage for Economic Efficiency. Universal coverage is essential for economic efficiency as well as for equity. Many of the skewed incentives and inefficiencies stem from problems created by uncompensated care. The best way to eliminate costly practices like cost shifting and patient dumping is not by creating more reviews, audits, or penalties. Reform should make everyone a paying customer. The cost of universal coverage will not be as high as some fear because the expense of the uninsured is already largely borne by the health care system through uncompensated care assessments that providers recoup by raising average prices. Moreover, the costs now borne to serve the uninsured will be reduced because patients who lack access to primary care currently use expensive emergency-room care as a substitute. Universal coverage is also important to ensure that competition will work in the interests of all patients. Otherwise, many providers that currently serve the poor will be forced to exit. The solution is to make the poor into paying customers who decide which providers will best serve them. Information for Meaningful Choice. Effective competition requires free choice, but choice without good information is useless. Competition will work only when decisions by providers, referring doctors, payers, and patients are based on relevant, comparable information about price and medical outcomes. That information must be at the level of specific treatments by specific providers and must include long-term outcomes and immediate results. There has been much discussion about providing consumers with information about insurance plans to help them in their purchasing decisions. It is far more critical to provide all parties with specific information about treatment outcomes and prices. Without this kind of information, reform risks sacrificing quality to the goals of access and cost containment. Hospitals may discharge patients before they are ready for outpatient care, and physicians may skimp when ordering tests or making referrals. Medical outcome information also guards against the perils of overconsolidation. Substandard providers should not be protected from healthy competition because customers are captive within consolidated health networks. The development of germane and accessible outcome measures should be one of the nation’s highest research priorities. Admittedly, this will be no easy task. But rapid progress is already being made, and nothing will speed the development of better measures faster than the widespread dissemination HARVARD BUSINESS REVIEW July-August 1994 137 © The McGraw−Hill Companies, 2002 Article of the data and measures already in use. With good information available to all parties, informed choice – not restricted choice – will promote productive competition that raises quality and drives down costs. Innovation for Dynamic Improvement. The national debate defines technology as the enemy and focuses on how to cut fat and eliminate waste in the current system with reforms like health plan buying alliances, consolidated networks, and price caps on drugs and devices. But these reforms are essentially ways to deliver today’s health care more efficiently and will not reduce costs enough. In fact, overconsolidation of networks and price restraints on or biases against new drugs and devices will undermine incentives for innovation. A real solution to our health care cost problem requires a dynamic view, one that fosters the kind of innovation that pushes down costs and enhances quality. Pharmaceutical, biotechnological, and medical device companies are beginning to deliver cost-reducing innovations. Private companies are beginning to develop quality comparisons and outcome measures. Small businesses are beginning to form buying groups to negotiate with payers for quality care at competitive prices. As a result, the rate of health care cost increases is slowing. Health care reform must build on this progress by creating still stronger incentives for both medical and managerial innovation. Reformers must not confuse onetime efficiencies with sustained cost improvement. Innovation, the missing principle in all the contending reform proposals, is the only true, long-term solution for high-quality, affordable health care. Notes 1. See, for example, J. Showstack, et al., “Association of Volume with Outcome of Coronary Artery Bypass Graft Surgery,” Journal of the American Medical Association, vol. 257 (1987), pp. 785-89; Charles Marwick, “Using High-Quality Providers to Cope with Today’s Rising Health Care Costs,” JAMA, vol. 268 (1992), pp. 2142-45; and James W. Winkelman, et al., “Cost Savings in a Hospital Clinical Laboratory with a Pay-for-Performance Incentive Program for Supervisors,” Archives of Pathology and Laboratory Medicine, vol. 115 (1991), pp. 38-41. 2. Steffie Woolhandler and David U. Himmelstein, “The Deteriorating Administrative Efficiency of the U.S. Health Care System,” New England Journal of Medicine, vol. 324, no. 18 (1991), pp. 1253-58. 3. See David Wessel and Walt Bogdanich, “Closed Market: Laws of Economics Often Don’t Apply in Health-Care Field,” Wall Street Journal, January 22, 1992, p. A1. 4. Philip Caper, “Database Strategies for the Management of Clinical Decision Making,” New Perspectives in Health Care Economics (London: Mediq Ltd., 1991), p. 65. 5. Roger A. Reynolds, John A. Rizzo, and Martin L. Gonzalez, “The Cost of Medical Professional Liability,” JAMA, vol. 257 (1987), pp. 2776-81. 6. See V.E. Stone, et al., “The Relation Between Hospital Experience and Mortality Rates for Patients with AIDS,” JAMA, vol. 268 (1992), pp. 265561; and H.S. Luft, et al., “Should Operations Be Regionalized?” New England Journal of Medicine, vol. 301 (1979), pp. 1364-69. Reprint 94408 141 138 Harvard Business School Industry and Competitive Strategy Articles Making Competition in Health Care Work © The McGraw−Hill Companies, 2002 Article Harvard Business Review HBR Subscriptions Harvard Business Review U.S. and Canada Subscription Service P.O. Box 52623 Boulder, CO 80322-2623 Telephone: (800) 274-3214 Fax: (617) 496-8145 Outside U.S. and Canada Tower House Sovereign Park Lathkill Street Market Harborough Leicestershire LE16 9EF Telephone: 44-85-846-8888 Fax: 44-85-843-4958 American Express, MasterCard, VISA accepted. Billing available. HBR Article Reprints HBR Index and Other Catalogs HBS Cases HBS Press Books Harvard Business School Publishing Customer Service - Box 230-5 60 Harvard Way Boston, MA 02163 Telephone: U.S. and Canada (800) 545-7685 Outside U.S. and Canada: (617) 495-6117 or 495-6192 Fax: (617) 495-6985 Internet address: custserv@cchbspub.harvard.edu HBS Management Productions Videos Harvard Business School Management Productions videos are produced by award winning documentary filmmakers. You’ll find them lively, engaging, and informative. HBR Custom Reprints Please inquire about HBR’s custom service and quantity discounts. We will print your company’s logo on the cover of reprints, collections, or books in black and white, two color, or four color. The process is easy, cost effective, and quick. Telephone: (617) 495-6198 or Fax: (617) 496-8866 Permissions For permission to quote or reprint on a one-time basis: Telephone: (800) 545-7685 or Fax: (617) 495-6985 For permission to re-publish please write or call: Permissions Editor Harvard Business School Publishing Box 230-5 60 Harvard Way Boston, MA 02163 Telephone: (617) 495-6849 A R T I C L E www.hbr.org Will Disruptive Innovations Cure Health Care? by Clayton M. Christensen, Richard Bohmer, and John Kenagy Included with this full-text Harvard Business Review article: 1 Article Summary The Idea in Brief—the core idea The Idea in Practice—putting the idea to work 3 Will Disruptive Innovations Cure Health Care? 13 Further Reading A list of related materials, with annotations to guide further exploration of the article’s ideas and applications Product 6972 Will Disruptive Innovations Cure Health Care? The Idea in Brief The Idea in Practice The U.S. health care industry is ailing. The symptoms? Expensive, inconvenient delivery systems that leave more and more consumers dissatisfied. Why? Major health care institutions have “overshot” the level of care most patients need. Researchers and practitioners focus on the most complicated diseases, while paying insufficient attention to the needs of patients with more common ailments. Disruptive innovations in other industries offer lessons for transforming health care: COPYRIGHT © 2004 HARVARD BUSINESS SCHOOL PUBLISHING CORPORATION. ALL RIGHTS RESERVED. The cure? All health care industry players must embrace disruptive innovations: cheaper, simpler, more convenient products or services that ultimately let less expensive professionals provide sophisticated service in affordable settings. Consider angioplasty, used by cardiologists with patients who not long ago would have needed invasive, costly surgery by open-heart specialists. Or the latest blood glucose meters, which allow diabetic patients to monitor their own health—accurately, conveniently, and inexpensively. We need many more of these disruptive innovations to revitalize the health care industry. Companies that develop them will grow profitably with less investment. Hospitals and managed-care institutions will stem their financial hemorrhaging. When industry players and consumers join forces to promote affordable, high-quality medical services, everyone will win. Create a system that matches clinicians’ skill levels to the level of medical difficulty. Use technology to channel simple problems (e.g., strep throat) to clinicians who can follow predictable rules for diagnosis and treatment. For example, expand nurse practitioners’ role as primary care providers and provide tools that allow them to accurately refer more complicated conditions to physicians with more sophisticated diagnostic abilities. cost savings. Regulators could support the new technology and address any concerns about possible risks. How? Require that all images interpreted by nonradiologists be transmitted via Internet to a secondopinion center. There, skilled radiologists could check or confirm initial diagnoses. Invest more money in technologies that simplify complex problems, and less in high-end technologies. Today most R&D dollars go to complex solutions for complex problems. But more venture capital must flow to projects focused on technologies that simplify diagnosis and treatment—especially of common diseases. By launching a series of such disruptive business ventures, major health care companies (Johnson & Johnson, Baxter, Merck) could spur significant growth—with less investment. Don’t be afraid to invent the institution that could put you out of business. We’ll always need some general hospitals for critical care (just as we still need mainframe computers after PCs transformed that industry). But most health care needs can be better met through specialized institutions that provide state-of-the-art care for a single category of disorders, such as cardiac or renal illnesses. Overcome the inertia of regulation. Instead of working to preserve the existing system at all costs, regulators should be asking, “How can we enable disruptive innovations to emerge?” Example: An entrepreneur creates a portable X-ray machine for use in medical offices rather than in hospitals—promising significant page 1 Health care may be the most entrenched, change-averse industry in the United States. The innovations that will eventually turn it around are ready, in some cases—but they can’t find backers. Will Disruptive Innovations Cure Health Care? by Clayton M. Christensen, Richard Bohmer, and COPYRIGHT © 2000 HARVARD BUSINESS SCHOOL PUBLISHING CORPORATION. ALL RIGHTS RESERVED. John Kenagy Imagine a portable, low-intensity X-ray machine that can be wheeled between offices on a small cart. It creates images of such clarity that pediatricians, internists, and nurses can detect cracks in bones or lumps in tissue in their offices, not in a hospital. It works through a patented “nanocrystal” process, which uses nightvision technology borrowed from the military. At 10% of the cost of a conventional X-ray machine, it could save patients, their employers, and insurance companies hundreds of thousands of dollars every year. Great innovation, right? Guess again. When the entrepreneur who developed the machine tried to license the technology to established health care companies, he couldn’t even get his foot in the door. Large-scale X-ray equipment suppliers wanted no part of it. Why? Because it threatened their business models. What happened to the X-ray entrepreneur is all too common in the health care industry. Powerful institutional forces fight simpler alternatives to expensive care because those alternatives threaten their livelihoods. And those oppo- harvard business review • september–october 2000 nents to low-cost change are usually lined up three or four deep. Imagine for a moment that our entrepreneur was able to license the technology. Even then, he would probably face insuperable barriers. Regulators, afraid of putting patients at risk, would withhold approvals. Radiologists, who establish the licensing standards that regulators enforce, don’t want to lose their jobs, so they’d fight it, too. Insurance companies, which approve only established licensed procedures, would refuse to reimburse for it. And hospitals, with their large investments in radiology and emergency departments, want injuries to flow to them—so they, too, would join the forces holding back change. This resistance to low-cost alternatives is understandable, but it’s not in the best interests of the industry or of the patients it serves. Quite the reverse—the health care industry desperately needs to open its doors to market forces. Health care professionals often shudder when they hear that phrase “market forces.” But when we use it, we’re not talking about letting insurance companies microman- page 3 Will Disruptive Innovations Cure Health Care? age doctors as they practice medicine or about putting profits above patient care. Rather, we’re talking about being open to disruptive technologies and business models that may threaten the status quo but will ultimately raise the quality of health care for everyone. Make no mistake: the U.S. health care industry is in crisis. Prestigious teaching hospitals lose millions of dollars every year. Health care delivery is convoluted, expensive, and often deeply dissatisfying to consumers. Managed care, which evolved to address some of these problems, seems increasingly to contribute to them—and some of the best managedcare agencies are on the brink of insolvency. We believe that a whole host of disruptive innovations, small and large, could end the crisis—but only if the entrenched powers get out of the way and let market forces play out. If the natural process of disruption is allowed to proceed, we’ll be able to build a new system that’s characterized by lower costs, higher quality, and greater convenience than could ever be achieved under the old system. What’s Wrong with Health Care Clayton M. Christensen is a professor of business administration at Harvard Business School in Boston. Richard Bohmer is a physician and also a senior lecturer at Harvard Business School. John Kenagy is a physician, a visiting scholar at Harvard Business School, and a clinical associate professor of surgery at the University of Washington in Seattle. page 4 In any industry, a disruptive innovation sneaks in from below. While the dominant players are focused on improving their products or services to the point where the average consumer doesn’t even know what she’s using (think overengineered computers), they miss simpler, more convenient, and less costly offerings initially designed to appeal to the low end of the market. Over time, the simpler offerings get better—so much better that they meet the needs of the vast majority of users. We’ve seen this happen recently in the telecommunications industry, where routers—initially dismissed by leading makers of the faster, more reliable circuit switches—came to take over the market. The graph “The Progress of Disruptive Innovation” illustrates this dynamic. The top solid line depicts the pace of technological innovation—the improvement an industry creates as it introduces new and more-advanced products to serve the more-sophisticated customers at the high end of the market. We call these sustaining innovations. The shaded area outlines the rate of improvement consumers can absorb over the same time. The pace of sustaining innovation nearly always outstrips the ability of customers to absorb it. That creates the poten- tial for upstart companies to introduce disruptive innovations—cheaper, simpler, more convenient products or services that start by meeting the needs of less-demanding customers. The progress of these disruptive innovations is shown by the bottom solid line. Disruptive technologies have caused many of history’s best companies to plunge into crisis and ultimately fail.1 This phenomenon of overshooting the needs of average customers and creating the potential for disruption quite accurately describes the health care industry. If we were to draw a graph to illustrate health care specifically, we would measure the complexity of diagnosing and treating various disorders on the vertical axis. The least-demanding tiers of the market are patients with disorders such as simple infectious diseases. The most-demanding tiers include patients with complex, interactive problems such as an elderly man with a broken hip complicated by poor health from long-standing diabetes, hypertension, and heart disease—situations in which multiple systems of the body are involved, and cause and effect are difficult to disentangle. Our major health care institutions—medical schools, groups of specialist physicians, general hospitals, research organizations—have together overshot the level of care actually needed or used by the vast majority of patients. Indeed, most players in today’s health care system are in a lockstep march toward the most scientifically demanding challenges. Between 1960 and now, for example, our medical schools and residency programs have churned out specialists and subspecialists with extraordinary capabilities. But most of the things that afflict us are relatively straightforward disorders whose diagnoses and treatments tap but a small fraction of what our medical schools have prepared physicians to do. Similarly, the vast majority of research funding from the National Institutes of Health is aimed at learning to cure diseases that historically have been incurable. Much less is being spent on learning how to provide the health care that most of us need most of the time in a way that is simpler, more convenient, and less costly. General hospitals—especially teaching hospitals—have likewise overshot the needs of most patients. Their impressive technological ability to deliver care enables them to address the needs of a relatively small population of harvard business review • september–october 2000 Will Disruptive Innovations Cure Health Care? very sick patients. But in the process of adding and incurring the costs of such capabilities, they have come to overserve the needs of the much larger population of patients with less serious disorders. Most types of patients that occupied hospital beds 20 years ago are not there today; they’re being treated in lower cost, morefocused settings. As the stand-alone cardiac care centers, outpatient surgery centers, and other focused institutions get better and better, they become the price setters. As a consequence, the old high-cost institutions can’t compete financially; nor are there enough really sick people to sustain them. Last year not a single teaching hospital in Massachusetts made money. As a group, the medical schools, specialist physicians, hospitals, and equipment suppliers have done an exceptional job of learning to treat and resolve difficult, intractable problems at the high end. We stand in awe of what they have accomplished. But precisely because of their achievements, health care is now ripe for disruption. How Disruptive Innovations Work To get a sense of what those disruptions might be, let’s look briefly at what has happened in other industries. Many of the most powerful innovations that disrupted other industries did so by enabling a larger population of lessskilled people to do in a more convenient, less expensive setting things that historically could be performed only by expensive specialists in centralized, inconvenient locations. The Progress of Disruptive Innovation For example, in the 1960s when people needed computing help, they had to take their punched cards to the corporate mainframe computer center and wait in line for the dataprocessing specialists to run the job for them. Minicomputers and then personal computers were disruptive technologies to the mainframe makers. At the outset, they weren’t nearly as capable as mainframes, and as a consequence the professionals who operated the sophisticated computers, and the companies that supplied them, discounted their value. But minicomputers enabled engineers to solve problems for themselves that had required centralized computing facilities. And personal computers enabled the unwashed masses—less-skilled people like the rest of us—to compute in the convenience of their offices and homes. Nearly every disruptive innovation in history has had the same impact. George Eastman’s camera made amateur photography widespread. Bell’s telephone let people communicate without the need for professional telegraph operators. Photocopying enabled office workers to do things that historically only professional printers could do. Online brokerages have made investing so inexpensive and convenient that even college students now actively manage their own portfolios. Indeed, disruptive technologies have been one of the fundamental mechanisms through which the quality of our lives has improved. In each of these cases, the disruption left consumers far better off than they had been—we don’t yearn Performance Dominant players in most markets focus on sustaining innovations—on improving their products and services to meet the needs of the profitable high-end customers. Soon, those improvements overshoot the needs of the vast majority of customers. That makes a market ripe for upstart companies seeking to introduce disruptive innovations—cheaper, simpler, more convenient products or services aimed at the lower end of the market. Over time, those products improve to meet the needs of most of the market, a phenomenon that has caused many of history’s best companies to plunge into crisis. harvard business review • september–october 2000 of r y ven o t ri ) ec raj gy (d tions t a ce lo an hno nov m n c r i e g rfo t t Pe esen ainin t r omers s p su anding cust Most-dem by ry c to e j ra gies et nc nolo a rm tech rfo p e ptive w Ne disru of omers anding cust Least-dem Performance that customers in the mainstream market can absorb Time page 5 Will Disruptive Innovations Cure Health Care? content on an expensive piece of laboratory equipment. Today, patients pack miniature blood glucose meters with them wherever they go; they themselves now manage most aspects of a disease that previously had required much more professional involvement. They get far higher quality care far more conveniently. No patient or professional pines for the good old days—even though the companies that made the large laboratory blood-glucose testers were all driven from the market, and endocrinologists now face significantly reduced demand for their services. Angioplasty is another example. Before the early 1980s, patients with coronary artery disease were treated through bypass surgery. It required a complex, technologically sophisticated surgical team, as well as multiple specialists in several disciplines, complicated equipment, days in the hospital, and weeks in recovery. The far simpler angioplasty uses a balloon to dilate narrowed arteries, causing less pain and disability. It enables less expensive or specialized practitioners to treat more people with coronary artery disease in lower cost settings. Initially, angioplasty was used in only the easiest cases and was much less effective than surgery. Experts viewed the procedure with skepticism because of all the things it and its practitioners couldn’t do. But over time the disruptive innovation improved. Increasing skill and experience, together with sustaining technological innovations such as stents, have allowed angioplasty to supplant surgery in many cases. Angioplasty can now be to return to the days of the corporate mainframe center, for example. Our health care system needs to be transformed in the same way. Rather than ask complex, high-cost institutions and expensive, specialized professionals to move down-market, we need to look at the problem in a very different way. Managers and technologies need to focus instead on enabling less expensive professionals to do progressively more sophisticated things in less expensive settings. We need diagnostic and therapeutic advances that allow nurse practitioners to treat diseases that used to require a physician’s care, for example, or primary care physicians to treat conditions that used to require specialists. Similarly, we need innovations that enable procedures to be done in less expensive, more convenient settings—for doctors to provide services in their offices that used to be done during a hospital stay, for example. The graphs “Disruptions of Health Care Professions” and “Disruptions of Health Care Institutions” suggest the patterns by which these disruptive innovations might transform health care. Some innovations of exactly this sort have transformed pockets of the health care system, and where they have happened, higher quality, greater convenience, and lower cost actually have been achieved. Before 1980, for example, patients with diabetes could only know whether they had abnormal levels of glucose in their blood indirectly; they used an often inaccurate urine test or visited a doctor who drew a blood sample and then measured its glucose Disruptions of Health Care Professions As specialist physicians continue to concentrate on curing the most incurable of illnesses for the sickest of patients, less-skilled practitioners could take on more complex roles than they are currently being allowed to do. Already, a host of over-the-counter drugs allow patients to administer care that used to require a doctor’s prescription. Nurse practitioners are capable of treating many ailments that used to require a physician’s care. And new procedures like angioplasty are allowing cardiologists to treat patients that in the past would have needed the services of open-heart surgeons. page 6 Complexity of diagnosis and treatment S ci pe im Pr rs Nu lf Se ali st a s nd e car ar y ep ra ub an tio c ti sp a eci am df ne ily list p si hy ct pra cia p ice ns si hy cia ns Performance that patients need or can use rs re - ca Time harvard business review • september–october 2000 Will Disruptive Innovations Cure Health Care? reliably performed in stand-alone cardiac care centers, which aren’t burdened with the tremendous overhead costs of hospitals. By enabling less expensive practitioners to treat diabetes and coronary artery disease in less costly locations, these disruptive innovations have made health care more efficient. But more important, no compromises in quality were made. On the contrary, more patients get more care. When care is complex, expensive, and inconvenient, many afflictions simply go untreated. Before the disruption of angioplasty, for example, many people with coronary artery disease were not treated. Patients had to be disabled with chest pain or at risk of heart attack to justify the expense and inconvenience of open-heart surgery. We need many more such disruptions—and today we have them within our reach. Unfortunately, the people and institutions whose livelihoods they threaten often resist them. We saw such resistance in the story of the portable X-ray machine. Here’s another example. An English entrepreneur has developed a system for customizing eyeglasses quickly and efficiently. The patient puts on a pair of eyeglasses with seemingly flat lenses and an odd-looking rubber bulb attached to each stem. Looking at a vision-test chart and covering one eye, she squeezes the bulb on the right stem until she can read the fine print on the chart. A monomer in the bulb shapes the lens until that eye can see perfectly. She repeats the process for the other eye. Within two minutes, she has perfectly tailored eyeglasses—at a cost of about Disruptions of Health Care Institutions $5. This is a disruptive technology. It lets patients do for themselves something that historically required the skill of professionals. Predictably, the established professions quickly mobilized to discredit the entrepreneur’s technology, asserting that dangers such as glaucoma might go undetected if patients corrected their own vision and that for the long-term well-being of patients, care of the eyes must be left in the hands of professionals. Of course this is a reasonable concern. But it frames the problem incorrectly. The problem should be, instead, let’s find a way to allow patients to correct vision for themselves while finding new ways for professionals to catch potentially serious disorders at an early stage. Such resistance affects not only technology but people as well. Take nurse practitioners and physicians’ assistants. Because of advances in diagnostic and therapeutic technologies, these clinicians can now competently, reliably diagnose and treat simple disorders that would have required the training and judgment of a physician only a few years ago. Accurate new tests, for example, allow physicians’ assistants to diagnose diseases as simple as strep infections and as serious as diabetes. In addition, studies have shown that nurse practitioners typically devote more time to patients during consultations than physicians do and emphasize prevention and health maintenance to a greater degree.2 But many states have regulations that prevent nurse practitioners from diagnosing diseases or from prescribing treatment that they are fully capable of handling. Complexity of diagnosis and treatment Teaching hospitals incur great costs to develop the ability to treat difficult, intractable illnesses at the high end. In the process, they have come to overserve the needs of the much larger population of patients whose disorders are becoming more and more routine. Most types of patients that occupied hospital beds 20 years ago are now being treated in more-focused care centers and outpatient clinics, doctors’ offices, and even at home. n Ge O e ati utp InIn- harvard business review • september–october 2000 era l te o h ach nt cli ing s nic h ls ita p s o an u oc df sed - en ec r a c ter s Performance that patients need or can use e car e c ff i e om e car Time page 7 Will Disruptive Innovations Cure Health Care? The flawed rationale behind such policies is that because nurse practitioners are not as highly trained as physicians, they are not capable of providing care of comparable quality. This is the same logic that minicomputer makers used to discredit the personal computer. When a physician diagnoses a simple infectious disease, the patient uses only that fraction of the physician’s training that relates to simple infectious diseases. Studies have shown that nurse practitioners with comparable training in simple infectious diseases can provide care of comparable quality in that tier of the market—even though they lack training in more complex disorders.3 Some nearsighted advocates of patients’ Patient Welfare in Disruptive Times How might patients fare amidst health care disruptions? The answer depends on whether competitive markets are allowed to work efficiently. If clinicians or patients are forced to use less expensive technologies, disaster will result. But if consumers and providers are given choices, the use of disruptive technologies will migrate to those applications where they create real value. Consider Sonosite, a Seattle-area company that makes a small, highly portable, inexpensive ultrasound machine. The machine is good, but it is disruptive—it lacks the analytical features and the degree of resolution found in more expensive ultrasound equipment. If a managed care organization forced echocardiologists and OB-GYN physicians to use these less expensive devices for situations in which they previously have used traditional equipment, a specialist could risk missing something important, and the patient’s well-being could be compromised. But suppose instead that because Sonosite’s technology now makes ultrasound accessible and affordable to generalist clinicians, they could begin to provide better, more accurate care within the low-cost and more convenient context of their offices. Instead of conducting exams in which they hypothesize about what’s going on inside a patient’s body by listening page 8 through a stethoscope or by using their fingers to probe for irregularities, they could use this simple ultrasound device that would let them see inside the body. By enabling generalists to diagnose more quickly and with greater precision, disruptive technologies such as Sonosite’s can improve, not compromise, the cost, quality, and convenience of care. Ultimately, we would expect that the disruptive portable machines will improve to the point that they will supplant the more expensive traditional ultrasound equipment in established applications as well. But the true transformative impact of such technologies in health care will come as they allow less expensive professionals to provide better care. If history is any guide, the established high-end providers of products and services are likely to be articulate and assertive about preserving existing systems in order to ensure patient well-being. Very often, however, their eloquence reflects concerns about their own well-being. Customers have almost always emerged from disruptive transitions better off— as long as the disruptions are not forced into an old mode, but instead enable better service to be delivered in a lesscostly, more convenient context. rights assert that nurse practitioners might not have the judgment to recognize when a disorder is beyond their expertise. But family practice doctors recognize when they can treat a disorder and when it merits referral to a specialist. Surely nurse practitioners, working at even simpler tiers of the market, can be equipped to do the same thing. The real reason for blocking such disruption, we suspect, is the predictable desire of physicians to preserve their traditional market hegemony. Instead of working to enable the natural upmarket migration that is an intrinsic part of economic progress, today’s managed care organizations, insurers, and regulators have done just the opposite. They have forced highly trained physicians down-market to diagnose ear infections and bronchitis and have prevented nurse practitioners from doing things that technology enables them to do perfectly well. The result of this policy is perverse. To maintain their incomes, primary care physicians are forced to churn patients at an alarming rate—frequently spending only a few minutes with each patient. That reduces the quality and convenience of care. This practice, which has become pervasive in most managed care organizations, is akin to what would have happened if some regulatory body in the early 1980s had decreed that because microprocessors were inferior in computing power to wired logic circuits, all personal computers had to be equipped with wired logic boards, not microprocessors. Such a regulation would have halted the industry’s progress. The fact that we were able to use microprocessorbased computers for the jobs they were capable of handling, and wired-logic-based machines for the jobs for which microprocessors weren’t suited, has been a key to the creation of highquality, convenient, cost-effective computing for all of us. Enabling less expensive people to do things that were previously unimaginable has been one of the fundamental engines of economic progress—and the established health care institutions have fought that engine tooth and nail. Solutions to the Crisis The crisis in health care is deep, to be sure. But the history of other disruptive revolutions offers a number of suggestions for how a systemic transformation might be managed. We describe some of these here: harvard business review • september–october 2000 Will Disruptive Innovations Cure Health Care? Create—then embrace—a system where the clinician’s skill level is matched to the difficulty of the medical problem. Medical problems range from the very simple to the very complex, as we’ve said. Let’s look more closely at that range for a moment. In the simplest tiers, diagnosis and treatment can be rulebased: accurate data yield an unambiguous diagnosis, indicating a proven therapeutic strategy. Many infectious diseases fall into this category. In the middle tiers, diagnosis and treatment occur through pattern recognition—no single piece of data yields an answer, but multiple data points lead to a definitive diagnosis. The onset of Type I diabetes, for example, is diagnosed when a pattern is observed—blurry vision, incessant thirst, weight loss, and frequent urination. Once a diagnosis is confirmed, relatively standardized treatment protocols often exist. In the most complex disorders, diagnosis and treatment occur in a problem-solving mode. These problems require the collective experience and judgment of a team of clinical investigators and often involve cycles of testing, hypotheses, and experimentation. By now it’s clear that the simplest tiers can be reliably treated and diagnosed by less highly skilled clinicians—and also that institutional forces will fight that reality. We cannot allow such opposition to arrest reform. Instead, we must invent processes that can channel complex problems, which can’t be solved in a rule-based mode, to clinicians whose skills are appropriate to a pattern-recognition or a problem-solving mode. Scientific progress moves disorders that used to be dealt with in a problem-solving mode toward a pattern-recognition mode and those that had to be addressed through pattern recognition toward a rule-based regime. Mapping the human genome will accelerate this process. Not long ago, for example, leukemia was thought to be a single disease. Diagnosing and treating it was complex—no two patients responded identically to the same therapy, and treatment required the experience, intuition, and problem-solving skills of the best oncologists. Our improved understanding of the human genetic code, however, has helped researchers see that what we previously called leukemia is really at least six different diseases. Each is characterized by a specific genetic pattern, and patients can be precisely diagnosed harvard business review • september–october 2000 by matching their patterns to a template. Where once therapy used to be applied experimentally, such precise definition of the disease will allow for precise treatment protocols. Disruptive technologies such as this are precisely what are needed to reform health care. They will continue to enable less-experienced caregivers to make more precise diagnoses and provide higher quality care than they could have in problem-solving mode. It’s in physicians’ interest to embrace this change. Rather than fight the nurse practitioners who are invading their turf, primary care physicians should move upmarket themselves, using advances in diagnostic and therapeutic technologies to perform many of the services they now refer to costly hospitals and specialists. They should, in other words, disrupt those above them rather than fight a reactionary and ultimately futile battle with disrupters from below.4 Let us be clear. Many managed care organizations today give primary care physicians a financial incentive not to refer patients to specialists—to continue treating patients they are not competent to care for. Inviting them to move incompetently upmarket is a recipe for disaster. Disruptive technologies such as those we have described will enable these caregivers to move competently upward. These innovations are the sort that will reform health care. This strategy—unlike the one that pushes these physicians down-market or encourages them upward without enabling technology—is consistent with the way technological progress and customer needs interact. Invest less money in high-end, complex technologies and more in technologies that simplify complex problems. Equity markets have not been generous to companies making health care products and equipment in recent years. Other sectors of the economy are perceived to exhibit greater growth and profit potential. One reason for this, we believe, is that much of the energy and capital spent in the development of new health care products and services have been targeted at the high end— at sustaining technologies that enable the most skilled practitioners to solve problems that could not be solved before. We do not contest the value of these innovations—but they will not transform health care. The great growth opportunities exist in the simpler tiers of the market. History tells us that major new growth markets coalesce when products, pro- When care is complex, expensive, and inconvenient, many afflictions simply go untreated. page 9 Will Disruptive Innovations Cure Health Care? cesses, and information technologies let less highly paid groups of people do things in more convenient settings. To truly disrupt the health care system, venture capital, entrepreneurial energy, and technology development need to flow toward these enabling initiatives. Rather than focus on complex solutions for complex problems, research and development need to focus on simplification. It’s not entirely clear why more venture capital hasn’t flowed in this direction. One possible reason is that individual entrepreneurial companies don’t get to pick fights with individual Goliaths—more often, they face an army of giants. Because regulators, litigators, insurers, physicians, hospitals, and medical schools have such powerful interlocking interests in the status quo, disruption might require the concerted strategic focus of major health care companies such as Johnson & Johnson, Baxter, Medtronic, or Merck. Over time, they could overcome the inertia of entrenched institutions. A series of disruptive business ventures launched by these companies would create far greater growth for them, with less investment, than would continued pursuit of sustaining technologies that enable specialists to push further into high-end complexities. Create new organizations to do the disrupting. The health care industry today is trying to preserve outmoded institutions. Yet the history of disruptive innovations tells us that those institutions will be replaced, soon enough, with new institutions whose business models are appropriate to the new technologies and markets. When disruptive innovations have invaded the mainstream markets of other industries, a difficult period typically has preceded the arrival of truly convenient, lower cost, higher quality products and services. Between 1988 and 1993, for example, as networked personal computers became the dominant information technology architecture, the former industry leaders fell into disarray. Together, the mainframe and minicomputer makers logged $20 billion in operating losses during that period. None of these companies was able to adapt its business model to compete in the personal computer world. Instead, they seemed able only to tighten the thumbscrews on their existing processes, attacking costs through mergers and layoffs, as they withered away. During this period, it wasn’t the computer industry that was in crisis—only its page 10 traditional institutions were. Disruptive innovators such as Intel, Sun, Microsoft, and Dell were creating extraordinary value. The massive financial losses that hospitals and managed care institutions are suffering today mirror exactly what happened to the dominant players in other disrupted industries. And they are responding in the same way—by tightening controls on their existing business models. They are merging, closing facilities, laying off workers, forming buying groups, delaying payments, adding layers of control-oriented overhead workers, and hiring consultants— while going about their work in a fundamentally unchanged way. In fact, the billions of dollars large general hospitals are spending to build information technology systems and to create integrated feeder systems of physicians’ group practices and primary-, secondary-, and tertiarycare hospitals are designed to preserve, rather than displace, the existing institutions. We will always need some general hospitals to provide intensive and critical care to the sickest patients, just as we still need IBM and Hitachi to make mainframe computers for the most complex computing applications. But it is very likely that the care of disorders that primarily involve one system in the body—from earaches to cardiac and renal illnesses—will migrate to focused institutions whose scope enables them to provide better care with less complexity-driven overhead. If history is any guide, the health care system can be transformed only by creating new institutions that can capably deliver the vast majority of such care, rather than attempting a tortuous transformation of existing institutions that were designed for other purposes. Leaders of today’s hospital and managed care companies might profit from comparing the approaches that S.S. Kresge and F.W. Woolworth took toward disruptive discount retailing, beginning in the early 1960s, as recounted in Clayton Christensen’s The Innovator’s Dilemma. Kresge addressed the disruption by systematically closing 10% of its variety stores every year and funneling all its cash into its disruptive start-up, Kmart. Woolworth, by contrast, tried to maintain its pace of investment in its traditional stores while building its discount-retailing arm, Woolco. Despite the fact that Woolworth was far larger and had much deeper pockets, Woolco—and ultimately all of Woolworth’s variety stores—folded. The les- harvard business review • september–october 2000 Will Disruptive Innovations Cure Health Care? sons for today’s medical institutions: don’t be scared to invent the institution that could put you out of business, and stop investing in dying business models. Overcome the inertia of regulation. Attempts to use regulation to stave off disruptive attacks are quite common. The U.S. automakers, for example, relied on import quotas as long as they could to keep disruptive Toyota and Honda at bay. Unfortunately, regulators are inclined to be even more protective of the entrenched professions and institutions in health care than they were of the U.S. automakers. The links between those institutions, federal and state regulators, and insurance companies are strong; they are wielded to preserve the status quo. (Nothing else could explain why nurse practitioners are forbidden from diagnosing simple illnesses in so many states.) Instead of working to preserve the existing system, regulators need to frame their jobs differently. They need to ask how they can enable disruptive innovations to emerge. Let’s return to the example we began with—the low-cost Xray machine. Suppose the regulators wanted to see this disruptive innovation work in doctors’ offices but were concerned about potential risks. They might require that all images interpreted in a physician’s office by a nonradiologist be transmitted via the Internet to a secondopinion center, where skilled radiologists could confirm those initial diagnoses. Admittedly, that would require a massive change in the way regulators do their work. The Need for Leadership Once an industry is in crisis, individual leaders often become paralyzed. They’re incapable of embracing disruptive approaches because the profitability of the institutions they lead has been so eroded. Typically, not only do they ignore the potential disruptions, they actively work to discredit and oppose them. Thus far, this pattern has held true in the health care industry as well. Successful disruptive revolution of this system will unfold more quickly, and far less painfully for everyone, if leaders at regional and national levels work together—not to regulate the existing system but to coordinate the removal of the barriers that have prevented disruptions from happening. Unfortunately, in this presidential election year, the proposals from both leading parties for dealing with the crisis in health care have been molded within the estab- harvard business review • september–october 2000 lished system. These proposals can be divided into three categories of solutions: control costs by consuming less health care; impose reimbursement controls that force high-end providers to become more efficient; and use government money to subsidize the high costs of health care for targeted segments of the population. None of these proposals addresses the fundamental causes of the dilemmas that the health care system faces. Government and health care industry leaders need to step forward—to help insurers, regulators, managed care organizations, hospitals, and health professionals work together to facilitate disruption instead of uniting to prevent it. If they do, some of the established institutions will fail. But many more health care providers will realize the opportunities for growth that come with disruption—because disruption is the fundamental mechanism through which we will build a higher quality, more convenient, and lower cost health care system. If leaders with such vision do indeed step forward, we will all have access to more health care, not less. The authors express appreciation to Jeff Elton and his staff at Integral, Incorporated for their contributions to this article. 1. Clayton M. Christensen, The Innovator’s Dilemma: When New Technologies Cause Great Firms to Fail (Harvard Business School Press, 1997). 2. See James Lardner, “For Nurses, a Barrier Is Broken,” U.S. News & World Report, July 1998. Instead of working to preserve the existing system, health care regulators need to ask how they can enable disruptive innovations to emerge. 3. Richard A. Cooper, MD, et al. “Roles of Non-physician Clinicians as Autonomous Providers of Patient Care,” JAMA, September 2, 1998. These market forces are already at work. It is estimated that by the year 2005, the number of nurse practitioners in clinical practice will equal the number of family physicians. Between 1992 and 1997, the number of schools offering qualification programs for NPs more than doubled, from less than 100 to approximately 250. During that same time, the number of students pursuing NP degrees quintupled, from 4,000 to over 20,000. 4. Evidence that specialists are already being disrupted in this manner can be found in a 1995 report by the Council of Graduate Medical Education, which predicted an excess of 115,000 specialists by the year 2000. See Stephen M. Shortell et al., Remaking Health Care in America: Building Organized Delivery Systems (Jossey-Bass Publishers, 1996), p. 298. Reprint R00501 Harvard Business Review OnPoint 6972 To order, see the next page or call 800-988-0886 or 617-783-7500 or go to www.hbr.org page 11 Will Disruptive Innovations Cure Health Care? Further Reading ARTICLES Disruptive Technologies: Catching the Wave by Joseph L. Bower and Clayton M. Christensen Harvard Business Review January–February 1995 Product no. 3510 The authors examine more closely what can happen to companies that ignore disruptive innovations—and offer guidelines for avoiding that fate. Established firms often reject disruptive technologies. Why? Their most profitable, high-end customers want more sophisticated technologies. And, the new technologies’ projected profit margins won’t cover their big-company cost structures. While they’re ignoring the disruptive innovations, upstart companies step in to bring these cheaper, simpler, more convenient products to less-demanding markets. Over time, these products improve to meet the needs of high-end customers as well. By the time established firms recognize disruptive threats, their competitive opportunities have been lost. To Order For reprints, Harvard Business Review OnPoint orders, and subscriptions to Harvard Business Review: Call 800-988-0886 or 617-783-7500. Go to www.hbr.org To prevent disruptive technologies from slipping through their fingers, established corporations must identify and nurture innovations on a more modest scale—so small orders are meaningful, ill-defined markets have time to mature, and overhead is low enough to permit early profits. Transforming Life, Transforming Business: The Life-Science Revolution by Juan Enriquez and Ray A. Goldberg Harvard Business Review March–April 2000 Product no. R00203 Where will the next disruptive innovations in health care come from? Enriquez and Goldberg argue that genetic engineering will not only revolutionize the practice of medicine, benefiting individuals and societies everywhere—it will also reshape vast sectors of the world economy. Ultimately, it will subsume health care (and other industries such as agribusiness, chemicals, and pharmaceuticals) into what promises to become the largest industry in the world: life sciences. As genetic advances continue to accelerate, more and more businesses will be drawn— by choice or by necessity—into the lifescience industry. Firms must rethink their business, financial, and M&A strategies, as well as make vast R&D investments with distant and uncertain payoffs. The actions companies take now will go a long way toward determining the ultimate role they play in this emerging industry. For customized and quantity orders of reprints and Harvard Business Review OnPoint products: Call Frank Tamoshunas at 617-783-7626, or e-mail him at ftamoshunas@hbsp.harvard.edu page 13 www.hbr.org U.S. and Canada 800-988-0886 617-783-7500 617-783-7555 fax